[
    {
        "pmid": "40821154",
        "title": "Effects of Stevia on Inflammatory Markers, Renal and Hematological Parameters in Patients With Stage I-III Chronic Kidney Disease: A Randomized, Placebo-Controlled Clinical Trial in Bangladesh.",
        "abstract": "Background Global public health policy concerned increasing prevalence chronic kidney disease CKD associated comorbidities Stevioside confirmed food regulatory safety body safe effective treating diabetes hypertension Stevia also demonstrated nephroprotective effect experimental animals clinical trial aimed investigate kidneyprotective effect stevioside CKD Stage IIII patients explore impact inflammatory markers kidney function hematological parameter potential new treatment option Methods trial prospective singleblind placebocontrolled study 93 participant 83 CKD patient Stage IIII 10 healthy controls 83 CKD patient randomly assigned stevia 250 mg twice daily placebo in addition standard care 10 healthy individual served control group study conducted Kidney Foundation Hospital Research Institute Dhaka Bangladesh December 2016 December 2018 Patients scheduled followup visit every three month total nine months Data collected using systematic validated structured questionnaire Results baseline 442 CKD patient Stage III second followup proportion dropped 382 Stevia treatment significantly reduced systolic blood pressure p  0043 diastolic blood pressure p  0001 microalbuminuria p  0003 postprandial blood sugar p  0001 erythrocyte sedimentation rate p  0023 highsensitivity Creactive protein p  0007 level second followup washout period with stevia improved value trended back toward baseline stevia group indicating loss treatment effect upon withdrawal Conclusion ninemonth clinical investigation found oral stevia positively impact biochemical indicator CKD patients potentially mitigating progression disease Therefore stevias benefit might offer new intervention alleviate cardiovascular metabolic risk earlystage CKD patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821154/"
    },
    {
        "pmid": "40757253",
        "title": "Long COVID Syndrome, Mortality and Morbidity in Patients Hospitalized with COVID-19 From 16 Countries: The World Heart Federation Global COVID-19 Study.",
        "abstract": "Longterm adverse consequence COVID19 infection affect many organ systems requires comprehensive understanding disease burden determinant persistent long COVID19 symptom diverse population However data long COVID complication sparse particularly low middleincome country LMICs World Heart Federation WHF global study assessed incidence vascular complications persistent long COVID symptom factor associated mortality major adverse cardiovascular event MACE among patient COVID19 one year hospitalization recruited total 2535 patient hospitalized COVID19 followed oneyear posthospital discharge collected data long COVID symptoms quality life clinical outcomes including new onset diseases MACE mortality 1 3 6 912 month postdischarge Descriptive generalized estimating equation GEE regression analysis performed assess factor associated mortality MACE majority participant recruited LMICs 64 male 56 mean SD age 595 200 years Among tested COVID19 strain 52 Omicron strain prevalent 98 followup rate one year 90 half participant 56 reported experiencing least one major long COVID symptom fatigue breathlessness anxiety chest pain palpitations 1month onequarter participant reported persistent long COVID symptom 912 months EQ5D scale 49 reported difficulty usual activities 33 reported anxietydepression 23 reported problem mobility within first 6 months frequent newonset illness pulmonary embolism 8 kidney disease 4 hypertension 3 cumulative allcause mortality rate 15 n  382 oneyear postdischarge Long COVID symptom common among females individual preexisting comorbidities severe acute illness Age obesity ICU admission underlying cardiovascular pulmonary disease associated increased risk mortality MACE study showed substantial burden mortality morbidity quarter patient reported least one persistent long COVID symptom one year finding underscore need early identification management long COVID symptom LMICs",
        "mesh_terms": [
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Cardiovascular Diseases",
            "COVID-19",
            "Global Health",
            "Hospitalization",
            "Incidence",
            "Morbidity",
            "Post-Acute COVID-19 Syndrome",
            "Quality of Life",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757253/"
    },
    {
        "pmid": "40747186",
        "title": "Prevalence and Associated Factors of Prediabetes and Diabetes in Rural and Peri-Urban Bangladesh: A Community-Based Cross-Sectional Study.",
        "abstract": "Background objective global burden prediabetes diabetes rising rapidly particularly low middleincome country like Bangladesh lifestyle nutritional transition accelerating Economically disadvantaged rural population often lack awareness access care making highly vulnerable Measuring prevalence identifying associated factor essential guiding public health strategy resource allocation study aimed assess prevalence associated factor prediabetes diabetes rural periurban Bangladeshi community inform targeted prevention control strategies Methodology recruited 891 adult crosssectional study JanuaryJune 2020 random sampling Mirzapur Demographic Surveillance System Bangladesh ensuring least five year residency Trained Community Health Workers collected sociodemographic data using semistructured questionnaire performed physical examination anthropometric measurements used fasting blood sugar screen patient prediabetes diabetes measured serum creatinine urine albumin creatinine ratio diagnose chronic kidney disease CKD also collected blood sample measure serum albumin hemoglobin total cholesterol triglycerides Blood urine sample tested accredited laboratory Results Prevalence prediabetes 38 n343 diabetes 17 n151 Agespecific prevalence prediabetes 5 12 22 diabetes 1 3 13 age group 1830 3145 ≥46 years respectively Sexspecific prevalence prediabetes 22 17 diabetes 9 8 female male participants respectively multiple multinomial logistic regression prediabetes significant risk factor age ≥31 year adjusted odds ratio aOR 284 95CI 164492 protective factor smokeless tobacco use aOR 058 95CI 036094 hypoalbuminemia aOR 048 95CI 024099 diabetes significant risk factor age ≥31 year aOR 404 95CI 1371195 abdominal obesity aOR 280 95CI 149530 CKD aOR 280 95 CI 170462 hypercholesterolemia aOR 197 95CI 117330 hypertriglyceridemia aOR 233 95CI 144379 protective factor female aOR 021 95CI 0066068 smokeless tobacco user aOR 032 95CI 017063 Conclusion study reveals high burden prediabetes diabetes rural periurban Bangladeshi population finding underscore urgent need strengthen communitybased screening targeted prevention strategy address growing diabetes burden underserved areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747186/"
    },
    {
        "pmid": "40535386",
        "title": "Nonlinear Associations Between Kidney Function Markers and Body Mass Index Among Women of Reproductive Age in Bangladesh.",
        "abstract": "Background Normal kidney function essential maintaining good health objective study explore association sociodemographic characteristic body mass index BMI serum uric acid urea creatinine level among woman reproductive age WRA selected area Bangladesh Methodology crosssectional study conducted among 178 WRA selected district Bangladesh Data demographic socioeconomic anthropometric variable collected Blood sample collected processed stored analyzed using DIALAB GmbH semiautomatic biochemistry analyzer DTN405 Austria measure uric acid urea creatinine Results study found 42 woman 236 underweight 35 197 classified overweight obese average mean ± SD serum level mgdL 574 ± 207 uric acid 1793 ± 983 urea 089 ± 028 creatinine 9218 ± 3586 mLmin173 m² estimated glomerular filtration rate eGFR Elevated level creatinine uric acid urea observed 47 27 56 315 73 41 participants respectively Additionally chronic kidney disease CKD identified 32 individual 18 Overall normal kidney function marker found 55 participant about 31 9 participant about 5 showed elevated level three markers odds one elevated kidney function marker significantly higher adjusted odds ratio AOR  28 95 CI 122642 p  005 among individual BMI greater 185 kgm² compared underweight women adjusting related factors BMI found significantly associated risk elevated kidney function markers Conclusion onethird WRA displayed normal kidney function indicators BMI demonstrated significant nonlinear relationship one elevated kidney function indicators even within normal BMI range Therefore study larger sample size necessary gain deeper insights",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40535386/"
    },
    {
        "pmid": "40463970",
        "title": "In-hospital mortality among hospitalized COVID-19 patients in a tertiary care hospital in Dhaka City: a retrospective cohort study.",
        "abstract": "Inhospital mortality COVID19 treatment crucial metric used assess severity disease effectiveness medical interventions identifying mortality risk factors aim inform policy decisions optimize resource allocation improve preparedness future pandemics retrospective cohort study conducted tertiary hospital Dhaka City Bangladesh Data gathered hospitals electronic medical record July 2021 September 2021 applying specific inclusion exclusion criteria 218 patient complete medical record selected analysis independent variable examined included demographic characteristics comorbidities clinical features assess inhospital mortality relative risk RR 95 confidence interval calculated using multivariable logistic regression analysis employing Delta method study included 218 hospitalized COVID19 patients primarily male 514 average age 564 year standard deviation 15 years overall inhospital mortality rate 183 Older age ≥60 RR310 95 CI 116829 longstanding hypertension ≥5 years RR278 95 CI154502 chronic kidney disease CKD RR443 95 CI293670 significant risk factor mortality Patients diabetes ≥3 years moderately increased risk RR168 95 CI 101283 Notably shorter hospital stay ≤7 days associated higher mortality potentially due delayed treatment initiation Moreover Vaccinated patient significantly lower risk death RR 007 compared unvaccinated patients highlighting protective effect vaccination Greater lung involvement especially lower lobes higher Total Severity Scores TSS ≥ 14 strongly predict COVID19 mortality nonsurvivors exhibiting significantly worse radiographic damage Age particularly combined chronic condition like hypertension chronic kidney disease key predictor inhospital COVID19 mortality gender independent risk factor male tend higher mortality rates Delayed treatment reflected shorter hospital stays also increase risk Vaccination markedly lower mortality resourcelimited settings lower lobe involvement 50 TSS ≥ 14 serve early triage marker guide ICU admission intensified care indicator inform risk assessment tools resource allocation targeted intervention reduce pandemicrelated mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463970/"
    },
    {
        "pmid": "40406922",
        "title": "Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.",
        "abstract": "Nontraumatic subarachnoid hemorrhage SAH represents third common stroke type unique etiologies risk factors diagnostics treatments Nevertheless epidemiological study often cluster SAH stroke type leaving distinct burden estimate obscure estimate worldwide burden SAH Based repeated crosssectional Global Burden Disease GBD 2021 study global burden SAH 1990 2021 estimated Moreover SAH burden compared diseases association 14 individual risk factor investigated available data GBD 2021 study GBD study included burden estimate nontraumatic SAH among age 204 country territory 1990 2021 SAH 14 modifiable risk factors Absolute number agestandardized rate 95 uncertainty interval UIs SAH incidence prevalence mortality disabilityadjusted lifeyears DALYs well risk factorspecific population attributable fraction PAFs 2021 global agestandardized SAH incidence 83 95 UI 7395 prevalence 922 95 UI 8411006 mortality 42 95 UI 3748 DALY rate 1252 95 UI 11051426 per 100 000 people highest burden estimate found Latin America Caribbean Oceania highincome Asia Pacific Although absolute number SAH case increased especially region low sociodemographic index agestandardized burden rate decreased 1990 2021 incidence 288 95 UI 257316 prevalence 161 95 UI 148177 mortality 561 95 UI 407643 DALY rate 546 95 UI 428619 300 diseases SAH ranked 36th common cause death 59th common cause DALY world worldwide SAHrelated DALYs 716 95 UI 638786 associated 14 modeled risk factor high systolic blood pressure population attributable fraction PAF  516 95 UI 380626 smoking PAF  144 95 UI 124165 highest attribution Although global agestandardized burden rate SAH halved last 3 decades SAH remained one common cardiovascular neurological cause death disability world increasing absolute case numbers finding suggest evidence potential health benefit proactive public health planning resource allocation toward prevention SAH",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40406922/"
    },
    {
        "pmid": "40351257",
        "title": "Regional burden, trends, and future projections of chronic kidney disease due to type 2 diabetes mellitus in South Asia: insights from the global burden of disease study (1990-2021) and ARIMA forecasting.",
        "abstract": "Chronic kidney disease CKD due Type 2Diabetes Mellitus T2DM increasing health burden South Asia study evaluates burden trends future projection CKD 19902021 using Global Burden Disease GBD data ARIMA modeling analyzed agestandardized rate ASR prevalence incidence mortality DALYs CKD due T2DM South AsiaIndia Pakistan Bangladesh Bhutan Nepal Join point regression ARIMAmodels applied trend analysis projections 1990 2021 prevalence decreased slightly eg India 54 52 mortality increased egPakistan 337 421 per 100000 Incidence increased across countries Nepal 13 increase Bhutan 17 increase showing highest growth Projections indicate continued rise CKD burden especially inNepal India CKD due T2DM increasing emphasizing need targeted interventions",
        "mesh_terms": [
            "Humans",
            "Diabetes Mellitus, Type 2",
            "Renal Insufficiency, Chronic",
            "Global Burden of Disease",
            "Prevalence",
            "Incidence",
            "Forecasting",
            "Female",
            "Male",
            "Middle Aged",
            "Bangladesh",
            "Bhutan",
            "Asia",
            "India",
            "Adult",
            "Cost of Illness",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40351257/"
    },
    {
        "pmid": "40347843",
        "title": "Deep learning for early detection of chronic kidney disease stages in diabetes patients: A TabNet approach.",
        "abstract": "Chronic kidney disease CKD pose significant risk diabetes patients often leading severe complications Early accurate CKD stage detection crucial timely intervention However remains challenging due asymptomatic progression oversight routine CKD test diabetes checkups limited access nephrologists study aimed address challenge developing multiclass CKD stage prediction model diabetes patient using longitudinal data Chronic Renal Insufficiency Cohort CRIC study novel iterative backward feature selection strategy employed determine key predictor CKD stage TabNet attentionbased deep learning architecture used build classification model complete simplified categories complete model used 31 features including complex kidney biomarkers simplified model used 15 feature readily available routine checkups performance TabNet compared traditional treebased ensemble method XGBoost random forest AdaBoost multilayer perceptron Modelspecific modelagnostic explainable AI XAI technique applied interpret model decisions enhancing transparency clinical applicability proposed approach TabNet model demonstrated superior performance achieving 9406  9271  accuracy crossvalidation complete simplified models respectively 9100  8800  accuracy test sets XAI analysis identified serum creatinine cystatin C sex age influential factor CKD stage classification proposed TabNet model offer robust approach early CKD severity detection diabetes patients potentially improving clinical decisionmaking patient outcomes",
        "mesh_terms": [
            "Humans",
            "Deep Learning",
            "Renal Insufficiency, Chronic",
            "Early Diagnosis",
            "Female",
            "Male",
            "Middle Aged",
            "Aged",
            "Biomarkers",
            "Disease Progression"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40347843/"
    },
    {
        "pmid": "40343747",
        "title": "Telenursing Health Education and Lifestyle Modification Among Patients With Diabetes in Bangladesh: Protocol for a Pilot Study With a Quasi-experimental Pre- and Postintervention Design.",
        "abstract": "global burden chronic disease increasing becoming public health issue throughout world use telenursing increasing significantly COVID19 pandemic treat prevent chronic diseases Telenursing growing many country reduce health care costs increase number aging chronically ill populations increase health care coverage distant rural small sporadically populated regions Among many benefits telenursing may help solve increasing shortage nurses reduce distances save travel time keep patient hospital objective study apply selfmanagement telenursing program telenursing system developed researcher Bangladesh evaluate feasibility efficacy improved diabetes control participants pilot quasiexperimental pre postintervention study Diabetes patient attend Grameen Primary Health Centers PHCs Bangladesh enrolled September 2024 August 2025 include patient diagnosed type 2 diabetes sexes age 1875 year old type treatment willing participate give u consent exclude patient diagnosed gestational diabetes diabetes secondary cause complication chronic kidney disease CKD stage 5 Hemoglobin A1c HbAsub1csub less 7 past 1 year CKD stage 1 2 complication complication good control enough knowledge had education before implemented good practice regarding diabetes management assessed research nurses disabled person need persons support daily living sample size calculated found 70 Written informed consent obtained participants study protocol got approval National Research Ethics Committee Bangladesh Medical Research Council BMRCNREC20222025336 September 08 2024 outcome study evaluate effect telenursing intervention controlling HbAsub1csub project funded 2024 enrollment participant started October 26 2024 required sample n70 enrollment completed February 2025 Data analysis started completion data collection result expected submitted publication 2026 Diabetic patient acquire diseasespecific management skills Setting monitoring goal ensures continuation desired behavior give patient control lifestyle developing selfmanagement skills patient assess lab data lifestyle including diet understand condition work physiological data acquiring knowledge disease selfcare making selfsupported decisions patient able manage diet exercise medication ClinicalTrialsgov NCT06632652 httpsclinicaltrialsgovstudyNCT06632652 DERR110219671849",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Pilot Projects",
            "COVID-19",
            "Diabetes Mellitus, Type 2",
            "Female",
            "Male",
            "Adult",
            "Self-Management",
            "Telemedicine",
            "Middle Aged",
            "Health Education",
            "SARS-CoV-2",
            "Glycated Hemoglobin",
            "Patient Education as Topic",
            "Life Style",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40343747/"
    },
    {
        "pmid": "40335470",
        "title": "Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.",
        "abstract": "Chronic care manages longterm progressive conditions acute care address shortterm conditions Chronic condition increasingly strain health systems often unprepared demands study examines burden condition requiring acute versus chronic care including sequelae Conditions sequela Global Burden Diseases Study 2019 classified acute chronic care categories Data analysed age sex sociodemographic index presenting total number contribution burden metric DisabilityAdjusted Life Years DALYs Years Lived Disability YLD Years Life Lost YLL Approximately 68 DALYs attributed chronic care 27 due acute care Chronic care need increased age representing 86 YLDs 71 YLLs accounting 93 YLDs sequelae finding highlight chronic care need far exceed acute care need globally necessitating health system adapt accordingly",
        "mesh_terms": [
            "Humans",
            "Chronic Disease",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Middle Aged",
            "Aged",
            "Adult",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Aged, 80 and over",
            "Health Services Needs and Demand",
            "Adolescent",
            "Acute Disease",
            "Persons with Disabilities",
            "Child",
            "Child, Preschool",
            "Infant",
            "Cost of Illness"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40335470/"
    },
    {
        "pmid": "40255755",
        "title": "Comparative Cardiovascular and Renal Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Systematic Review.",
        "abstract": "systematic review evaluates cardiovascular renal outcome associated sodiumglucose cotransporter2 SGLT2 inhibitor glucagonlike peptide1 GLP1 receptor agonist patient type 2 diabetes focusing finding randomized controlled trials comprehensive search conducted across PubMed Embase Cochrane Library adhering Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines Seven highquality trial met inclusion criteria combined focus major adverse cardiovascular event MACE heart failure hospitalizations allcause cardiovascular mortality renal function decline SGLT2 inhibitor demonstrated superior efficacy reducing heart failure renal outcomes GLP1 receptor agonist effective preventing MACE improving glycemic control Combination therapy showed potential additive benefits particularly improving myocardial arterial function finding highlight complementary role drug classes underscoring importance personalized therapy based individual patient profiles research including longterm headtohead trials warranted validate result optimize treatment strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40255755/"
    },
    {
        "pmid": "40190944",
        "title": "Duodenal Amyloidosis Inducing Malabsorption in Hepatitis B-Related Liver Cirrhosis: A Rare Case Presentation.",
        "abstract": "Chronic hepatitis B virus HBV infection major cause liver cirrhosis worldwide hepatic complication welldocumented extrahepatic manifestation secondary amyloidosis less common lead diverse complex clinical outcomes Here present case 60yearold male history chronic hepatitis B progressed liver cirrhosis presented chronic unexplained intractable diarrhea unresponsive standard treatments also experienced significant unintentional weight loss generalized weakness investigation revealed amyloid deposition duodenum confirming secondary amyloidosis affecting gastrointestinal tract cause malabsorption Persistent diarrhea malabsorption necessitated nutritional support symptomatic management case highlight rare association chronic liver disease CLD secondary amyloidosis malabsorption syndrome emphasizing importance clinical suspicion timely diagnosis Early recognition prompt intervention crucial managing complex cases improving outcomes preventing complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40190944/"
    },
    {
        "pmid": "40169952",
        "title": "Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort.",
        "abstract": "global prevalence endstage kidney disease ESKD increasing despite optimal management traditional risk factor hyperglycaemia hypertension dyslipidaemia study examines influence cardiorenal risk factors socioeconomic status ethnic cardiovascular comorbidities ESKD outcome general population crosssectional study analysed data 502408 UK Biobank study participant recruited 2006 2010 Multivariable logistic regression model fitted assess risk factor ESKD result presented adjusted odds ratio aOR 95 confidence interval 95 CI total 1191 02 study participant reported ESKD Diabetes increased ESKD risk 62 162 136193 earlyonset diabetes before age 40 conferring higher odds compared lateronset after age 40 226 157324 Similarly earlyonset hypertension before age 40 compared later onset after age 40 increased ESKD odds 73 173 121244 Cardiovascular comorbidities including stroke hypertension myocardial infarction angina strongly associated ESKD 597 399872 535 438656 494 356678 489 347681 respectively Males 22 higher risk ESKD female 122 104143 additional year diabetes duration increased ESKD odds 2 102 101103 Nonwhite ethnicity compared white socioeconomically deprived compared least deprived quintiles 70 83 higher odds ESKD unit HbA1c rise increased odds ESKD 2 Compared microalbuminuria macroalbuminuria increased odds ESKD almost 10fold 947 7951127 normoalbuminuria reduced odds 73 027 022032 Early onset diabetes hypertension male sex nonwhite ethnicity deprivation poor glycaemic control prolonged hyperglycaemia significant risk factor ESKD finding highlight complexity ESKD need multifactorial targeted intervention highrisk populations applicable",
        "mesh_terms": [
            "Humans",
            "Kidney Failure, Chronic",
            "Male",
            "Female",
            "United Kingdom",
            "Middle Aged",
            "Risk Factors",
            "Cross-Sectional Studies",
            "Adult",
            "Aged",
            "Hypertension",
            "Cohort Studies",
            "Biological Specimen Banks",
            "Comorbidity",
            "Diabetes Mellitus",
            "Cardiovascular Diseases",
            "UK Biobank"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40169952/"
    },
    {
        "pmid": "40160047",
        "title": "Status of Lipid Profile among Patients with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD increasing threat healthcare system world Primary cause CKD diabetes vascular diseases So optimal management CKD includes cardiovascular risk reduction treatment albuminuria avoidance potential nephrotoxin adjustment drug dosing Patients also require monitoring complication CKD hypocalcemia hyperkalemia dyslipidemia metabolic acidosis hyperphosphatemia vitamin deficiency secondary hyperparathyroidism anaemia crosssectional study executed Department Biochemistry Mymensingh Medical College collaboration Department Nephrology Mymensingh Medical College Hospital Mymensingh Bangladesh July 2022 June 2023 subject selected based inclusion exclusion criterion purposive nonrandom sampling sum 120 subject included study them 60 selected case CKD patient another 60 apparently normal healthy person selected control study serum lipid profile measured analytical study value showed mean±SD serum TC 14985±3884 Group 17892±4185mgdl Group II Serum TG 12277±3688 Group 17593±6350mgdl Group II Serum LDLC 9513±2443 Group 11560±4562 mgdl Group II Serum HDLC 4862±870 4155±279mgdl Group Group II respectively Statistical analysis done using statistical package social science SPSS window package version 260 statistical significance difference case control evaluated using Students unpaired t test careful evaluation present study found mean serum total cholesterol TC Triglyceride TG Low density lipoprotein LDLC level significantly increased High density lipoprotein HDLC level significantly decreased CKD patients",
        "mesh_terms": [
            "Humans",
            "Renal Insufficiency, Chronic",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Lipids",
            "Bangladesh",
            "Triglycerides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160047/"
    },
    {
        "pmid": "40060060",
        "title": "Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anemia in Chronic Kidney Disease: Guidelines for South Asia.",
        "abstract": "guideline address use hypoxiainducible factor prolyl hydroxylase inhibitor HIFPHIs patient 18 year chronic kidney disease CKD anemia South Asia Bangladesh Bhutan Nepal India Pakistan Sri Lanka also summarizes recommendation anemia treatment individual HIFPHI molecule two categories dialysisdependent nondialysisdependent CKD patients recommendation apply pediatric ≤12 years adolescent 12 18 patient primary anemia anemia secondary cause blood loss cancer any type polycystic kidney disease infectious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40060060/"
    },
    {
        "pmid": "40049185",
        "title": "Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.",
        "abstract": "Despite well documented consequence obesity childhood adolescence future risk excess body mass noncommunicable disease adulthood coordinated global action excess body mass early life still insufficient Inconsistent measurement reporting barrier specific targets resource allocation interventions Article report current estimate overweight obesity across childhood adolescence progress time forecast inform specific actions Using established methodology Global Burden Diseases Injuries Risk Factors Study 2021 modelled overweight obesity across childhood adolescence 1990 2021 forecasted 2050 Primary data model included 1321 unique measured selfreported anthropometric data source 180 country territory survey microdata reports published literature data used estimate agestandardised global regional national overweight prevalence obesity prevalence separately child young adolescent aged 514 years typically school cared child health services older adolescent aged 1524 years increasingly school cared adult services sex 204 country territory 1990 2021 Prevalence estimate 1990 2021 generated using spatiotemporal Gaussian process regression models leveraged temporal spatial correlation epidemiological trend ensure comparability result across time geography Prevalence forecast 2022 2050 generated using generalised ensemble modelling approach assuming continuation current trends every agesexlocation population across time 19902050 estimated obesity vs overweight predominance using log ratio obesity percentage overweight percentage 1990 2021 combined prevalence overweight obesity child adolescent doubled obesity alone tripled 2021 93·1 million 95 uncertainty interval 89·696·6 individual aged 514 year 80·6 million 78·283·3 aged 1524 year obesity superregion level 2021 prevalence overweight obesity highest north Africa Middle East eg United Arab Emirates Kuwait greatest increase 1990 2021 seen southeast Asia east Asia Oceania eg Taiwan province China Maldives China 2021 female age groups many country Australasia eg Australia highincome North America eg Canada already transitioned obesity predominance male female number country north Africa Middle East eg United Arab Emirates Qatar Oceania eg Cook Islands American Samoa 2022 2050 global increase overweight not obesity prevalence forecasted stabilise yet increase absolute proportion global population obesity forecasted greater 1990 2021 substantial increase forecast 2022 2030 continue 2031 2050 2050 superregion obesity prevalence forecasted remain highest north Africa Middle East eg United Arab Emirates Kuwait forecasted increase obesity still expected largest across southeast Asia east Asia Oceania eg TimorLeste North Korea also south Asia eg Nepal Bangladesh Compared aged 1524 years superregions except Latin America Caribbean highincome superregion greater proportion aged 514 year forecasted obesity overweight 2050 Globally 15·6 12·717·2 aged 514 year forecasted obesity 2050 186 million 141221 compared 14·2 11·415·7 aged 1524 year 175 million 136203 forecasted 2050 young male aged 514 years living obesity 16·5 13·318·3 overweight 12·9 12·213·6 female aged 524 years older male aged 1524 years overweight remain prevalent obesity regional level following population forecast transitioned obesity vs overweight predominance 204150 child adolescent males female aged 524 years north Africa Middle East Tropical Latin America male aged 514 year east Asia central southern subSaharan Africa central Latin America female aged 514 year Australasia female aged 1524 year Australasia highincome North America southern subSaharan Africa male aged 1524 year highincome North America overweight obesity increased substantially every world region 1990 2021 suggesting current approach curbing increase overweight obesity failed generation child adolescents Beyond 2021 overweight childhood adolescence forecast stabilise due increase population obesity Increases obesity expected continue population world regions substantial change forecasted occur 2022 2030 immediate action needed address public health crisis Bill  Melinda Gates Foundation Australian National Health Medical Research Council",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Child",
            "Prevalence",
            "Female",
            "Male",
            "Forecasting",
            "Global Burden of Disease",
            "Pediatric Obesity",
            "Child, Preschool",
            "Young Adult",
            "Global Health",
            "Overweight",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40049185/"
    },
    {
        "pmid": "39979539",
        "title": "Global epidemiology of HIV among dialysis patients: a systematic review and meta-analysis.",
        "abstract": "HIV transmission infection among dialysis patient become major healthcare concern rising threat throughout world current systematic review metaanalysis targeted determine global epidemiologic state HIV infection among dialysis patients Three online databases Google Scholar PubMed ScienceDirect searched eligible study using specific keywords 15 study matched eligibility criterion included study worldwide pooled prevalence HIV among dialysis patient 08 95 CI 04 12 high degree heterogeneity 95 among included studies Substantial variation pooled prevalence found among different continent subgroup analysis Africa 211 95 CI 64 358 North America 193 95 CI 00 398 higher prevalence HIV dialysis patient whereas Europe 03 95 CI 00 06 South America 07 95 CI 00 16 Asia 07 95 CI 00 16 frequency much lower Perhaps due lack awareness preventive knowledge insufficient healthcare facility breach infection control protocol dialysis centers risky attitude practice immigration issue prevalence HIV among dialysis patient Africa North America enhanced compared Europe Asia South America Strict adherence HIV preventive practices raising public awareness advanced healthcare system suggested reduce prevalence HIV among dialysis patient world",
        "mesh_terms": [
            "Humans",
            "HIV Infections",
            "Renal Dialysis",
            "Global Health",
            "Prevalence",
            "Kidney Failure, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39979539/"
    },
    {
        "pmid": "39959269",
        "title": "Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis.",
        "abstract": "Type 2 diabetes T2D well obesity risk factor chronic kidney disease CKD endstage renal disease renal impact glucoselowering weightlowering drug potential benefit preventing CKD often guide clinician choosing appropriately limited data based randomized controlled trial RCTs currently available renal effect safety profile tirzepatide explore renal benefit safety tirzepatide ivsi controls RCTs involving patient receiving tirzepatide indication intervention arm placebo active comparator control arm searched multiple electronic databases coprimary outcome percent change baseline CFB urine albumintocreatinine ratio UACR absolute CFB estimated glomerular filtration rate eGFR mLmin173 msup2sup secondary outcome tirzepatides renal safety profile RevMan web used conduct metaanalysis using randomeffects models Outcomes presented mean difference MD risk ratio 95 confidence intervals Fifteen RCTs ini  14471 mostly low risk bias RoB included 2672 weeks tirzepatide 10 mg MD 2695 4013 1376 iPi  00001 15 mg MD 1803 2858 747 iPi  00008 superior placebo percent reduction UACR Tirzepatide doses outperformed insulin percent reduction UACR Compared placebo percent UACR reduction greater subject T2D obesity without T2D MD 3325 ivsi 793 iPi  0001 CFB eGFR dos tirzepatide comparable 5 mg MD 036 141 214 10 mg MD 117 022 256 15 mg MD 142 004 288 iPi  005 all ivsi insulin Tirzepatide pooled separate doses increase risk adverse renal events urinary tract infection nephrolithiasis acute kidney injury renal cancer compared placebo insulin glucagonlike peptide1 receptor agonists Shortterm data RCTs low RoB suggests tirzepatide positively impact UACR without detrimental effect eGFR subject T2D obesity without T2D reassuring renal safety profile Larger RCTs warranted prove longerterm renal benefit tirzepatide might also prevent eGFR decline worsening CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39959269/"
    },
    {
        "pmid": "39944160",
        "title": "Multisystemic impact of autosomal dominant polycystic kidney disease: A case report highlighting renal, hepatic, and neurological involvement.",
        "abstract": "present case 64yearold male Autosomal Dominant Polycystic Kidney Disease ADPKD characterized systemic involvement including renal hepatic neurological complications patient presented persistent micturition difficulties hematuria abdominal pain compounded hypertension chronic obstructive pulmonary disease Imaging revealed bilateral renal enlargement hemorrhagic cysts kidney stone hepatic cyst causing hepatomegaly Neurological evaluation identified chronic recent intracerebral hemorrhage associated poorly controlled hypertension underscoring ADPKDs multisystem impact ADPKD caused PKD1 PKD2 mutations often lead progressive renal dysfunction hypertension extrarenal manifestation hepatic cyst intracranial aneurysms Advances like tolvaptan demonstrate efficacy slowing renal disease progression somatostatin analog offer promise hepatic cyst management case emphasizes necessity multidisciplinary approach including strict blood pressure control regular imaging pharmacological intervention address ADPKDs complexity optimize patient outcomes Early diagnosis vigilant monitoring remain crucial preventing complication enhancing quality life report underscore importance integrated care managing ADPKD highlighting emerging therapy ongoing need personalized treatment strategy challenging cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39944160/"
    },
    {
        "pmid": "39919056",
        "title": "Health-related quality of life and its predictors among chronic kidney disease patients: A hospital-based cross-sectional study.",
        "abstract": "Chronic kidney disease CKD significant impact healthrelated quality life HRQoL affected individual due progressive disabling nature aim study evaluate HRQoL predictor among CKD patients crosssectional study carried kidney foundation Hospital research Institute Dhaka Bangladesh Kidney Disease Quality Life KDQoL™ 36 questionnaire used measure HRQoL CKD patients study also used kidneytargeted KDQoL36 Summary Score KSS Sociodemographic medical record also collected Descriptive statistics multiple linear regression performed 430 patients 779 moderate advanced stage CKD Patients aged occupation income comorbidities diabetes hypertension medication used serum hemoglobin found significantly p 005 associated different stage CKD mean domain score physical component summary PCS mental component summary MCS burden kidney disease BKD effect kidney disease EKD symptom problem kidney disease SPKD subscales 3719 4594 3149 6395 7335 respectively KSS 6324 stage CKD documented important predictor HRQoL subscales KDQoL36 well KSS older age group also showed clear link lower HRQoL subscales KDQoL36 except SPKD multiple linear regression analysis stage CKD patient age employment status use medication found significant predictor KSS Further higher level education married absence diabetes heart disease independent predictor higher MCS Whereas retirement low duration CKD use three drug strongly linked worse score PCS addressing determinant poor HRQoL healthcare provider tailor treatment plan better meet need individual ultimately enhance overall wellbeing",
        "mesh_terms": [
            "Humans",
            "Quality of Life",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Renal Insufficiency, Chronic",
            "Adult",
            "Surveys and Questionnaires",
            "Aged",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39919056/"
    },
    {
        "pmid": "39890773",
        "title": "Human proximal tubular epithelial cell interleukin-1 receptor signalling triggers G2/M arrest and cellular senescence during hypoxic kidney injury.",
        "abstract": "Hypoxia interleukin IL1β independent mediator tubulointerstitial fibrosis histological hallmark chronic kidney disease CKD Here examine hypoxia IL1β act synergy augment maladaptive proximal tubular epithelial cell PTEC repair human CKD Ex vivo patientderived PTECs cultured normoxic 21 Osub2sub hypoxic 1 Osub2sub condition absence presence IL1β examined maladaptive repair signatures Hypoxic PTECs incubated IL1β displayed discrete transcriptomic profile distinct PTECs cultured hypoxia alone IL1β alone normoxia HypoxiaIL1βtreated PTECs 692 unique differentially expressed gene DEGs compared normoxic PTECs cell cycle significantly enriched KEGG pathway based unique downregulated DEGs including CCNA2 CCNB1 CCNB2 HypoxiaIL1βtreated PTECs displayed signature cellular senescence reduced proliferation G2M cell cycle arrest increased p21 expression elevated senescenceassociated βgalactosidase SAβgal activity increased production proinflammatoryfibrotic senescenceassociated secretory phenotype SASP factor compared normoxic conditions Treatment HypoxiaIL1βtreated PTECs either type IL1 receptor IL1RI neutralizing antibody senolytic drug combination quercetindasatinib attenuated senescent cell burden vitro finding validated human CKD biospecimens kidney tissue urine elevated PTEC IL1RI expression senescence SAβgal activity detected fibrotic kidney number senescent SAβgalsupsup urinary PTECs correlating urinary IL1β level severity interstitial fibrosis data identify mechanism whereby hypoxia combination IL1βIL1RI signalling trigger PTEC senescence providing novel therapeutic diagnostic checkpoints restoring tubular regeneration human CKD",
        "mesh_terms": [
            "Humans",
            "Cellular Senescence",
            "Kidney Tubules, Proximal",
            "Epithelial Cells",
            "G2 Phase Cell Cycle Checkpoints",
            "Signal Transduction",
            "Interleukin-1beta",
            "Cell Hypoxia",
            "Receptors, Interleukin-1",
            "Renal Insufficiency, Chronic",
            "Cell Proliferation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39890773/"
    },
    {
        "pmid": "39886537",
        "title": "Evaluation of Xanthine Oxidase Inhibitors Febuxostat and Allopurinol on Kidney Dysfunction and Histological Damage in Two-Kidney, One-Clip (2K1C) Rats.",
        "abstract": "chronic kidney disease CKD hyperuricemia common phenomenon presumably due reduced renal clearance uric acid study investigated effect xanthine oxidase XO inhibitor allopurinol febuxostat prevent oxidative stress kidney twokidney oneclip 2K1C rats investigation 2K1C rat used experimental animal model kidney dysfunction 2K1C rat provided food drinking water received febuxostat dose 10 mgkg allopurinol 100 mgkg respectively treatment completion rat sacrificed tissue sample collected 2K1C rat exhibited increased plasma creatinine uric acid level glomerular injury assessed based microscopic findings allopurinol febuxostat significantly normalized creatinine uric acid levels Furthermore 2K1C rat showed increased lipid peroxidation LPO nitric oxide NO advanced oxidation protein product AOPP alongside decreased superoxide dismutase SOD catalase activity Again drug treatment ameliorated elevated oxidative stress parameter 2K1C rats antioxidant gene Nrf2 HO1 SOD also restored kidney 2K1C rat allopurinol febuxostat treatment 2K1C rat also showed increased IL1β IL6 TNFα NFкB mRNA expression kidney normalized allopurinol febuxostat treatment Thus data suggest XO inhibition protects kidney function potentially restoring antioxidant enzyme function suppressing inflammation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39886537/"
    },
    {
        "pmid": "39825369",
        "title": "Palliative care needs and quality of life among adults with advanced chronic illnesses in low-income communities of Bangladesh.",
        "abstract": "Palliative care PC interdisciplinary approach aimed improving physical psychological spiritual wellbeing patient family affected lifethreatening diseases study aimed investigate need PC among critically ill patient quality life QOL lowincome group Bangladesh crosssectional study conducted four healthcare facility March April 2023 involving 553 registered patient advanced chronic conditions applying inclusion exclusion criteria 183 patient advanced stage illness included collected data sociodemographic comorbidities disabilities 10item African Palliative Outcome Scale APOS Supportive Palliative Care Indicators Tool SPICT used identify individual requiring PC study investigated patient Eastern Cooperative Oncology Group ECOG performance status 34 indicating significant functional impairment explored QOL across four domains physical health psychological health social relationships environmental factors mean age 183 patient 538 ± 1453 years 695 female found 103 patient chronic illness required PC particularly cancer patient 87 chronic kidney disease CKD 533 APOS score indicated family anxiety 486 burdensome issue followed severe pain 155 severe worry illness 224 feeling life unworthy 94 Patients severe functional limitation ECOG 34 significantly likely need PC 58 compared moderate limitation ECOG 02 24 Among requiring PC 701 rated QOL poor verypoor 238 patient needing PC reported similar ratings Female patient poorer QOL male across domains facing financial hardship also experienced significantly lower QOL Bangladeshs lowincome communities significant proportion patient chronic illness require palliative care PC due advanced conditions finding emphasize importance integrating PC early treatment process cancer CKD patients greatly improve QOL provide essential support patient families result advocate holistic approach PC address physical psychological social environmental factor affecting patients QOL",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Bangladesh",
            "Quality of Life",
            "Palliative Care",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Chronic Disease",
            "Adult",
            "Poverty",
            "Aged",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39825369/"
    },
    {
        "pmid": "39821533",
        "title": "Approach to Endocrine Hypertension: A Case-Based Discussion.",
        "abstract": "Hypertension remains major chronic disease morbidity across world even twentyfirst century affecting ≈40 global population adversely impacting healthcare budget managing high incidence cardiovascular disease CVD complication mortality elevated blood pressure BP However evaluation management endocrine hypertension optimal clinical practice three unique clinical case scenarios update evidence base diagnostic evaluation management endocrine hypertension review inform appropriate daytoday clinical practice decisions Although individual high BP suffer essential hypertension ≈85 patient may clear underlying etiology termed secondary hypertension significant proportion patient endocrine hypertension ≈10 consequent hormone excess dysfunction one endocrine glands Even relatively common disease general population correct diagnosis appropriate treatment endocrine hypertension often delayed poor awareness among clinicians including primary care provider physician secondary care settings accurate timely diagnosis endocrine hypertension crucial potentially cure least properly manage patient consequence delay diagnosis catastrophic markedly higher endorgan complication CVD chronic kidney disease even premature mortality among sufferers",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Endocrine System Diseases",
            "Male",
            "Female",
            "Middle Aged",
            "Antihypertensive Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39821533/"
    },
    {
        "pmid": "39802844",
        "title": "Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications.",
        "abstract": "strong association type 2 diabetes mellitus T2DM fatty liver well known nomenclature even recently changed metabolic dysfunctionassociated steatotic liver disease MASLD Healthy MASLD patient frequently overlooked maltreated especially Bangladesh present study tried correlate T2DM burden apparently healthy incidentally diagnosed fatty liver patient ultrasound crosssectional study done Sheikh Hasina Medical College Hospital Tangail Bangladesh August 2022 February 2023 total 92 patient ultrasonological evidence grade II fatty change liver included evaluated Known T2DM hypothyroidism consumption alcohol HBV HCV infection Wilsons disease autoimmune liver disease hemochromatosis chronic liver kidney disease patient excluded patient assessed presence absence T2DM using OGTT 2 hour 75 gm glucose ≥ 111 mmolL andor HbA1c ≥65 diagnostic criteria Data analyzed SPSS version 23 92 patients 48 male 44 female total 50 patient 543 newly diagnosed T2DM Statistically significant difference seen T2DM group nonDM group AST 5033 IU v 3653 IU TG 270 mgdL v 189 mgdL Although noteworthy difference evident mean age 41 year v 38 years ALT 589 IU v 6023 IU BMI 2885 v 2929 present study 54 patient grade II fatty liver newly diagnosed T2DM would later present advanced T2DM related complications Although larger study needed physician healthcare worker Bangladesh concerned treating MASLD patient early diagnosis T2DM recommending prompt lifestyle interventions prescribing drug necessary Gani ABMS Mahmood AA Alam AFMS iet ali Higher Incidence Diabetes Asymptomatic Healthy Fatty Liver Patients Bangladesh Prompt Intervention Avert Complications Euroasian J HepatoGastroenterol 2024142172175",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39802844/"
    },
    {
        "pmid": "39760054",
        "title": "Factors affecting poor prognosis of COVID-19 in people living with human immunodeficiency virus: A systematic review and meta-analysis of co-infection.",
        "abstract": "study aim assess correlation clinical feature mortality human immunodeficiency virus HIVinfected individual COVID19 systematic literature search conducted cohort crosssectional case series reported coinfection HIV COVID19 published January September 2020 Clinical feature age comorbidities CD4supsupT lymphocyte counts HIV RNA levels antiretroviral regimen evaluated using metaanalyses systematic reviews Metaanalysis performed using Stata 150 software total 24 article 939 case HIVCOVID19 coinfection included study overall mortality rate 103 97939 Older age comorbidities including hypertension diabetes renal insufficiency chronic obstructive pulmonary diseaseasthma tumor significantly associated increased mortality 95 confidence interval 00050050 00422294 03902754 05132848 03483743 19437101 respectively iPi  0021 0043 0012 0008 0022 0005 significant correlation mortality CD4supsupT lymphocyte count 200μL 500μL HIV RNA level detection limit antiretroviral drug including tenofovir all iPi  005 Improved HIV treatment complex immune interactions study population variability lack direct SARSCoV2 targeting ART likely obscure correlation CD4supsup count ART COVID19 mortality HIV patients HIVinfected individual COVID19 similar prognosis general population However older age comorbidities hypertension diabetesetc lower CD4supsup Tcell count associated increased mortality Mainstream antiHIV drug offer significant protection COVID19",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39760054/"
    },
    {
        "pmid": "39739469",
        "title": "Status of Serum Magnesium among Patients with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD one largest public health issue major cause death worldwide Due increase incidence systemic disease like diabetes hypertension two main cause CKD kidney damage prevalence CKD rising globally Chronic Kidney Disease result mineral disorder well profound lipid disorder due improper balancing mineral  hormone level body crosssectional study completed Department Biochemistry Mymensingh Medical College collaboration Department Nephrology Mymensingh Medical College Hospital period July 2022 June 2023 subject selected based inclusion exclusion criterion purposive nonrandom sampling Total 120 subject included study them 60 selected chronic kidney disease patient Group II another 60 apparently normal healthy person selected control Group I study serum magnesium level measured analytical study value demonstrated mean±SD value serum magnesium Group 199±050 mgdl Group II 224±019 mgdl Statistical analysis performed using statistical package social science SPSS version 260 statistical significance difference case control evaluated using Students unpaired ttest p0001 careful evaluation study found mean serum magnesium level significantly increased CKD patients",
        "mesh_terms": [
            "Humans",
            "Magnesium",
            "Renal Insufficiency, Chronic",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Case-Control Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39739469/"
    },
    {
        "pmid": "39739466",
        "title": "Evaluation of Socio-Demographic Profile, Biochemical Parameters and Etiology of End Stage Renal Disease Patients in a Tertiary Care Hospital of Bangladesh.",
        "abstract": "Globally incidence prevalence chronic kidney disease CKD increasing day day Various biochemical hematological abnormality associated CKD lead morbidity mortality aim observational study evaluate sociodemographic profile biochemical hematological parameter chronic kidney disease patient Mymensingh Medical College Hospital Mymensingh Bangladesh January 2020 December 2020 study also showed variation biochemical parameter lower calcium hemoglobin level due improper renal function total 179 End Stage Renal Disease ESRD patient enrolled study Male female ratio 20861 study male patient female Mean±SD age patient 4614±1425 year maximum CKD patient belonged age group 4160 years study depicted Glomerulonephritis leading cause CKD Second common cause Diabetes mellitus portion CKD unknown etiology CKDu found 1731 Routine biochemical parameter also seen study study showed majority patient living level poverty came rural area study aimed evaluate derangement serum biochemical parameter association risk factor CKD demographic character biochemical profile etiology association CKD progression So early evaluation parameter may reduce incidence CKD",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Bangladesh",
            "Middle Aged",
            "Adult",
            "Kidney Failure, Chronic",
            "Tertiary Care Centers",
            "Risk Factors",
            "Aged",
            "Renal Insufficiency, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39739466/"
    },
    {
        "pmid": "39703447",
        "title": "Mortality Rate and Its Contributing Factors in Post-Surgical and Medical Patients with AKI Underwent CRRT.",
        "abstract": "Acute kidney injury AKI requires continuous renal replacement therapy CRRT one important problem medical surgical patients Therefore important identify influencing factor reduce dimension problem study conducted investigate mortality rate medical surgical patient AKI requiring CRRT treatment observational study conducted cross sectional analytical study 100 patient AKI requiring CRRT treatment including medical surgical patients selected 2018 2021 Masih Daneshvari Hospital mortality rate estimated Also effective factor investigated compared dead surviving patients 85 case 85 patient died underlying demographic variable statistically significant difference dead surviving patient P005 However case primary calcium P0001 primary leukocyte P0037 bicarbonate hospitalization P0025 bicarbonate AKI P0028 magnesium hospitalization P0038 magnesium end CRRT P0019 difference statistically significant conclusion mortality observed 5 6 patient acute kidney failure need CRRT treatment related risk factor bicarbonate magnesium leukocyte calcium levels Therefore multifaceted planning needed reduce dimension improve prognosis group patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39703447/"
    },
    {
        "pmid": "39636884",
        "title": "Regional hotspots for chronic kidney disease: A multinational study from the ISN-GKHA.",
        "abstract": "Chronic kidney disease CKD disproportionately affect certain population demonstrated wellestablished subnational geographic hotspot CKD Central America South Asia Using data third iteration International Society Nephrology Global Kidney Health Atlas ISNGKHA aimed systematically identify subnational geographic population cluster high prevalence CKD ISNGKHA survey conducted July September 2022 included question regarding whether regional CKD hotspot existed respondents country possible contributors CKD hotspot defined population cluster high risk kidney failure requiring dialysis transplant people dying kidney failure Overall 46 162 responding country reported subnational hotspot CKD within country Hotspots reported across regions except Middle East Latin America highest percentage 12 21 57 country reporting regional CKD hotspot followed region North East Asia Western Europe Adults aged 18 44 year rural population commonly identified primary group affected Clinical factor commonly identified contributor CKD hypertension 74 diabetes 72 followed cultural eg diet herbal medication 67 environmental eg polluted water 43 factors Latin American country commonly reported climate cultural environmental factor contributor compared regions Across world number subnational region incountry expert identify disproportionately higher burden CKD commonly occurring among younger age group clinical cultural environmental contributor specific geographic regions Indepth studies starting systematic epidemiology efforts needed investigate aetiopathogenesis CKD hotspot around world tailored intervention offered",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39636884/"
    },
    {
        "pmid": "39566993",
        "title": "Ophthalmological changes in children with advanced stage of chronic kidney disease: a hospital-based study.",
        "abstract": "Ocular disorder arise advanced stage chronic kidney disease CKD various reasons including uraemia biochemical abnormalities hypertension inadequate haemodialysis treatment conducted crosssectional study Pediatric Nephrology Department inpatient outpatient January 2020 July 2021 study aimed identify compare ophthalmological change among child different stage CKD assess potential visual threats total 92 child advancedstage CKD aged 518 years meeting inclusion exclusion criteria included study Comprehensive assessments including medical history physical examinations relevant test detailed ophthalmological examinations conducted mean age participant 121±368 years child boy 66 Twentynine patient exhibited impaired visual acuity child 660624 score Snellens chart Lid oedema conjunctival pallor observed 207 609 cases respectively found statistically significant advancing CKD stage p0001 Dry eye found 98 CKD stage V patient receiving dialysis VD p0003 One patient posterior subcapsular cataract 76 conjunctival congestion Patients conjunctival congestion hypertensive retinopathy significantly higher level serum phosphate calcium phosphate product p0001 Hypertensive retinopathy present 163 cases significantly higher proportion haemodialysis group 93 Haemodialysis patient exhibited higher blood pressure lower haemoglobin levels severe reduction estimated glomerular filtration rate p0001 study highlight significant ocular complication associated CKD underscoring need regular ophthalmological screenings",
        "mesh_terms": [
            "Cross-Sectional Studies",
            "Humans",
            "Male",
            "Child",
            "Adolescent",
            "Eye Diseases",
            "Renal Dialysis",
            "Renal Insufficiency, Chronic",
            "Child, Preschool",
            "Visual Acuity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39566993/"
    },
    {
        "pmid": "39432502",
        "title": "Genetic insights into the connection between pulmonary TB and non-communicable diseases: An integrated analysis of shared genes and potential treatment targets.",
        "abstract": "Pulmonary Tuberculosis PTB significant global health issue due high incidence drug resistance contagious nature impact people compromised immune systems mentioned World Health Organization WHO TB responsible global fatality infectious illness side also claim noncommunicable disease NCDs kill 41 million people yearly worldwide regard several study suggest PTB NCDs linked various way people PTB likely acquire NCDs time NCDs increase susceptibility active TB infection Furthermore potential drug interaction therapeutic challenges treating individual PTB NCDs difficult study focus seven NCDs lung cancer LC diabetes mellitus DM Parkinsons disease PD silicosis SI chronic kidney disease CKD cardiovascular disease CVD rheumatoid arthritis RA rigorously present genetic relationship PTB regarding shared gene outline possible treatment plans BlueThis study aim identify drug component regulate abnormal gene expression NCDs study reveal hub genes potential biomarkers drug component associated hub gene statistical measures contribute targeted therapeutic interventions Numerous investigations including proteinprotein interaction PPI gene regulatory network GRN enrichment analysis physical interaction proteinchemical interaction carried demonstrate genetic correlation PTB NCDs study nine shared gene TNF IL10 NLRP3 IL18 IFNG HMGB1 CXCL8 IL17A NFKB1 discovered TB abovementioned NCDs five hub gene NFKB1 TNF CXCL8 NLRP3 IL10 selected based degree values study found hub gene linked 10 drug components observed aspirin CTD 00005447 mostly associated hub genes bioinformatics study may help researcher better understand cause PTB relationship NCDs eventually lead exploring effective treatment plans",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Pulmonary",
            "Noncommunicable Diseases",
            "Gene Regulatory Networks",
            "Lung Neoplasms",
            "Silicosis",
            "Protein Interaction Maps",
            "Renal Insufficiency, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39432502/"
    },
    {
        "pmid": "39366729",
        "title": "Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Smoking leading behavioural risk factor mortality globally accounting 175 million death nearly 4·30 billion year life lost YLLs 1990 2021 pace decline smoking prevalence slowed recent year many countries although strategy recently proposed achieve tobaccofree generations none implemented date Assessing could happen current trend smoking prevalence persist could happen additional smoking prevalence reduction occur important communicating effect potential smoking policies analysis use Institute Health Metrics Evaluations Future Health Scenarios platform forecast effect three smoking prevalence scenario allcause causespecific YLLs life expectancy birth 2050 YLLs computed scenario using Global Burden Disease Study 2021 reference life table forecast causespecific mortality scenario reference scenario forecast could occur past smoking prevalence risk factor trend continue Tobacco Smoking Elimination 2023 Elimination2023 scenario quantifies maximum potential future health benefit assuming zero percent smoking prevalence 2023 onwards whereas Tobacco Smoking Elimination 2050 Elimination2050 scenario provides estimate country considering policy steadily reduce smoking prevalence 5 Together scenario underscore magnitude health benefit could reached 2050 country take decisive action eliminate smoking 95 uncertainty interval UI estimate based 2·5th 97·5th percentile draw carried multistage computational framework Global agestandardised smoking prevalence estimated 28·5 95 UI 27·929·1 among male 5·96 5·766·21 among female 2022 reference scenario smoking prevalence declined 25·9 25·226·6 among males 30·0 26·132·1 among female 2022 2050 scenario forecast cumulative 29·3 billion 95 UI 26·832·4 overall YLLs among male 22·2 billion 20·124·6 YLLs among female period Life expectancy birth scenario would increase 73·6 year 95 UI 72·874·4 2022 78·3 year 75·980·3 2050 Elimination2023 scenario forecast 2·04 billion 95 UI 1·902·21 fewer cumulative YLLs 2050 compared reference scenario life expectancy birth would increase 77·6 year 95 UI 75·179·6 among male 81·0 year 78·583·1 among females Elimination2050 scenario forecast 735 million 675808 141 million 131154 cumulative YLLs would avoided among male females respectively Life expectancy 2050 would increase 77·1 year 95 UI 74·679·0 among male 80·8 year 78·382·9 among females Existing tobacco policy must maintained smoking prevalence continue decline forecast reference scenario addition substantial smokingattributable burden avoided accelerating pace smoking elimination Implementation new tobacco control policy crucial avoiding additional smokingattributable burden coming decade ensure gain past three decade lost Bloomberg Philanthropies Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Life Expectancy",
            "Forecasting",
            "Smoking",
            "Prevalence",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Adult",
            "Middle Aged",
            "Global Health",
            "Aged",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39366729/"
    },
    {
        "pmid": "39351736",
        "title": "Proportion of Peripheral Arterial Disease in Patients with Chronic Kidney Disease.",
        "abstract": "Among different complication chronic kidney diseases peripheral arterial disease uncommon Though indicator widespread atherosclerosis sometimes neglected CKD patients study done evaluate frequency pattern PAD chronic kidney disease patient admitted tertiary care hospital Bangladesh One hundred 100 admitted patient CKD taken nonrandom purposive sampling considering inclusion exclusion criteria clinical evaluation Ankle brachial index ABI measurement 5 cc venous blood collected sent Clinical Pathology Biochemistry department CMCH Data collected structured proforma analyzed Among 100 patients 20 patient belonged stage 3 280 stage 4 remaining 700 stage 5 found proportion PAD CKD 180 Among 18 PAD patients 6667 stage 5 2222 stage 4 1111 stage 3 Regarding right lower limb 12 patient PAD 3 patient moderate PAD 2 patient borderline 1 patient calcified PAD left lower limb 10 patient PAD 4 patient moderate PAD 4 patient borderline PAD mean AB PAD patient right limb 087 left limb 084 500550 patient asymptomatic Among PAD patient 389 DM 722 HTN 333 DM HTN 444 vascular events 556 smokers 333 dyslipidemia 222 family history PAD Renal disease seem strong association vascular disease PAD uncommon",
        "mesh_terms": [
            "Humans",
            "Peripheral Arterial Disease",
            "Female",
            "Male",
            "Renal Insufficiency, Chronic",
            "Middle Aged",
            "Bangladesh",
            "Ankle Brachial Index",
            "Adult",
            "Aged",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39351736/"
    },
    {
        "pmid": "39341789",
        "title": "Mechanisms that potentially contribute to the development of post-streptococcal glomerulonephritis.",
        "abstract": "Poststreptococcal glomerulonephritis PSGN primarily associated preceding group streptococcal skin throat infections mainly observed economically disadvantaged communities condition significantly predisposes individual laterlife chronic kidney disease concurrent renal complications elderly experiencing increased severity less favourable outcomes Streptococcal pyrogenic exotoxin B nephritisassociated plasmin receptor identified nephritogenic antigen nephritogens Pathogenesis PSGN multifactorial involve formation antigenantibody immune complexes causing inflammatory damage renal glomeruli Deposition circulating immune complex situ formation immune complex glomeruli both result glomerulonephritis Additionally molecular mimicry hypothesized mechanism wherein crossreactivity antistreptococcal antibody glomerular intrinsic matrix protein lead glomerulonephritis Besides observed clinical studies streptococcal inhibitor complement streptococcalsecreted protein also associated PSGN However interplay streptococcal antigen pathogenesis PSGN necessitates investigation Despite clinical significance PSGN lack credible animal model pose challenge understanding association streptococcal antigen disease process review outline postulated mechanism implicated development PSGN possible therapeutic approaches",
        "mesh_terms": [
            "Humans",
            "Glomerulonephritis",
            "Streptococcal Infections",
            "Streptococcus pyogenes",
            "Antigens, Bacterial",
            "Animals",
            "Antigen-Antibody Complex",
            "Molecular Mimicry",
            "Kidney Glomerulus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39341789/"
    },
    {
        "pmid": "39304265",
        "title": "Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Uptodate estimate stroke burden attributable risk trend global regional national level essential evidencebased health care prevention resource allocation planning aimed provide estimate period 19902021 estimated incidence prevalence death disabilityadjusted lifeyear DALY count agestandardised rate per 100 000 people per year overall stroke ischaemic stroke intracerebral haemorrhage subarachnoid haemorrhage 204 country territory 1990 2021 also calculated burden stroke attributable 23 risk factor six risk cluster air pollution tobacco smoking behavioural dietary environmental metabolic risks global regional level 21 GBD region Sociodemographic Index SDI quintiles using standard GBD methodology 95 uncertainty interval UIs individual future estimate derived 2·5th 97·5th percentile distribution generated propagating 500 draw multistage computational pipeline 2021 stroke third common GBD level 3 cause death 7·3 million 95 UI 6·67·8 deaths 10·7 9·811·3 deaths ischaemic heart disease COVID19 fourth common cause DALYs 160·5 million 147·8171·6 DALYs 5·6 5·06·1 DALYs 2021 93·8 million 89·099·3 prevalent 11·9 million 10·713·2 incident strokes found disparity stroke burden risk factor GBD region country territory SDI well stagnation reduction incidence 2015 onwards even increase stroke incidence death prevalence DALY rate southeast Asia east Asia Oceania country lower SDI people younger 70 years Globally ischaemic stroke constituted 65·3 62·467·7 intracerebral haemorrhage constituted 28·8 28·328·8 subarachnoid haemorrhage constituted 5·8 5·76·0 incident strokes substantial increase DALYs attributable high BMI 88·2 53·4117·7 high ambient temperature 72·4 51·1 179·5 high fasting plasma glucose 32·1 26·738·1 diet high sugarsweetened beverage 23·4 12·735·7 low physical activity 11·3 1·834·9 high systolic blood pressure 6·7 2·511·6 lead exposure 6·5 4·511·2 diet low omega6 polyunsaturated fatty acid 5·3 0·510·5 Stroke burden increased 1990 2021 contribution several risk factor also increased Effective accessible affordable measure improve stroke surveillance prevention with emphasis blood pressure lifestyle environmental factors acute care rehabilitation need urgently implemented across country reduce stroke burden Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Global Burden of Disease",
            "Risk Factors",
            "Stroke",
            "Global Health",
            "Disability-Adjusted Life Years",
            "Incidence",
            "Prevalence",
            "Quality-Adjusted Life Years",
            "Male",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39304265/"
    },
    {
        "pmid": "39042940",
        "title": "Perceived barriers to peritoneal dialysis utilization amongst South Asian nephrologists.",
        "abstract": "Peritoneal dialysis PD wellestablished modality kidney replacement therapy KRT globally offering benefit better preservation residual kidney function improved quality life reduced resource requirements Despite advantages global utilization PD remains suboptimal particularly South Asia SA significant gap PD delivery exists study aim uncover perceived barrier hindering PD utilization among nephrologists SA crosssectional survey involving 732 nephrologists SA region  majority respondent 447 reported initiating less six PD case annually reflecting low PD utilization Cost financial reimbursement policy emerged major barriers 443 considering PD expensive haemodialysis HD Accessibility negative attitude toward PD fear complication identified critical factor influencing PD adoption study also highlighted variation PD cost among SA countries emphasizing need tailored health economic strategies analysis provides insight multifaceted challenge faced SA nephrologists promoting PD underscore importance targeted interventions",
        "mesh_terms": [
            "Humans",
            "Peritoneal Dialysis",
            "Cross-Sectional Studies",
            "Male",
            "Nephrologists",
            "Female",
            "Kidney Failure, Chronic",
            "Middle Aged",
            "Attitude of Health Personnel",
            "Adult",
            "Surveys and Questionnaires",
            "Practice Patterns, Physicians'",
            "Asia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39042940/"
    },
    {
        "pmid": "39028721",
        "title": "Comparative analyses of adsorbed circulating proteins in the PMMA and PES hemodiafilters in patients on predilution online hemodiafiltration.",
        "abstract": "Acute chronic inflammation common patient endstage kidney disease ESKD So adsorption proinflammatory cytokine hollow fiber dialysis membrane expected modify inflammatory dysregulation ESKD patients However remains determined detail molecule fiber material preferably adsorb protein circulating circuit aimed study analyze directly adsorbed protein polymethyl methacrylate PMMA polyethersulfone PES membrane patient predilution online hemodiafiltration OLHDF compare adsorbed protein PMMA PES hemodiafilters membrane initially performed predilution OLHDF using PES MFX25Seco membrane switched PMMA PMF™A membrane condition three patients extracted protein collected hemodiafilters extraction SDSPAGE extracted sample protein isolation ingel tryptic digestion nanoLC MSMS analyses concentration adsorbed protein PMMA PES membrane extract 356±79 μgμL 261±92 μgμL SDSPAGE analysis revealed distinct variation adsorbed protein mainly molecular weight 10 25 kDa tryptic gel digestion mass spectrometric analysis PMMA membrane exhibited higher adsorption β2 microglobulin dermcidin retinolbinding protein4 lambda1 light chain PES membrane contrast amyloid A1 protein adsorbed potently PES membrane Western blot analysis revealed PMMA membrane adsorbed interleukin6 IL6 approximately 5 118 time compared PES membrane finding suggest PMMAbased OLHDF therapy may useful controlling inflammatory status ESKD patients",
        "mesh_terms": [
            "Humans",
            "Hemodiafiltration",
            "Polymethyl Methacrylate",
            "Adsorption",
            "Sulfones",
            "Polymers",
            "Membranes, Artificial",
            "Male",
            "Blood Proteins",
            "Middle Aged",
            "Kidney Failure, Chronic",
            "Female",
            "Aged",
            "Tandem Mass Spectrometry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39028721/"
    },
    {
        "pmid": "38992660",
        "title": "The spectrum of health conditions in community-based cross-sectional surveys in Southeast Asia 2010-21: a scoping review.",
        "abstract": "Southeast Asia undergoing epidemiological transition noncommunicable illness becoming increasingly important yet infectious disease tuberculosis HIV hepatitis B malaria remain widely prevalent populations emerging zoonotic disease threaten also limited populationlevel estimate many important heath conditions restricts evidencebased decisionmaking disease control prevention priorities Crosssectional survey efficient epidemiological tool measure prevalence wide range diseases systematic assessment coverage different health condition produced region conducted systematic search Medline Embase Global Health CINAHL Scopus Web Science Core Collection Global Index Medicus additionally Google Scholar inclusion criterion crosssectional survey conducted communitybased recruitment Bangladesh Cambodia Laos Myanmar Thailand published January 1 2010 January 27 2021 reporting prevalence health condition 542 publication 337 survey included Noncommunicable condition n  205 reported survey infectious condition n  124 Disability n  49 selfreport history disease symptom n  35 selfperceived health status n  34 reflect holistic picture health studied many fewer surveys addition 45 survey studied symptomatic condition overlap noncommunicable infectious conditions surveyed condition undernutrition obesity hypertension diabetes intestinal parasites malaria anemia diarrhea fever acute respiratory infections condition overlap important cause death disability Global Burden Disease study However highburden condition eg hearing loss headache disorder low back pain chronic liver kidney diseases cancers rarely studied relatively recent survey estimate representative prevalence trend health condition beyond known high burden Expanding spectrum health condition crosssectional survey could improve understanding evolving disease pattern region",
        "mesh_terms": [
            "Humans",
            "Asia, Southeastern",
            "Communicable Diseases",
            "Cross-Sectional Studies",
            "Health Status",
            "Health Surveys",
            "Noncommunicable Diseases",
            "Prevalence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38992660/"
    },
    {
        "pmid": "38944713",
        "title": "Evaluation of Determinants to Achieve Target Urea Reduction Ratio on Maintenance Hemodialysis Patients in Bangladesh.",
        "abstract": "Among patient chronic kidney disease stage5 treated dialysis urea clearance hemodialysis determinant mortality Decreased serum albumin serum calcium increased phosphorus associated reduction URR mortality patients study compare two group Urea Reduction Ratio URR different type biochemical parameters URR aimed target according Kidney Disease Outcomes Quality Initiative KDOQI guideline study observational study carried department Nephrology Serum Albumin serum calcium phosphate hemoglobin pre dialysis urea post dialysis urea measured blood sample URR calculated  1 postdialysis ureapredialysis urea × 100 Among patient went hemodialysis 1731 patient URR 650 Mean±SD URR 6721±19 hand 8268 patient URR less 650 Mean±SD URR 574±52 Biochemical parameter study significantly different two groups as significant difference Age Sex Body Mass Index BMI URR accurate indicator help determination adequate dialysis study aimed find mean value urea reduction ratio association biochemical parameter among End Stage Renal Disease ESRD patient maintenance hemodialysis",
        "mesh_terms": [
            "Humans",
            "Renal Dialysis",
            "Urea",
            "Female",
            "Male",
            "Bangladesh",
            "Middle Aged",
            "Adult",
            "Kidney Failure, Chronic",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38944713/"
    },
    {
        "pmid": "38889138",
        "title": "Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.",
        "abstract": "Major depressive disorder MDD common debilitating mental illness characterized persistent feeling sadness hopelessness lack interest daily activities objective study investigate whether level macrophage inflammatory protein1β MIP1β macrophage chemoattractant protein2 MCP2 blood associated pathophysiology development MDD compared healthy control HCs casecontrol study conducted involving 50 MDD patient 38 HCs performed comprehensive assessment match age sex BMI sociodemographic profile groups study excluded participant chronic infection inflammatory diseases coexisting psychiatric disorder history liver kidney diseases individual antipsychotic medications professional psychiatrist diagnosed MDD patient evaluated HCs based Diagnostic Statistical Manual Mental Disorders5 DSM5 criteria severity depression assessed using Hamilton Depression HamD rating scale Commercially available enzymelinked immunosorbent assay ELISA kit used quantify serum MIP1β MCP2 levels result indicated elevated serum MIP1β level 20773±2424 pgml MDD patient compared HCs 5877±914 pgml difference concentration positively correlated severity disease symptom r  0451 p0001 Similarly level MCP2 found elevated patient compared control 14361±1992 vs 5684±402 pgml p  0003 positive correlation HamD score r  0373 p  0004 According study elevated level MIP1β MCP2 may associated pathophysiology development MDD increased serum MIP1β MCP2 level could used risk assessment tool MDD present finding urge research development therapeutic diagnostic approach depression",
        "mesh_terms": [
            "Humans",
            "Depressive Disorder, Major",
            "Male",
            "Female",
            "Case-Control Studies",
            "Adult",
            "Chemokine CCL4",
            "Chemokine CCL2",
            "Middle Aged",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38889138/"
    },
    {
        "pmid": "38634072",
        "title": "The impact of comorbidity on the quality of life of people who recovered from COVID-19 in Bangladesh.",
        "abstract": "COVID19 affect quality life QoL reverse way recovery might multiplied comorbid noncommunicable diseases study explored relationship comorbidities QoL people recovered COVID19 Bangladesh crosssectional study conducted among 3244 participant June 2020 November 2020 using pretested questionnaire overthephone interviews WHOQOLBREF used explore QoL among study participants multivariable linear regression model conducted identify effect number comorbidities QoL score four domains 3244 patient recovered COVID19 onethird 394 one chronic diseases hypertension diabetes mellitus ischemic heart disease bronchial asthmachronic obstructive pulmonary disease chronic kidney disease cancer Around 4685 participant aged 40 year presented one two chronic diseases 1633 three chronic diseases Among comorbidities participant cancer chronic kidney disease found relatively lower score four domain comorbidities lowest QoL score observed psychological domain three simultaneous chronic comorbidities lowest QoL score four domains physical psychological social relationship environmental Persons recovered COVID19 comorbidities undergo lower QoL Therefore special attention required vulnerable group ensure smooth recuperation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38634072/"
    },
    {
        "pmid": "38624203",
        "title": "Complete genome sequence of hepatitis B virus identified from a patient suffering from chronic kidney disease in Bangladesh.",
        "abstract": "Hepatitis B virus HBV infection reported risk factor chronic kidney disease CKD study sequenced complete genome HBV strain identified CKD patient Bangladesh followed genomic characterization mutational analyses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38624203/"
    },
    {
        "pmid": "38618495",
        "title": "Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).",
        "abstract": "South Asia region facing high burden chronic kidney disease CKD limited health resource low expenditure health care addition burden CKD kidney failure traditional risk factors CKD unknown etiology India Sri Lanka compound challenge optimal management CKD region third edition International Society Nephrology Global Kidney Health Atlas ISNGKHA present status CKD burden infrastructure funding resources health care personnel using World Health Organizations building block health system South Asia region poor status public health care system low health care expenditure resulted high outofpocket expenditure people kidney disease compounded situation insufficient country capacity across region provide kidney replacement therapy cover burden infrastructure also uniformly distributed among country region chronic hemodialysis center Afghanistan peritoneal dialysis service available Bangladesh India Nepal Pakistan Sri Lanka Kidney transplantation available Afghanistan Bhutan Maldives Conservative kidney management reported available 63 n  5 countries yet country reported availability core CKM care components high hospitalization rate early mortality inadequate kidney care lack national registry actual disease burden estimate reported region prevent policymakers attention CKD important cause morbidity mortality Data 2023 ISNGKHA although limitations may used advocacy improving CKD care region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38618495/"
    },
    {
        "pmid": "38582094",
        "title": "Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Regular detailed reporting population health underlying cause death fundamental public health decision making Causespecific estimate mortality subsequent effect life expectancy worldwide valuable metric gauge progress reducing mortality rates estimate particularly important following largescale mortality spikes COVID19 pandemic systematically analysed mortality rate life expectancy allow comparison consequence cause death globally time providing nuanced understanding effect cause global populations Global Burden Diseases Injuries Risk Factors Study GBD 2021 causeofdeath analysis estimated mortality year life lost YLLs 288 cause death agesexlocationyear 204 country territory 811 subnational location year 1990 2021 analysis used 56 604 data sources including data vital registration verbal autopsy well surveys censuses surveillance systems cancer registries among others previous GBD rounds causespecific death rate cause estimated using Cause Death Ensemble modela modelling tool developed GBD assess outofsample predictive validity different statistical model covariate permutation combine result produce causespecific mortality estimateswith alternative strategy adapted model cause insufficient data substantial change reporting study period unusual epidemiology YLLs computed product number death causeagesexlocationyear standard life expectancy age part modelling process uncertainty interval UIs generated using 2·5th 97·5th percentile 1000draw distribution metric decomposed life expectancy cause death location year show causespecific effect life expectancy 1990 2021 also used coefficient variation fraction population affected 90 death highlight concentration mortality Findings reported count agestandardised rates Methodological improvement causeofdeath estimate GBD 2021 include expansion under5years age group include four new age groups enhanced method account stochastic variation sparse data inclusion COVID19 pandemicrelated mortalitywhich includes excess mortality associated pandemic excluding COVID19 lower respiratory infections measles malaria pertussis analysis 199 new countryyears vital registration causeofdeath data 5 countryyears surveillance data 21 countryyears verbal autopsy data 94 countryyears data type added used previous GBD rounds leading cause agestandardised death globally 2019 1990 descending order were ischaemic heart disease stroke chronic obstructive pulmonary disease lower respiratory infections 2021 however COVID19 replaced stroke secondleading agestandardised cause death 94·0 death 95 UI 89·2100·0 per 100 000 population COVID19 pandemic shifted ranking leading five causes lowering stroke thirdleading chronic obstructive pulmonary disease fourthleading position 2021 highest agestandardised death rate COVID19 occurred subSaharan Africa 271·0 death 250·1290·7 per 100 000 population Latin America Caribbean 195·4 death 182·1211·4 per 100 000 population lowest agestandardised death rate COVID19 highincome superregion 48·1 death 47·448·8 per 100 000 population southeast Asia east Asia Oceania 23·2 death 16·337·2 per 100 000 population Globally life expectancy steadily improved 1990 2019 18 22 investigated causes Decomposition global regional life expectancy showed positive effect reduction death enteric infections lower respiratory infections stroke neonatal deaths among others contributed improved survival study period However net reduction 1·6 year occurred global life expectancy 2019 2021 primarily due increased death rate COVID19 pandemicrelated mortality Life expectancy highly variable superregions study period southeast Asia east Asia Oceania gaining 8·3 year 6·79·9 overall smallest reduction life expectancy due COVID19 0·4 years largest reduction life expectancy due COVID19 occurred Latin America Caribbean 3·6 years Additionally 53 288 cause death highly concentrated location less 50 global population 2021 cause death became progressively concentrated since 1990 44 cause showed pattern concentration phenomenon discussed heuristically respect enteric lower respiratory infections malaria HIVAIDS neonatal disorders tuberculosis measles Longstanding gain life expectancy reduction many leading cause death disrupted COVID19 pandemic adverse effect spread unevenly among populations Despite pandemic continued progress combatting several notable cause death leading improved global life expectancy study period seven GBD superregions showed overall improvement 1990 2021 obscuring negative effect year pandemic Additionally finding regarding regional variation cause death driving increase life expectancy hold clear policy utility Analyses shifting mortality trend reveal several causes widespread globally increasingly concentrated geographically change mortality concentration alongside investigation changing risks interventions relevant policy present important opportunity deepen understanding mortalityreduction strategies Examining pattern mortality concentration might reveal area successful public health intervention implemented Translating success location certain cause death remain entrenched inform policy work improve life expectancy people everywhere Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Life Expectancy",
            "Cause of Death",
            "Global Burden of Disease",
            "Female",
            "COVID-19",
            "Male",
            "Aged",
            "Middle Aged",
            "Adult",
            "Child, Preschool",
            "Infant",
            "Global Health",
            "Adolescent",
            "Young Adult",
            "Child",
            "Aged, 80 and over",
            "SARS-CoV-2",
            "Infant, Newborn",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38582094/"
    },
    {
        "pmid": "38578541",
        "title": "APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure.",
        "abstract": "Acuteonchronic liver failure ACLF syndrome characterized rapid development organ failure predisposing patient high risk shortterm early death main cause organ failure patient bacterial infection systemic inflammation severe majority patients prompt liver transplant still effective course treatment Kidneys one frequent extrahepatic organ affected patient ACLF since acute kidney injury AKI reported 22834 patient ACLF Approach management kidney injury could improve overall outcome patients Importantly patient ACLF frequently stage 3 AKI low rate response current treatment modalities objective present position paper critically review analyze published data AKI ACLF evolve consensus provide recommendation early diagnosis pathophysiology prevention management AKI patient ACLF absence direct evidence propose expert opinion guidance managing AKI challenging group patient focus area future research consensus major importance hepatologists liver transplant surgeons intensivists across globe",
        "mesh_terms": [
            "Humans",
            "Acute Kidney Injury",
            "Acute-On-Chronic Liver Failure",
            "Liver Transplantation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38578541/"
    },
    {
        "pmid": "38557540",
        "title": "Assessment of Kidney Function among the Employees of Sylhet MAG Osmani Medical College and Hospital.",
        "abstract": "kidney carry variety physiological processes including excretion nitrogenous waste products maintenance fluid electrolyte acidbase mineral homeostasis regulation blood pressure well synthesis release erythropoietin endocrine substances Chronic kidney disease CKD lead endstage renal disease ESRD increased cardiovascular morbidity mortality CKD long period asymptomatic stage symptom CKD usually present advanced stage disease Chronic kidney disease CKD potentially fatal impact various physiological systems crosssectional observational study conducted Department Physiology collaboration Department Nephrology Sylhet MAG Osmani Medical College Hospital SMAGOMCH July 2022 June 2023 observe status kidney function among employee SMAGOMCH Bangladesh study population consisted willingly participating volunteer working SMAGOMCH age 18 59 years Participants acute illness malignancy pregnancy diagnosed case CKD history kidney transplant excluded study thorough history taken physical examination done Serum creatinine spot urine albumin creatinine ratio ACR participant measured eGFR estimated glomerular filtration rate estimated using NKF National Kidney Foundation eGFR calculator app Semistructured questionnaire used data collection participant 5059 year 460 mean age study subject 4525±1008 years mean serum creatinine level 085±018 mgdl mean eGFR 10292±1621 mlmin173m² mean urinary ACR 2744±1248 mggm found study total participants 165 stage 1 CKD 65 stage 2 CKD 25 stage 3 CKD according eGFR CKDEPI Chronic kidney disease epidemiology collaboration equation Seventy five percent 750 participant normal mildly increased ACR 250 moderately increased ACR Pearsons correlation test revealed significant negative correlation eGFR age serum creatinine urinary ACR p0001 study revealed 165 65 25 study participant CKD stage 1 stage 2 stage 3 respectively Assessment renal function help early identification CKD apparently healthy asymptomatic subjects",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Young Adult",
            "Adult",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Creatinine",
            "Bangladesh",
            "Glomerular Filtration Rate",
            "Kidney",
            "Renal Insufficiency, Chronic",
            "Hospitals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38557540/"
    },
    {
        "pmid": "38557530",
        "title": "Dysfunction of Thyroid Hormones Following Acute Coronary Syndrome in a Tertiary Care Hospital in Dhaka City.",
        "abstract": "cardiovascular homeostasis thyroid hormone play important role planned study change thyroid hormone profile acute coronary syndrome patient admitted coronary care unit compare two groups unstable anginanonST elevated Myocardial infarction UANSTEMI ST elevated Myocardial infarction STEMI study hospital based descriptive cross sectional study conducted 01 March 2018 01 February 2019 Coronary Care Unit Bangladesh Medical College Hospital laboratory test done Microbiology Department Bangladesh Medical College Dhaka Bangladesh Eighty three case acute coronary syndrome taken study TroponinI measured cardiac marker Electrocardiogram Complete blood count blood glucose level Blood urea serum creatinine serum electrolytes Fasting lipid profile Thyroid profile Echocardiography 2D done respondent distributed age group 4660 year 346415 male 193585 female 83 Acute Coronary Syndrome ACS patients 273253 hypertensive 222650 diabetic 161927 Chronic kidney disease CKD Abnormal lipid profile present 304347 patients Among total 52 male 31 female 91730 male 61935 female abnormal thyroid function elaborated abnormal thyroid function test STEMI group UANon STEMI group ACS patients found 10 patient STEMI group 5 patient UANon STEMI group abnormal thyroid function 2941 1020 respectively statistically significant p0025 study depicts abnormality thyroid hormone profile 1807 patient ACS Abnormal thyroid function increase risk coronary artery disease TSH level ACS patient hospital admission could helpful evaluate prognosis disease",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Middle Aged",
            "Acute Coronary Syndrome",
            "ST Elevation Myocardial Infarction",
            "Tertiary Care Centers",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Thyroid Hormones",
            "Lipids"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38557530/"
    },
    {
        "pmid": "38557519",
        "title": "Evaluation of Intradialytic Complications and Protein Catabolic Rate on Maintenance Hemodialysis Patients in Bangladesh.",
        "abstract": "Among patient chronic kidney disease stage5 treated dialysis intradialytic complication commonly occur routine hemodialysis HD could either patient related mechanical Protein catabolic rate hemodialysis determinant mortality nPCR aimed target according International guideline observational study conducted Department Nephrology Mymensingh Medical College Hospital Bangladesh January 2020 December 2020 compare two group nPCR different value biochemical parameters study involving patient inclusion criterion patient underwent routine HD least three months patient underwent conventional intermittent HD lowflux dialyser total 179 patient enrolled Serum albumin serum calcium phosphate hemoglobin predialysis urea post dialysis urea measured blood sample nPCR calculated standard international equation nPCR value 140 patient 10 gmkgday average nPCR mean±SD patient 0903±009gmkgday 860 patient nPCR less 10 gmkgday Biochemical parameter significantly differing two groups nPCR indicator help determination nutritional status study aimed find intradialytic complications mean value nPCR correlation biochemical parameter among ESRD patient maintenance hemodialysis",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Renal Dialysis",
            "Kidney Failure, Chronic",
            "Nutritional Status",
            "Urea"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38557519/"
    },
    {
        "pmid": "38557506",
        "title": "Status of Serum Magnesium, Serum Zinc and C-reactive Protein in Hospitalized Patients with Chronic Kidney Disease in Mymensingh Locality.",
        "abstract": "Chronic Kidney Disease CKD important public health issue leading cause death disability around world crosssectional study conducted January 2021 December 2021 department Biochemistry Mymensingh Medical College cooperation Department Nephrology Mymensingh Medical College Hospital Mymensingh Bangladesh study carried evaluate status serum magnesium zinc CRP patient CKD dialysis monitoring disease progression purpose 110 subject included 55 Hospitalized CKD patient considered Group 55 normal healthy individual Group II Study subject selected basis inclusion exclusion criterion purposive convenient sampling method Serum magnesium zinc determined colorimetric method CRP measured CRPLatex Test Slide Agglutination Test sample SPSS window package version 210 used perform statistical analysis Statistical significance difference Group Group II evaluated using students unpaired ttest significance defined p005 Correlation done using Pearsons correlation coefficient test Mean age Group 5265±493 Group II 5115±632 years Pvalue 0165 statistically insignificant mean ±SD BMI 2446±184 Kgm² Group 2450±105 Kgm² Group II Pvalue 0886 statistically insignificant Among study group mean serum magnesium 225±017 195±005mgdl zinc 8864±921 10211±1293μgdl CRP 2400±1673 60±000mgL Group Group II respectively Analysis showed that mean serum magnesium CRP significantly increased serum zinc significantly decreased CKD patient comparison healthy individual negative correlation serum zinc CRP study done within context facility available us",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Middle Aged",
            "C-Reactive Protein",
            "Magnesium",
            "Cross-Sectional Studies",
            "Case-Control Studies",
            "Renal Dialysis",
            "Bangladesh",
            "Zinc",
            "Renal Insufficiency, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38557506/"
    },
    {
        "pmid": "38510072",
        "title": "ML-CKDP: Machine learning-based chronic kidney disease prediction with smart web application.",
        "abstract": "Chronic kidney disease CKDs significant public health issue potential severe complication hypertension anemia renal failure Timely diagnosis crucial effective management Leveraging machine learning within healthcare offer promising advancement predictive diagnostics paper developed machine learningbased kidney disease prediction MLCKDP model dual objectives enhance dataset preprocessing CKD classification develop webbased application CKD prediction proposed model involves comprehensive data preprocessing protocol converting categorical variable numerical values imputing missing data normalizing via MinMax scaling Feature selection executed using variety technique including Correlation ChiSquare Variance Threshold Recursive Feature Elimination Sequential Forward Selection Lasso Regression Ridge Regression refine datasets model employ seven classifiers Random Forest RF AdaBoost AdaB Gradient Boosting GB XgBoost XgB Naive Bayes NB Support Vector Machine SVM Decision Tree DT predict CKDs effectiveness model assessed measuring accuracy analyzing confusion matrix statistics calculating Area Curve AUC specifically classification positive cases Random Forest RF AdaBoost AdaB achieve 100 accuracy rate evident across various validation method including data split 7030 8020 KFold set 10 15 RF AdaB consistently reach perfect AUC score 100 across multiple datasets different splitting ratios Moreover Naive Bayes NB stand efficiency recording lowest training testing time across datasets split ratios Additionally present realtime webbased application operationalize model enhancing accessibility healthcare practitioner stakeholders Web app link httpsrajibresearchkedneydiseasespredictiononrendercom",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38510072/"
    },
    {
        "pmid": "38508914",
        "title": "The 25-hydroxyvitamin D level in Kidney Transplant Recipients and Its Association With Renal Function and Other Cardio-Metabolic Risk Markers.",
        "abstract": "Vitamin main hormone play critical role controlling mineral homeostasis Transplant recipient frequently altered level 25hydroxyvitamin 25OH D 1 25hydroxyvitamin 1 25OH D explore status vitamin level renal allograft recipient association renal function cardiometabolic risk markers One hundred two adult kidney transplant recipient KTRs included Clinical history information transplantation immunosuppression recorded Blood urine sample collected relevant laboratory tests including chronic kidney disease CKDmineral bone disorder marker Ca PO4 25OH D mean age 35 ± 8 years malefemale ratio 8911 transplant duration 34 ± 26 45112 months donor involved livingrelated father comprised 44 wife 16 sister 13 mother 11 others 16 ie brothers sons daughters uncles aunts immunosuppression regimen included prednisolone tacrolimus all mycophenolate mofetil 96 estimated glomerular filtration rate showed CKD distribution stage 1 5 6 29 44 15 6 respectively Vitamin level lower 22 20 ngmL insufficient 2030 ngmL 48 adequate 30 ngmL 30 compared different clinical laboratory variable 3 different vitamin group found difference cardiorenal risk factor P  Significant Similarly correlation seen vitamin level clinical metabolic factors According conventional cutoffs vitamin 25OH D level inadequate 70 renal allograft recipients hormone level apparent association renal function major cardiometabolic risk factors",
        "mesh_terms": [
            "Humans",
            "Kidney Transplantation",
            "Vitamin D",
            "Female",
            "Male",
            "Adult",
            "Biomarkers",
            "Risk Factors",
            "Transplant Recipients",
            "Glomerular Filtration Rate",
            "Middle Aged",
            "Kidney",
            "Immunosuppressive Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38508914/"
    },
    {
        "pmid": "38361176",
        "title": "Health trends in Canada 1990-2019: An analysis for the Global Burden of Disease Study.",
        "abstract": "Monitoring trend key population health indicator important informing health policies aim study examine population health trend Canada past 30 year relation countries used data disabilityadjusted life year DALYs year life lost YLL year lived disability life expectancy LE child mortality Canada country 1990 2019 provided Global Burden Disease Study Life expectancy agestandardized YLL agestandardized DALYs improved Canada 1990 2019 although rate improvement leveled since 2011 top five cause allage DALYs Canada 2019 neoplasms cardiovascular diseases musculoskeletal disorders neurological disorders mental disorders greatest increase allage DALYs since 1990 observed substance use diabetes chronic kidney disease sense organ disorders Agestandardized DALYs declined conditions except substance use diabetes chronic kidney disease musculoskeletal disorders increased 946 146 73 respectively since 1990 Canadas world ranking agestandardized DALYs declined 9th place 1990 24th 2019 Canadians healthier today 1990 progress slowed Canada recent year comparison highincome countries growing burden substance abuse diabeteschronic kidney disease musculoskeletal disease require continued action improve population health",
        "mesh_terms": [
            "Humans",
            "Canada",
            "Diabetes Mellitus",
            "Global Burden of Disease",
            "Global Health",
            "Life Expectancy",
            "Musculoskeletal Diseases",
            "North American People",
            "Quality-Adjusted Life Years",
            "Renal Insufficiency, Chronic",
            "Substance-Related Disorders"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38361176/"
    },
    {
        "pmid": "38344624",
        "title": "A Systematic Review of Pediatric Dialysis in Asia: Unveiling Demographic Trends, Clinical Representation, and Outcomes.",
        "abstract": "Dialysis pediatric group complicated wide range factor affect longterm prognosis purpose metaanalysis systematic review better understand demographic clinical factor affect dialysis success children searched variety database relevant article included 14 report dealt case study pediatric patient undergoing dialysis wide range renal diseases Patients demographics clinical presentations laboratory findings treatment outcome primary area data collection get better sense overall prevalence certain outcome spot noteworthy trend pattern disease process conducted metaanalysis Variations dialysis efficacy outcome highlighted throughout wide range age pediatric dialysis cohort neonate teenagers Acute kidney injury AKI tended impact boys chronic kidney disease CKD lupus nephritis disproportionately afflicted girls Many different ethnic group represented evidence disease hereditary component common area others However potential longterm consequence remained concern Hemodialysis found effective controlling endstage renal disease ESRD AKI patient going kidney transplant time peritoneal dialysis associated increased risk infection comprehensive analysis highlight importance demographic clinical parameter determining pediatric dialysis outcomes 1447 mortality rate gender disparity revealed metaanalysis pediatric renal diseases included cohort 235 patient condition like lupus nephritis hepatitis C infection finding stress necessity individualized treatment technique suggest demographic characteristic addressed prognostic models better patient outcomes study also suggests standardized reporting pediatric dialysis studies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38344624/"
    },
    {
        "pmid": "38344458",
        "title": "Factors associated with the malnutrition inflammation score (MIS) among hemodialysis patients in Dhaka city: a cross-sectional study in tertiary care hospitals.",
        "abstract": "Chronic kidney disease CKD progressive disease lead endstage renal disease ESRD Malnutrition increase risk mortality among patient ESRD study aimed determine malnutrition prevalence associated factor among twiceweekly n  94120 thriceweekly n  26120 hemodialysis patientsHDP crosssectional study conducted two tertiarylevel public hospital Dhaka city using consecutive sampling technique April June 2021 Nutritional status assessed Malnutrition Inflammation Score MIS Multivariable ordinal logistic regression performed determine socioeconomic clinical anthropometric biochemical dietary factor associated MIS prevalence malnutrition high among HDP severe 155 mildmoderate 567 average dialysis vintage 287 months Comorbidities 808 gastrointestinal symptomsGIS 683 ubiquitous dialysis frequencies associated MIS bivariate analysis Multivariable ordinal regression showed anthropometric factor like midupper arm circumferenceMUAC adjusted odds ratioAOR  0978 postdialysis body mass indexBMI AOR  0957 biochemical parameter like albumin AOR  0733 TIBCtotal iron binding capacity AOR  0996 negatively iPi  05 associated MIS Moreover no GIS AOR  0672 iPi  001 330 less likely associated MIS Contrarily month dialysis increases MIS increase 220 AOR  122 Significant association clinical anthropometric biochemical characteristic MIS indicate importance routine screening nutritional status patient CKD improve health status prevent proteinenergy wasting MIS could simple noninvasive tool testing nutritional status patient CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38344458/"
    },
    {
        "pmid": "38285519",
        "title": "Risk Factors for Poor Outcomes in Children Hospitalized With Virus-associated Acute Lower Respiratory Infections: A Systematic Review and Meta-analysis.",
        "abstract": "Acute lower respiratory infection ALRI caused respiratory virus among common cause hospitalization mortality children aimed identify risk factor poor outcome child 5 year old hospitalized ALRI caused respiratory syncytial virus RSV influenza severe acute respiratory syndrome coronavirus 2 SARSCoV2 searched Embase Medline Global Health database included observational study reporting risk factor poor outcome defined use supplemental oxygen mechanical ventilation intensive care unit admission prolonged hospital stay mortality published January 2011 January 2023 Two author independently extracted data study characteristics outcome risk factors Due limited data metaanalyses conducted RSVALRI poor outcome risk factor using random effect model least 3 studies included 30 studies RSVrelated ALRI significant risk factor based metaanalysis were neurological disease odds ratio OR 614 95 confidence interval CIs 2391577 Downs syndrome 543 302976 chronic lung disease 364 1311009 immunocompromised status 341 185629 prematurity 298 193459 congenital heart disease 280 184424 underlying disease 245 194309 age 2 month 229 178294 age 6 month 208 181239 viral coinfection 201 127319 low birth weight 188 119295 underweight 180 138235 influenzarelated ALRI chronic condition age 624 month identified risk factor poor outcomes Cardiovascular disease immunosuppression chronic kidney disease diabetes high blood pressure reported risk factor mortality due SARSCoV2 associated ALRI finding might contribute development guideline prophylaxis management ALRI caused RSV influenza SARSCoV2",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "COVID-19",
            "Hospitalization",
            "Respiratory Tract Infections",
            "Infant",
            "Respiratory Syncytial Virus Infections",
            "Child, Preschool",
            "SARS-CoV-2",
            "Influenza, Human",
            "Infant, Newborn"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38285519/"
    },
    {
        "pmid": "38163790",
        "title": "Cardiovascular Risk Scoring of Hospitalized Chronic Kidney Disease Patients by Framingham Risk Score.",
        "abstract": "Patients chronic kidney disease CKD likely complication due cardiovascular disease CVD cross sectional descriptive study conducted Department Medicine Nephrology Chittagong Medical College CMC Chittagong Bangladesh June December 2014 performed estimate risk cardiovascular event according Framinghams Risk Score CKD patients research 100 patient diagnosed CKD admitted Chittagong Medical College Hospital enrolled Estimated glomerular filtration rate eGFR calculated MDRD formula Cardiovascular risk factor analyzed Framinghams criterion compilation data analyzed SPSS180 Among 100 patients patient 60 year age male 560 female 440 Framingham Cardiovascular Risk Score revealed male high risk group compared female Regarding different component lipid profile Framingham risk score higher risk group high mean total cholesterol 21217mgdl also low mean HDL level 3858mgdl Patient different stage CKD cardiovascular risk showed stage 5 CKD 80 stage 4 150 rest 5 stage 3 low risk group 560 significant positive correlation found age serum total cholesterol level cardiovascular risk scoring HDL eGFR predominant cardiovascular risk factor age male gender smoking high serum total cholesterol",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Risk Factors",
            "Cardiovascular Diseases",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Renal Insufficiency, Chronic",
            "Heart Disease Risk Factors",
            "Glomerular Filtration Rate",
            "Cholesterol"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38163790/"
    },
    {
        "pmid": "38163777",
        "title": "Assessment of Dialysis Adequacy Using Small Solute Clearance Indices among Twice versus Thrice Weekly Maintenance Hemodialysis Patients in a Tertiary Care Hospital of Bangladesh.",
        "abstract": "observational study carried Department Nephrology Mymensingh Medical College Hospital Bangladesh January 2020 December 2020 total 179 patient included study according inclusion exclusion criteria Informed written consent taken patient patient underwent detail history taking thorough physical examination relevant investigations Data collection conducted structured questionnaire Collected data analyzed using statistical software SPSS 230 Mean age ±SD study patient 4706±141 majority age group 4150 years Male predominance observed male female ratio 2191 687 male patients Level predialysis postdialysis urea study population 12377±2686mgdl 5027±1570mgdl respectively mean ±SD Urea Reduction Ratio URR hemodialysis target 650 672±19 8 hour two times per week hemolysis patient could achieve target value dialysis adequacy parameters hand maximum people 12 hour three times per week hemodialysis group achieved target value dialysis adequacy parameters important calculate KtV URR individualize dialysis dos patient",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Kidney Failure, Chronic",
            "Bangladesh",
            "Dialysis",
            "Tertiary Care Centers",
            "Renal Dialysis",
            "Urea"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38163777/"
    },
    {
        "pmid": "38163766",
        "title": "Status of C-reactive protein, Serum Albumin and Serum Zinc in Hospital Admitted Patients with Chronic Kidney Disease.",
        "abstract": "Chronic Kidney Disease CKD one concerned noncommunicable disease day Multiple complication arise different biochemical parameter change disease crosssectional study conducted January December 2021 Department Biochemistry Mymensingh Medical College help Department Nephrology Mymensingh Medical College Hospital Bangladesh motive study explore status Creactive protein CRP serum albumin serum zinc patient CKD monitoring disease progression study 110 subject included 55 Hospital admitted CKD patient act Group 55 normal healthy individual act Group II subject selected basis inclusion exclusion criterion purposive convenient sampling method study CRP levels serum albumin serum zinc measured value expressed Mean±SD statistical analysis done using SPSS statistical package social science window package version 210 Statistical significance difference Group Group II evaluated using Students unpaired ttest significance defined p005 Correlation done using Pearsons correlation coefficient test Mean age Group 5265±493 Group II 5115±632 P value 0165 statistically insignificant mean±SD BMI 2446±184 Group 2450±105 Group II P value 0886 statistically insignificant mean±SD value CRP 2400±1673mgL 60±000mgL Group Group II respectively So found significant p005 increase CRP levels mean±SD value serum albumin 362±026gdl 416±069gdl Group Group II respectively found highly significant p0001 decrease serum albumin Among study group mean serum zinc 8864±921μgdl 10211±1293μgdl Group Group II respectively mean serum zinc highly significantly 0001 decreased negative correlation CRP serum albumin CRP serum zinc positive correlation serum albumin serum zinc Analyzing finding present study significant increase CRP levels significant decrease serum albumin serum zinc observed CKD patients",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "C-Reactive Protein",
            "Case-Control Studies",
            "Cross-Sectional Studies",
            "Hospitals",
            "Renal Insufficiency, Chronic",
            "Serum Albumin",
            "Zinc",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38163766/"
    },
    {
        "pmid": "37930771",
        "title": "Tailoring Educational Materials to Cultural Context Matters.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37930771/"
    },
    {
        "pmid": "37869615",
        "title": "Smokeless tobacco consumption and its association with risk factors of chronic kidney disease in rural and peri-urban Bangladesh.",
        "abstract": "Compared smoking major consequence chronic kidney disease CKD initiation progression smokeless tobacco SLT consumption considered fewer health consequences investigated prevalence SLT consumption association risk factor CKD rural periurban Bangladeshi population Using random sampling recruited 872 adult 2020 Mirzapur Demographic Surveillance System Bangladesh resided area least five years Interviews using semistructured questionnaire physical examination anthropometric measurement done followed blood urine testing blood urine test repeated selected participant three month per CKD Epidemiology Collaboration equation prevalence SLT consumption 29 aged ≥46 year OR710 95 CI 4791094 female OR164 95 CI 121222 housewife OR182 95 CI 135245 farmer OR171 95 CI 106276 widow OR340 95 CI 224517 formal schooling OR491 95 CI 359672 family income 100month OR166 95 CI 113243 sleeping duration 7 hour per day OR233 95 CI 170319 associated significantly higher odds SLT consumption However aged 3145 year OR025 95 CI 016038 significantly lower odds SLT consumer Among disease investigated undernutrition OR163 95 CI 115233 hypertension OR152 95 CI 113205 anemia OR194 95 CI 139271 CKD OR162 95 CI 115227 significantly associated SLT consumption multivariable analysis aged 3145 year AOR306 95 CI 191490 ≥46 year AOR1569 95 CI 4645309 formal schooling AOR247 95 CI 172355 found significant association SLT consumer SLT consumption associated established risk factor CKD within studied population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37869615/"
    },
    {
        "pmid": "37777888",
        "title": "Hypoalbuminaemia as a Marker of Severity of Patients of Community Acquired Pneumonia.",
        "abstract": "Communityacquired pneumonia CAP common presentation acute infection pulmonary parenchyma occurring community level Despite availability potent antibiotics remains serious illness significant morbidity mortality developed developing countries study undertaken determine relation serum Albumin severity CAP cross sectional descriptive study carried Department Medicine Mymensingh Medical College Hospital MMCH Bangladesh July 2019 December 2019 sample size 67 Purposive sampling technique employed Patients community acquired pneumonia CAP aged ≥14 year sex recently developed radiological pulmonary shadowing compatible clinical symptom sign included Patients chronically immunosuppressed chronic starvation advanced liver disease chronic kidney disease without receiving haemodialysis excluded Data analysis done SPSS software Windows version 230 mean age 657±153 years majority 13194 patient chronic lung disease 12179 diabetes mellitus 9134 heart failure 690 cerebrovascular disease 690 neoplastic disease 575 chronic renal failure Majority 22328 patient CURB65 score 3 12545 albumin level 20gl 9409 albumin level 200249gl 145 albumin level 2529gl 17254 score 45 10588 albumin level 20gl 7412 albumin level 200249gl 15224 score 2 13194 score 01 Negative significant correction r0782 p0001 found CURB65 score albumin level Significant number patient severe CAP show low serum albumin level admission statistically significant compared CURB65 score Thus hypoalbuminaemia may good marker severity patient CAP",
        "mesh_terms": [
            "Humans",
            "Middle Aged",
            "Aged",
            "Aged, 80 and over",
            "Hypoalbuminemia",
            "Cross-Sectional Studies",
            "Pneumonia",
            "Community-Acquired Infections",
            "Serum Albumin",
            "Severity of Illness Index",
            "Prognosis",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37777888/"
    },
    {
        "pmid": "37777883",
        "title": "Status of Serum Zinc and Albumin in Hospital Admitted Chronic Kidney Disease Patients in Mymensingh Locality.",
        "abstract": "crosssectional study conducted department Biochemistry Mymensingh Medical College cooperation Nephrology department Mymensingh Medical College Hospital Bangladesh January December 2021 study carried evaluate status serum zinc albumin patient CKD dialysis monitoring disease progression purpose 110 subject included 55 Hospital admitted CKD patient considered Group 55 normal healthy individual Group II Serum zinc albumin determined colorimetric method sample Statistical analysis performed SPSS window package version 210 Among study group mean serum zinc 8864±921μgdl 10211±1293μgdl serum albumin 362±026gdl 416±069gdl Group Group II respectively Analysis showed mean serum zinc albumin highly significantly p0001 decreased CKD patient comparison healthy individual Significant positive correlation found serum zinc albumin",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Case-Control Studies",
            "Serum Albumin",
            "Bangladesh",
            "Renal Insufficiency, Chronic",
            "Hospitals",
            "Zinc"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37777883/"
    },
    {
        "pmid": "37777881",
        "title": "Study on Blood Pressure, e-GFR, Serum Albumin, C-reactive Protein in Normal Subjects and Patients with CKD.",
        "abstract": "general Kidney disease silent apparent early symptom chronic kidney disease CKD marked gradual loss kidney function time High rate inflammation common CKD cause high CRP level High CRP level associated low eGFR low serum albumin level study conducted determine change blood pressure estimated glomerular filtration rate serum albumin Creactive protein chronic kidney diseased patient compared healthy subjects analytical type cross sectional study carried Department Physiology Mymensingh Medical College Bangladesh July 2021 June 2022 total number 140 subjects age range 2570 year included study Among them 70 healthy subject taken control group Group I 35 male IA 35 female IB 70 chronic kidney diseased patient taken study group Group II 35 male IIA 35 female IIB Calculation estimated glomerular filtration rate eGFR done chronic kidney disease epidemiology collaboration CKDEPI equation Data expressed mean±SD statistical significance difference among group calculated unpaired ttest study found eGFR in IIA 2983±073 mlmin IIB 3080±073mlmin serum albumin in IIA 296±004gdl IIB 207±002gdl significantly decreased study group comparison control group Blood pressure SBP IIA 15057±170 mm Hg IIB 14371±132 mm Hg DBP IIA 9440±070 IIB 9120±070 mm Hg Creactive protein CRP in IIA 1214±090mgl IIB 2180±258mgl significantly increased study group comparison control group CKD associated increased risk several comorbidities including cardiovascular complication chronic renal failure Detection CKD early stage help reduce progression renal disease burden end stage renal disease",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Aged",
            "C-Reactive Protein",
            "Serum Albumin",
            "Blood Pressure",
            "Cross-Sectional Studies",
            "Renal Insufficiency, Chronic",
            "Glomerular Filtration Rate",
            "Kidney Failure, Chronic",
            "Chronic Disease",
            "Mercury",
            "Creatinine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37777881/"
    },
    {
        "pmid": "37733829",
        "title": "Dialysis capacity and nutrition care across Bangladesh: A situational assessment.",
        "abstract": "Hemodialysis HD treatment ensuring survival endstage kidney disease ESKD patients nutrition care integral management sent questionnaire evaluate total dialysis service capacity nutrition service across dialysis facility DF Bangladesh response 149 166 active DFs Survey result revealed 497 DFs operated two shifts 423 operated three shift daily 745 holding one ten dialysis machines Sixtythree percent DFs served one 25 patient per week 77 patient received twiceweekly dialysis average cost firsttime dialysis 2800 BDT per session range 25003000 BDT lower reused dialyzer used 2100 BDT range 17002800 BDT Nutritionists available 21 DFs Parameters related nutritional health screening serum albumin BMI MISmalnutrition inflammation assessment dietary intakes carried 376 235 2 2 DFs respectively recommended physicians Nutrition education recommended provided 685 DFs 176 delivered nutritionists recommendation using renalspecific oral nutrition supplement ONS familiar practice Bangladeshi DFs and therefore scarcely recommended Dialysis capacity across Bangladesh inadequate meet current projected need nutrition education support across DFs benefit improving patients quality life also inadequate",
        "mesh_terms": [
            "Humans",
            "Renal Dialysis",
            "Bangladesh",
            "Quality of Life",
            "Nutrition Therapy",
            "Kidney Failure, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37733829/"
    },
    {
        "pmid": "37531211",
        "title": "Global Dialysis Perspective: Bangladesh.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Renal Dialysis",
            "Bangladesh",
            "Kidney Failure, Chronic",
            "Peritoneal Dialysis, Continuous Ambulatory"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37531211/"
    },
    {
        "pmid": "37391950",
        "title": "Status of Serum Calcium and Magnesium in Hospital Admitted Chronic Kidney Disease Patients in Mymensingh Locality of Bangladesh.",
        "abstract": "study designed evaluate serum calcium magnesium level hospitalized patient Chronic Kidney Disease CKD crosssectional study carried Department Biochemistry Mymensingh Medical College MMC Bangladesh help Department Nephrology Mymensingh Medical College Hospital Bangladesh period January 2021 December 2021 subject selected basis inclusion exclusion criterion purposive convenient sampling method total 110 subject included study Among them 55 diagnosed CKD patient denoted Group 55 normal healthy individual denoted Group II subject briefed written consent taken aseptic precaution 50ml venous blood collected median cubital vein Analyses carried Department Biochemistry Mymensingh Medical College serum calcium magnesium level measured value expressed Mean±SD statistical analysis done using SPSS statistical package social science window package version 210 Statistical significance difference Group Group II evaluated using Students unpaired t test significance defined p005 Correlation done using Pearsons correlation coefficient test mean±SD value serum calcium 815±054mgdl 980±050mgdl serum magnesium 225±017mgdl 195±050mgdl Group Group II respectively found mean serum calcium highly significantly 0001 decreased serum magnesium highly significantly increased 0001 CKD patient comparison healthy individual",
        "mesh_terms": [
            "Humans",
            "Magnesium",
            "Calcium",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Hospitals",
            "Renal Insufficiency, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37391950/"
    },
    {
        "pmid": "37351121",
        "title": "An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.",
        "abstract": "rising global prevalence fatty liver disease related metabolic dysfunction association common liver condition chronic kidney disease CKD become increasingly evident 2020 inclusive term metabolic dysfunctionassociated fatty liver disease MAFLD proposed replace term nonalcoholic fatty liver disease NAFLD observed association MAFLD CKD understanding CKD consequence underlying metabolic dysfunction support notion individual MAFLD higher risk developing CKD compared without MAFLD However date appropriate guidance CKD individual MAFLD Furthermore little attention paid link MAFLD CKD Nephrology community Using Delphibased approach multidisciplinary panel 50 international expert 26 country reached consensus open research question regarding link MAFLD CKD Delphibased consensus statement provided guidance epidemiology mechanisms management treatment MAFLD CKD well relationship severity MAFLD risk CKD establish framework early prevention management two common interconnected diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37351121/"
    },
    {
        "pmid": "37315095",
        "title": "Risk factors for COVID-19 mortality among telehealth patients in Bangladesh: A prospective cohort study.",
        "abstract": "Estimating contribution risk factor mortality due COVID19 particularly important setting low vaccination coverage limited public health clinical resources study risk factor COVID19 mortality used highquality data individual level low middleincome country LMICs examined contribution demographic socioeconomic clinical risk factor COVID19 mortality Bangladesh lower middleincome country South Asia used data 290488 labconfirmed COVID19 patient participated telehealth service Bangladesh May 2020 June 2021 linked COVID19 death data national database study risk factor associated mortality Multivariable logistic regression model used estimate association risk factor mortality used classification regression tree identify risk factor important clinical decisionmaking study one largest prospective cohort study COVID19 mortality LMIC covering 36 labconfirmed COVID19 case country study period found male young elderly low socioeconomic status chronic kidney liver disease infected latter pandemic period significantly associated higher risk mortality COVID19 Males 115 time higher odds 95 Confidence Interval CI 109 122 death compared females Compared reference age group 2024 year olds odds ratio mortality increased monotonically age ranging odds ratio 135 95 CI 105 173 age 3034 odds ratio 216 95 CI 1708 2738 age 7579 year group child 04 year old odds mortality 393 95 CI 274 564 time higher 2024 year olds significant predictor severe symptom COVID19 breathing difficulty fever diarrhea Patients assessed physician severe episode COVID19 based telehealth interview 1243 95 CI 1104 1399 time higher odds mortality compared assessed mild episode finding telehealth doctors assessment disease severity highly predictive subsequent COVID19 mortality underscore feasibility value telehealth services finding confirm universality certain COVID19 risk factorssuch gender agewhile highlighting risk factor appear or less relevant context Bangladesh finding demographic socioeconomic clinical risk factor COVID19 mortality help guide public health clinical decisionmaking Harnessing benefit telehealth system optimizing care risk mortality particularly context LMIC key takeaway study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37315095/"
    },
    {
        "pmid": "37113855",
        "title": "Exploring the possible therapeutic role of influenza vaccine in chronic kidney disease patients.",
        "abstract": "Chronic kidney disease CKD irreversible change kidney function structure prevalence 91 worldwide Toxins heavy metal exposure well hypertension diabetes mellitus common cause CKD Despite extensive therapeutic option renal replacement therapy renal transplants change kidney function remain irreversible causing lifelong morbidity affecting quality life patients Increased susceptibility infection well serious complication influenza major cause concern nephrological care Therefore imperative consider protective role influenza vaccination seasonal influenza worsen preexisting kidney dysfunction commentary explores possible relationship influenza vaccine patient outcome CKD term complications hospitalization possibly prognostic improvement patient outcome CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37113855/"
    },
    {
        "pmid": "37113294",
        "title": "Trends in elevated waist-to-height ratio and waist circumference in U.S. adults and their associations with cardiometabolic diseases and cancer, 1999-2018.",
        "abstract": "Although waisttoheight ratio WHtR established association cardiometabolic disease trend change elevated WHtR among general population examined adequately study examined prevalence elevated WHtR waist circumference WC trend time using Joinpoint regression model among adult participated United States National Health Nutrition Examination Survey US NHANES 19992018 performed weighted logistic regression identify association central obesity subtypes prevalence comorbidities including diabetes chronic kidney disease hypertension cardiovascular disease cancer prevalence elevated WHtR increased 748 19992000 827 20172018 elevated WC also increased 469 19992000 603 20172018 Men older adults former smokers people lower education level likely elevated WHtR total 255 American adult normal WC elevated WHtR significantly higher chance suffering diabetes odds ratio OR  206 166 255 hypertension OR  175 158 193 CVD OR  132 111 157 conclusion burden elevated WHtR WC increasing among US adult throughout years change significant across subgroups also notable approximately quarter population normal WC elevated WHtR increased likelihood cardiometabolic diseases especially diabetes Future clinical practice pay attention subgroup population overlooked health risks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37113294/"
    },
    {
        "pmid": "37069256",
        "title": "Detection of the chronic kidney disease using XGBoost classifier and explaining the influence of the attributes on the model using SHAP.",
        "abstract": "Chronic kidney disease CKD condition distinguished structural functional change kidney time Studies show 10 adult worldwide affected kind CKD resulting 12 million deaths Recently CKD emerged leading cause mortality worldwide making necessary develop ComputerAided Diagnostic CAD system diagnose CKD automatically Machine Learning ML based CAD system used clinician automatically diagnosis mass people Since ML model considered black box also necessary expose influential cause behind models prediction particular output that doctor make rational decision based models output analysis feature influence model paper used XGBoost ML classifier predict whether patient CKD not Using XGBoost classifier obtained accuracy precision recall F1 score Formula see text Formula see text respectively using Formula see text features Furthermore used Biogeography Based Optimization BBO algorithm find effective subset features BBO algorithm selected almost half initial features obtained accuracy precision recall F1 score Formula see text Formula see text respectively using 13 feature selected BBO algorithm Finally explained impact feature ML model using SHapley Additive exPlanations SHAP analysis Using SHAP analysis BBO algorithm found hemoglobin albumin mostly contribute detection CKD",
        "mesh_terms": [
            "Adult",
            "Humans",
            "Renal Insufficiency, Chronic",
            "Kidney",
            "Albumins",
            "Algorithms",
            "Computer Systems",
            "Hydrolases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37069256/"
    },
    {
        "pmid": "37040382",
        "title": "Association of exposure to salinity in groundwater with chronic kidney disease among diabetic population in Bangladesh.",
        "abstract": "Globally chronic kidney disease CKD one major public health concerns CKD renal failure reported high area higher salinity however association still unclear aimed assessing association degree groundwater salinity CKD among diabetic population two selected area Bangladesh crosssectional analytic study carried among 356 diabetic patient aged 4060 year high groundwater salinity exposed Pirojpur n  151 nonexposed Dinajpur n  205 southern northern district Bangladesh respectively primary outcome presence CKD via estimated glomerular filtration rate 60 mlmin using Modification Diet Renal Disease equation Binary logistic regression analysis done nonexposed mean age 512±69 years exposed mean age 508±69 years respondents men 576 woman 629 predominant respectively proportion patient CKD found higher exposed group nonexposed group 331 vs 268 P 0199 odds OR 95 confidence interval P CKD found significantly higher high salinity exposed respondent 135 085214 0199 compared nonexposed However odds hypertension found significantly higher high salinity exposed respondent 210 137323 0001 compared nonexposed And interaction high salinity hypertension showed significant association CKD P  0009 conclusion finding suggest groundwater salinity may directly associated CKD southern Bangladesh however may indirect association disorder association hypertension groundwater salinity large scaled study required answer research hypothesis clearly",
        "mesh_terms": [
            "Male",
            "Humans",
            "Female",
            "Adult",
            "Middle Aged",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Salinity",
            "Renal Insufficiency, Chronic",
            "Diabetes Mellitus",
            "Hypertension",
            "Groundwater"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37040382/"
    },
    {
        "pmid": "37002749",
        "title": "Effect of Duration of Hemostatic Compression on Radial Artery Occlusion after Transradial Percutaneous Coronary Intervention.",
        "abstract": "Radial artery occlusion RAO major concern transradial approach TRA RAO limit future radial artery use TRA conduit CABG invasive hemodynamic monitoring creation arteriovenous fistula hemodialysis Chronic Kidney Disease CKD patient vascular approach effect duration hemostatic compression RAO unknown Bangladesh prospective observational study conducted department Cardiology National Institute Cardiovascular Diseases Dhaka Bangladesh NICVD September 2018 August 2019 evaluate effect duration hemostatic compression incidence radial artery occlusion RAO transradial percutaneous coronary intervention total 140 patient underwent percutaneous coronary intervention PCI TRA RAO defined absence antegrade flow monophasic flow invert flow Duplex study study 70 patient Group I received 2 hour hemostatic compression transradial PCI Another 70 patient Group II received 6 hour hemostatic compression transradial PCI Radial arterial blood flow assessed early 24 hours late 30 days color duplex study procedure groups Early radial artery occlusion occurred 43 patient Group 128 patient Group II p004 Late radial artery occlusion occurred 28 patient Group 114 patient Group II difference statistically significant p004 multivariate logistic regression analysis duration hemostatic compression time 6 hour p001 postprocedural nitroglycerine use p003 procedure time p003 predictor RAO Shorter duration hemostatic compression associated lower incidence early late radial artery occlusion transradial intervention",
        "mesh_terms": [
            "Humans",
            "Percutaneous Coronary Intervention",
            "Hemostatics",
            "Radial Artery",
            "Bangladesh",
            "Arterial Occlusive Diseases",
            "Cardiac Catheterization",
            "Coronary Angiography",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37002749/"
    },
    {
        "pmid": "37002740",
        "title": "Study on Body Mass Index and Fasting Serum Glucose in Patient with Chronic Kidney Disease.",
        "abstract": "BMI fasting serum glucose estimated chronic kidney diseased patient observe low body mass frequency high fasting serum glucose level chronic kidney diseased patient CKD BMI fluctuation may indicate serious comorbid conditions Wasting prevalent among patient chronic kidney disease distinguished chronic inflammation malnutrition defined consequence insufficient food intake Diabetes common cause kidney disease chronic hyperglycemia diabetes mellitus associated longterm damage dysfunction failure kidneys blood vessels nerves heart cross sectional study carried department Physiology Mymensingh Medical College Mymensingh July 2014 June 2015 study total 200 subject selected age ranged 25 60 year divided 100 healthy person control group 100 CKD patient study group control study group divided 50 male 50 female Unpaired students test used Statistical data analysis mean±SE BMI control group male study group male 2504±013 2387±041 kgm² respectively study group male mean±SE BMI decreased Result statistically significant p005 mean±SE BMI control group female study group female 2413±043 2290±027 kgm² respectively study group female mean±SE BMI decreased result significant p005 BMI decreased study group control group result statistically significant Fasting serum glucose evaluated Enzymatic colorimetric GODPAP method result showed mean±SE fasting serum glucose control group male  study group male 531±017mmolL 756±037mmolL respectively study group male mean±SE FSG increased Result statistically highly significant p00001 mean±SE FSG control group female  study group female 511±011mmolL 737±033mmolL respectively study group female mean±SE FSG increased  result highly significant p00001 According result FSG increased study group control group result statistically significant Fasting serum glucose level increased significantly chronic kidney disease patient normal healthy persons increasing frequency blood glucose level CKD may predispose patient diabetes increasing complications",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Blood Glucose",
            "Body Mass Index",
            "Cross-Sectional Studies",
            "Renal Insufficiency, Chronic",
            "Fasting",
            "Chronic Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37002740/"
    },
    {
        "pmid": "37002739",
        "title": "Serum Albumin and C-reactive protein in Hospital Admitted Patients with Chronic Kidney Disease.",
        "abstract": "Adequate knowledge cause chronic kidney disease potential prevention improve poor clinical outcome chronic kidney disease CKD patients study designed evaluate serum albumin Creactive protein CRP level hospitalized patient Chronic Kidney Disease crosssectional study carried Department Biochemistry Mymensingh Medical College Mymensingh Bangladesh collaboration Department Nephrology Mymensingh Medical College Hospital Mymensingh January 2021 December 2021 subject selected basis inclusion exclusion criterion purposive convenient sampling method total 110 subject included study Among them 55 diagnosed CKD patient denoted Group 55 normal healthy individual denoted Group II study serum albumin CRP level measured value expressed Mean±SD statistical analysis done using SPSS statistical package social science window package version 210 Statistical significance difference Group Group II evaluated using students unpaired ttest significance defined p005 Correlation done using Pearsons correlation coefficient test Mean age Group 5265±493 Group II 5115±632 p0165 mean±SD BMI 2446±184 Group 2450±105 Group II p0886 mean±SD value serum albumin 362±026gdl 416±069gdl Group Group II respectively found highly significant p0001 decrease serum albumin mean±SD value CRP 2400±1673mgL 60±000mgL Group Group II respectively So found significant p005 increase CRP levels negative correlation serum albumin CRP Analyzing finding study significant decrease serum albumin significant increase CRP level observed CKD patients",
        "mesh_terms": [
            "Humans",
            "C-Reactive Protein",
            "Serum Albumin",
            "Cross-Sectional Studies",
            "Case-Control Studies",
            "Bangladesh",
            "Renal Insufficiency, Chronic",
            "Hospitals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37002739/"
    },
    {
        "pmid": "36963092",
        "title": "National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas.",
        "abstract": "National strategy addressing chronic kidney disease CKD crucial improving kidney health sought describe countrylevel variation noncommunicable disease NCD strategy CKDspecific policy across different region income level worldwide International Society Nephrology Global Kidney Health Atlas GKHA multinational crosssectional survey conducted July October 2018 Responses key opinion leader country regarding national NCD strategies presence scope CKDspecific policies government recognition CKD health priority described overall according region income level 160 country participated GKHA survey comprising 978 worlds population Seventyfour 47 country established national NCD strategy 53 34 country reported existence CKDspecific policies substantial variation across region income levels CKDspecific policy existed nondialysis CKD care variably addressed 79 51 country identified government recognition CKD health priority Low lowmiddle income country less likely strategy policy addressing CKD government recognise health priority existence CKDspecific policies national NCD strategy broadly varied substantially across different region around world overall suboptimal major discrepancy burden CKD many country governmental recognition CKD health priority Greater recognition CKD within national health policy critical improving kidney healthcare globally",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36963092/"
    },
    {
        "pmid": "36962985",
        "title": "Healthcare-seeking experiences of older citizens in Bangladesh: A qualitative study.",
        "abstract": "Despite improvement many health indicator last decades providing access affordable quality healthcare older citizen remains considerable challenge Bangladesh study aimed understand individual experiences regarding healthcareseeking treatment cost accessibility coping mechanism promotion appropriate strategy enhance quality life older citizen BangladeshA qualitative descriptive approach used study total 27 InDepth Interviews IDIs conducted district Bangladesh older people January February 2020 gender distribution equal Facetoface interview conducted trained experienced interviewer regarding healthcareseeking accessibility affordability healthcare coping strategy Thematic analysis conducted analyse data found health condition older population satisfactory suffering several disease benign tumor chronic kidney disease body aches gastric ulcer longer period time majority participant suffering multiple noncommunicable disease diabetes hypertension foremost diseases study provides insight challenge managing healthcare service older citizen Bangladesh Healthcare facility available high outofpocket payments lack caregivers time distance created barrier service provision finding indicated geriatric care policymakers service provider prioritize olderfriendly health infrastructure affordable cost treatment betterment health status older citizen Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36962985/"
    },
    {
        "pmid": "36803682",
        "title": "Association between hyperuricemia and chronic kidney disease: a cross-sectional study in Bangladeshi adults.",
        "abstract": "Chronic kidney disease CKD public health concern worldwide recognized significant risk factor cardiovascular disease elevated level uric acid hyperuricemia suggested associated obesity hypertension cardiovascular disease diabetes However limited information relationship hyperuricemia CKD Therefore study aimed estimate prevalence CKD assess relationship hyperuricemia Bangladeshi adults study blood sample collected 545 participant 398 male 147 females aged ≥ 18 years Biochemical parameter serum uric acid SUA lipid profile markers glucose creatinine urea measured colorimetric methods estimated glomerular filtration rate eGFR CKD determined based serum creatinine level existed formula Multivariate logistic regression analysis performed evaluate association SUA CKD overall prevalence CKD 59 61 male 52 females Hyperuricemia prevalent 187 participant 232 male 146 females increasing trend CKD prevalence observed increasing age groups mean eGFR level significantly lower male 951 ± 318 mlmin173msup2sup female 1093 ± 774 mlmin173msup2sup subject p  001 mean level SUA significantly higher p  001 participant CKD 71 ± 19 mgdL participant without CKD 57 ± 16 mgdL decreasing trend eGFR concentration increasing trend CKD prevalence observed across SUA quartile p  0001 regression analysis significant positive association found hyperuricemia CKD study showed independent association hyperuricemia CKD Bangladeshi adults mechanistic study needed explore potential link hyperuricemia CKD",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Male",
            "Female",
            "Hyperuricemia",
            "Cross-Sectional Studies",
            "Uric Acid",
            "Cardiovascular Diseases",
            "Renal Insufficiency, Chronic",
            "Risk Factors",
            "Glomerular Filtration Rate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36803682/"
    },
    {
        "pmid": "36768246",
        "title": "Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease.",
        "abstract": "Inappropriate mineralocorticoid receptor MR activation different cardiovascular cell type deleterious effect cardiac remodeling function Therefore MR inhibition crucial pharmacological strategy overcome cardiovascular dysfunction Despite efficient blockade MR steroidal MR antagonist MRAs clinical application unsatisfactory due adverse effects Newer nonsteroidal MRAs greater potency could suitable clinical application especially patient type 2 diabetes mellitus chronic kidney disease Although clinical evidence shown beneficial effect nonsteroidal MRAs cardiovascular outcome patient heart failure reduced ejection fraction clinical trial ongoing evaluate efficacy heart failure preserved ejection fraction Therefore comparative pharmacological characterization nonsteroidal MRAs classic steroidal MRAs crucial Here summarize preclinical evidence nonsteroidal MRAs suggests improvement cardiac dysfunction well underlying molecular mechanism animal model mimicking different clinical conditions addition discus uptodate information clinical trial regarding beneficial effect nonsteroidal MRAs meaningful cardiovascular outcomes preclinical clinical evidence support treatment nonsteroidal MRAs patient cardiovascular disease",
        "mesh_terms": [
            "Animals",
            "Cardiovascular Diseases",
            "Mineralocorticoid Receptor Antagonists",
            "Diabetes Mellitus, Type 2",
            "Mineralocorticoids",
            "Heart Failure"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36768246/"
    },
    {
        "pmid": "39077396",
        "title": "Identifying Risk Factors for Prolonged Length of Stay in Hospital and Developing Prediction Models for Patients with Cardiac Arrest Receiving Targeted Temperature Management.",
        "abstract": "Prolonged length stay LOS following targeted temperature management TTM administered cardiac arrest may affect healthcare plan expenditures study identified risk factor prolonged LOS patient cardiac arrest receiving TTM explored association LOS neurological outcome TTM retrospective cohort consisted 571 nontraumatic cardiac arrest patient aged 18 year older treated cardiopulmonary resuscitation CPR Glasgow Coma Scale score math xmlnshttpwwww3org1998MathMathMLmomomath 8 unable comply command restoration spontaneous circulation ROSC received TTM less 12 hour ROSC Prolonged LOS defined LOS beyond 75th quartile entire cohort analyzed compared relevant variable neurological outcome patient without prolonged LOS established prediction model estimating risk prolonged LOS patient inhospital cardiac arrest longer LOS outofhospital cardiac arrest ipi  00001 Duration CPR ipi  002 underlying heart failure ipi  0001 chronic obstructive pulmonary disease ipi  0008 chronic kidney disease ipi  0026 postTTM seizure ipi  0003 risk factor prolonged LOS LOS associated survival hospital discharge patient lowest highest Cerebral Performance Category score discharge shorter LOS logistic regression model based parameter discharge achieved area curve 0840 0896 prolonged LOS prediction indicating favorable performance model predicting LOS patient receiving TTM study identified clinically relevant risk factor prolonged LOS following TTM developed prediction model exhibited adequate predictive performance finding study broaden understanding regarding factor associated hospital stay beneficial making clinical decision patient cardiac arrest receive TTM",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39077396/"
    },
    {
        "pmid": "36714452",
        "title": "Chronic kidney disease prediction based on machine learning algorithms.",
        "abstract": "Chronic kidney disease CKD dangerous ailment last persons entire life caused either kidney malignancy decreased kidney functioning feasible halt slow progression chronic disease endstage wherein dialysis surgical intervention method preserve patients life Earlier detection appropriate therapy increase likelihood happening Throughout research potential several different machine learning approach providing early diagnosis CKD investigated significant amount research conducted topic Nevertheless bolstering approach making use predictive modeling Therefore approach investigate link exists data factor well characteristic target class capable constructing collection prediction model help machine learning predictive analytics thanks better measure attribute introduced using predictive modeling study start 25 variable addition class property end narrowed list 30 parameter best subset identify CKD Twelve different machine learningbased classifier tested supervised learning environment Within confines supervised learning environment total 12 different machine learningbased classifier indeed examined greatest performance indicator accuracy 0983 precision 098 recall 098 F1score 098 XgBoost classifier way research done lead conclusion recent improvement machine learning along help predictive modeling make interesting way find new solution used test accuracy prediction field kidney disease beyond",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36714452/"
    },
    {
        "pmid": "36595846",
        "title": "Association of hypernatremia with outcomes of COVID-19 patients: A protocol for systematic review and meta-analysis.",
        "abstract": "systematic review metaanalysis aimed assess association hypernatremia outcome COVID19 patients performed systematic literature search PubMed Google Scholar Science Direct October 2021 found total 131 papers meticulous screening finally 17 paper met inclusion criteria COVID19 patient sodium level greater reference level study population outcome interest poor outcome mortality mechanical ventilation intensive care unit ICU admission prolonged hospital stay pooled estimate calculated odds ratio OR 19032 patient hypernatremia 17 study included overall random effect metaanalysis showed hypernatremia associated mortality OR 318 161 628 P  0001 I2  9199 prolong hospitalization OR 197 137 283 P  001 I2  000 Ventilation OR 540 189 1542 P  001 I2  7735 ICU admission OR 399 089 1778 P  07 I2  8679 Metaregression analysis showed association age ICU outcome hypernatremia patients Whereas parameter like male hypertension chronic kidney disease diabetes mellitus significantly influence odds ratio Hypernatremia markedly associated poor outcome patient COVID19 Hence blood ionogram warranted special attention must given hypernatremia COVID19 patients",
        "mesh_terms": [
            "Humans",
            "Male",
            "COVID-19",
            "Hypernatremia",
            "Intensive Care Units",
            "Meta-Analysis as Topic",
            "Systematic Reviews as Topic",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36595846/"
    },
    {
        "pmid": "36594314",
        "title": "Relationship between Renal Function and Bone Mineral Density in Postmenopausal Women.",
        "abstract": "Renal insufficiency risk factor osteoporosis increase risk fracture may result agerelated decline renal function chronic kidney disease patient CKD accurate diagnosis osteoporosis CKDMBD important determining appropriate treatment cross sectional study done Institute nuclear medicine Allied Sciences BSMMU Dhaka 1st January 2014 31st December 2014 Study population total 69 postmenopausal woman age 50 years Women Bilateral hip replacement bilateral hip pin screws metallic rod spine Carrying BMD scan within week radiological investigation using contrast medium eg Barium meal enema IVPs excluded study Clinical variable were age years height cm weight kg BMI Laboratory variable were serum creatinine BMD Dexa Estimated GFR determined using serum Creatinine MDRD formula Renal function test Bone mineral density BMD done patients Majority 434 patient 6th decade mean weight found 574±112kg Majority 41594 patient belonged score hip 1 25 mean score hip found 11±11 Osteopenia osteoporosis found 594 43 respectively according BMD High serum creatinine level found 101 cases Renal function impairment found 796 patient Majority 507 patient mild decrease eGFR 6089 mlmin173m² Pearsons correlation r0156 p0200 significant found age score hip patients Positive Pearsons correlation r0112 p0361 found significant age serum creatinine level significant negative Pearsons correlation r 0274 p0023 found score hip serum creatinine level patients significant negative Spearman correlation r0278 p0021 found BMD serum creatinine patients significant positive Spearman correlation r0580 p0001 found BMD estimated GFR patients study undertaken evaluate relationship renal function bone mineral density postmenopausal women Majority postmenopausal woman 6th decade overweight obese Renal function impairment found 796 patient Osteoporosis found 043 203 case according score hip score lumber spine respectively Significant negative Pearsons correlation found score hip serum creatinine level patients Significant negative Spearman correlation found BMD serum creatinine patients Significant positive Spearman correlation found BMD estimated GFR patients",
        "mesh_terms": [
            "Humans",
            "Female",
            "Middle Aged",
            "Bone Density",
            "Cross-Sectional Studies",
            "Creatinine",
            "Postmenopause",
            "Bangladesh",
            "Osteoporosis",
            "Renal Insufficiency, Chronic",
            "Kidney",
            "Absorptiometry, Photon"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36594314/"
    },
    {
        "pmid": "36529768",
        "title": "Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018.",
        "abstract": "Human immunodeficiency virus acquired immune deficiency syndrome HIVAIDS still among leading cause disease burden mortality subSaharan Africa SSA world track meet target set ending epidemic Joint United Nations Programme HIVAIDS UNAIDS United Nations Sustainable Development Goals SDGs Precise HIV burden information critical effective geographic epidemiological targeting prevention treatment interventions Age sexspecific HIV prevalence estimate widely available national level regionwide local estimate recently published adult overall add dimensionality previous analysis estimating HIV prevalence local scales stratified sexspecific 5year age group adult age 1559 year across SSA analyzed data 91 seroprevalence survey sentinel surveillance among antenatal care clinic ANC attendee using modelbased geostatistical method produce estimate HIV prevalence across 43 country SSA year 2000 2018 5 × 5km resolution presented among second administrative level typically district counties units found substantial variation HIV prevalence across localities ages sex masked earlier analyses Withincountry variation prevalence 2018 median 35 time greater across age sexes compared adult combined note large withindistrict prevalence difference age groups men 50 district displayed least 14fold difference age group highest lowest prevalence least 9fold difference women Prevalence trend also varied time 2000 2018 70 district saw reduction prevalence greater five percentage point least one sex age group Meanwhile 30 district saw least five percentage point prevalence increase one sex age group HIV epidemic persists evolves SSA geographic demographic shift prevention treatment effort necessary estimate offer epidemiologically informative detail better guide targeted interventions vital combating HIV SSA",
        "mesh_terms": [
            "Male",
            "Female",
            "Adult",
            "Humans",
            "Pregnancy",
            "Adolescent",
            "Young Adult",
            "Middle Aged",
            "HIV",
            "Acquired Immunodeficiency Syndrome",
            "Prevalence",
            "Seroepidemiologic Studies",
            "HIV Infections",
            "Africa South of the Sahara"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36529768/"
    },
    {
        "pmid": "36504990",
        "title": "Trends in global burden of diseases attributable to lead exposure in 204 countries and territories from 1990 to 2019.",
        "abstract": "Lead hazard ubiquitous environment lead exposure proved damage human health Nevertheless limited data global burden disease attributable lead exposure study evaluated temporalspatial trend disease burden caused lead exposure 204 country territory 1990 2019 Based Global Burden Disease GBD Study 2019 deaths disabilityadjusted life year DALYs agestandardized mortality rate ASMR DALYs rate ASDR estimated region country sex age estimated annual percentage change EAPC calculated assess temporal trend ASMR ASDR 1990 2019 Global death increased 053 95 UI 031 077 090 95 UI 055 129 million number DALYs increased 1602 95 UI 1032 2217 2168 95 UI 1381 3030 million 1990 2019 China India Bangladesh top three country largest number death DALYs 2019 ASMR per 100000 population decreased 1447 95 UI 840 2143 1148 95 UI 700 1649 EAPC 075 95 UI 087 064 ASDR per 100000 population decreased 37801 95 UI 24055 52418 26752 95 UI 17057 37344 EAPC 119 95 UI 132 107 disease burden lead exposure occurred men elderly population Stroke ischemic heart disease two key source disease burden lead exposure Also negative association sociodemographic index SDI disease burden lead exposure observed Lead exposure pose significant disease burden globally still great threat public health Primary prevention measure reducing lead exposure environment essential",
        "mesh_terms": [
            "Male",
            "Humans",
            "Aged",
            "Lead",
            "Cost of Illness",
            "Bangladesh",
            "China",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36504990/"
    },
    {
        "pmid": "36362919",
        "title": "An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1.",
        "abstract": "Fibrosis hallmark progressive kidney diseases overexpression profibrotic cytokine namely transforming growth factor β TGFβ due excessive inflammation tissue damage induces kidney fibrosis inhibition TGFβ signaling markedly limited experimental disease models Targeting TGFβ signaling therefore offer prospective strategy management kidney fibrosis Presently marketed drug numerous side effects plantderived compound relatively safer costeffective study TGFβR1 targeted identify lead compound among flavonoid using various computational approaches ADMET absorption distribution metabolism excretiontoxicity analysis molecular docking molecular dynamic simulation ADMET screening identified total 31 flavonoid druglike property 31 compounds total 5 compound showed higher binding affinity TGFβR1 Epicatechin Fisetin Luteolin ranking top three 1358 1317 1050 kcalmol respectively comparable control drug linagliptin 9074 kcalmol compound also exhibited outstanding proteinligand interactions molecular dynamic simulation revealed stable interaction compound binding site TGFβR1 finding indicate flavonoids particularly Epicatechin Fisetin Luteolin may compete ligandbinding site TGFβR1 suggesting compound evaluated development potential therapeutic kidney fibrosis Further iinvitroi iinvivoi study recommended support current findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36362919/"
    },
    {
        "pmid": "36316853",
        "title": "Effect of vitamin and mineral supplementation on nutritional status in children with chronic kidney disease: Protocol for a systematic review and meta-analysis.",
        "abstract": "Persistent kidney illness child dialysis therapy risk vitamin mineral deficiency due abnormal renal metabolism anorexia inadequate intake poor gastrointestinal absorption drugnutrient interaction dialysisrelated losses Adequate nutritional management essential achieve maintain optimal nutritional status usual pattern growth sexual neurocognitive development metabolic abnormalities ultimately reducing risk chronic mortality morbidity adulthood purpose paper describe protocol systematic review assess effect vitamin mineral supplementation child chronic renal disease systematic review protocol developed according Preferred Reporting Item Systematic Review MetaAnalysis Protocols PRISMAP well Cochrane group guidelines Comprehensive searching possible relevant work literature PubMed Google Scholar MEDLINE Embase Web Science Cochrane Central Register Controlled Trials CENTRAL ScienceDirect Scopus ResearchGate Clinical Trials randomized controlled studies full paper articles article written English considered primary outcome review measuring change such change body mass BMI overall Zscore nutritional status child age  18 years chronic kidney disease following vitamin mineral supplementations review help better understand effect vitamin mineral supplementation improve nutritional status CKD child create guideline determine applicability intervention different feasible settings systematic review protocol evaluated approved institutional review board North South University Finding shared using traditional approaches including scientific presentations openaccess peerreviewed platforms CRD42022341339",
        "mesh_terms": [
            "Child",
            "Humans",
            "Adult",
            "Adolescent",
            "Vitamins",
            "Nutritional Status",
            "Renal Dialysis",
            "Systematic Reviews as Topic",
            "Meta-Analysis as Topic",
            "Renal Insufficiency, Chronic",
            "Dietary Supplements",
            "Minerals",
            "Review Literature as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36316853/"
    },
    {
        "pmid": "36314741",
        "title": "System biology approaches identified novel biomarkers and their signaling pathways involved in renal cell carcinoma with different human diseases.",
        "abstract": "Renal cell carcinoma RCC type cancer develops renal epithelium kidney responsible approximately 3 adult malignancies 9095 neoplasm originate kidney Advances tumor diagnosis innovative immune therapeutics checkpoint inhibitorsbased treatment option improved survival rate patient RCC accompanied different risk factors RCC patient diabetes hepatitis C virus HCV obesity OB may comorbidity finding risk factor better clinical treatment urgent issue Therefore study focused networkbased gene expression analysis approach learning impact RCC comorbidities associated disease study found critical genetic factor signal transduction pathway share pathophysiology commonly use dysregulated gene illness Initially study identified 385 upregulated gene 338 downregulated gene involved RCC OB chronic kidney disease CKD type 2 diabetes T2D HCV significantly shared 28 14 5 3 genes respectively RCC shared one downregulated gene versican VCAN OB HCV one downregulated gene oxidase homolog 2 LOXL2 OB CKD Interestingly shared pathway linked metabolism study also identified six prospective biomarkers signaling pathways numerous critical regulatory associated drug candidate disease believe discovery help explain diseases complicated interplay aid developing novel therapeutic target drug candidates",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Carcinoma, Renal Cell",
            "Kidney Neoplasms",
            "Diabetes Mellitus, Type 2",
            "Biomarkers",
            "Signal Transduction",
            "Biology",
            "Hepatitis C",
            "Renal Insufficiency, Chronic",
            "Gene Expression Regulation, Neoplastic",
            "Biomarkers, Tumor"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36314741/"
    },
    {
        "pmid": "36217525",
        "title": "Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings.",
        "abstract": "Glomerular disease leading driver nondiabetic chronic kidney disease disabilityadjusted life year resourcelimited countries Proper diagnosis treatment relies resource including kidney biopsy ancillary testing access evidencebased therapies conducted crosssectional internetbased survey cascaded society mailing list among nephrologists country Asia Africa Eastern Europe collected data respondent demographics ability perform appropriately interpret kidney biopsy access complementary investigation treatment practices total 298 kidney care specialist 33 country 533 Asia 446 Africa 64 academic university hospitals participated survey specialists 85 performed kidney biopsy 61 respondent could obtain kidney biopsy 50 patient suspected glomerular disease 43 respondent Africa access light microscopy Overall inability undertake fully evaluate biopsy perform ancillary investigation profound Africa Asia Overall 59 participant reported 75 patient meet cost diagnosis treatment outofpocket payments Empirical use immunosuppression higher Africa Asia main barrier diagnosis treatment included delayed presentation incomplete diagnostic workup high cost treatment Major systemlevel barrier impede implementation guidelinedriven approach diagnosis treatment patient glomerular disease resourcelimited countries",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36217525/"
    },
    {
        "pmid": "36189556",
        "title": "Prevalence and Risk Factors of Secondary Hyperparathyroidism among CKD Patients and Correlation with Different Laboratory Parameters.",
        "abstract": "Hyperthyroidism one major complication CKD patient result number metabolic disorder contributes morbidity mortality objective study investigate prevalence risk factor secondary hyperparathyroidism among CKD patient well correlation different laboratory parameters crosssectional study conducted among admitted CKD patient Sylhet MAG Osmani Medical College Hospital Sylhet Bangladesh January 2019 December 2019 Following recruitment clinical parameter extracted patients medical records Afterward blood sample blood collected measure biochemical parameter serum parathyroid hormone levels binary logistic regression model used assess factor associated hyperparathyroidism mean±SD serum PTH CKD patient 21504±16815 pgml overall prevalence secondary hyperparathyroidism among CKD patient 750 320 stage 3 880 stage 4 930 stage 5 CKD Serum PTH level significant positive correlation serum creatinine serum phosphate level significant negative correlation serum albumin serum calcium levels However female sex revealed significant risk factor adjusted regression model aOR 026 95 CI 007098 male sex compared female sex prevalence secondary hyperparathyroidism increase advanced stage CKD early detection management CKD crucial prevent metabolic disorder could trigger development complication",
        "mesh_terms": [
            "Bangladesh",
            "Calcium",
            "Creatinine",
            "Cross-Sectional Studies",
            "Female",
            "Humans",
            "Hyperparathyroidism, Secondary",
            "Male",
            "Metabolic Diseases",
            "Parathyroid Hormone",
            "Phosphates",
            "Prevalence",
            "Renal Insufficiency, Chronic",
            "Risk Factors",
            "Serum Albumin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36189556/"
    },
    {
        "pmid": "36189552",
        "title": "Predictors of In-hospital Mortality in Patients Presenting with Acute Coronary Syndromes in a Tertiary Cardiac Center in Dhaka, Bangladesh.",
        "abstract": "outcome acute coronary syndrome ACS vary internationally given regional difference patient comorbidities access health care interventional procedure adherence guidelinebased management practices study aimed identify predictor mortality large ACS registry patient admitted tertiary care cardiac centre Dhaka Bangladesh hospital record based retrospective cross sectional observational study included patient presenting ACS Ibrahim Cardiac Hospital Research Institute Dhaka Bangladesh January 2013 December 2013 Data collected cardiac catheterization laboratory database hospital discharge records Statistical analysis done using Statistical Package Social Sciences SPSS version 160 p value 005 considered statistically significant Ethical approval obtained Institutional Review Board hospital total 1914 ACS patient studied 398 presented STelevation myocardial infarction STEMI 397 nonSTelevation myocardial infarction NSTEMI 205 unstable angina UA 146 inhospital death 76 Mortality highest among STEMI patient 105 followed NSTEMI 81 UA 103 mean age expired patient significantly higher survived 6482±1214 year vs 5732±1199 years p0001 Male patient 714 significant gender difference observed expired surviving groups Age 50 year odds ratio OR 256 p0005 chronic kidney disease CKD OR 21 p0001 shock OR 1682 p0001 left ventricular failure LVF OR 243 p0001 STEMI OR 192 p0002 independent predictor mortality among ACS patients Although diabetes per se associated mortality OR 13 95 CI089191 p0169 uncontrolled diabetes defined HbA1c level ≥75 significant risk mortality OR 514 p0001 ACS patient undergo angiography OR 164 p0001 PCI OR 189 p0001 greater risk mortality ACS patient complicated shock LVF uncontrolled diabetes CKD increased risk inhospital mortality Improved outcome may likely prompt angiography PCI index admission study preliminary initiative prospective multicentre registry nationwide involvement warranted",
        "mesh_terms": [
            "Acute Coronary Syndrome",
            "Aged",
            "Angina, Unstable",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Glycated Hemoglobin",
            "Hospital Mortality",
            "Humans",
            "Male",
            "Middle Aged",
            "Non-ST Elevated Myocardial Infarction",
            "Percutaneous Coronary Intervention",
            "Prospective Studies",
            "Renal Insufficiency, Chronic",
            "Retrospective Studies",
            "Risk Factors",
            "ST Elevation Myocardial Infarction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36189552/"
    },
    {
        "pmid": "36189533",
        "title": "Study on Serum Calcium Level in Patients with Chronic Kidney Disease.",
        "abstract": "Patients often present chronic kidney disease CKD complicated hypocalcaemia Lower serum calcium independently associated chronic kidney disease Aim study assess serum calcium level chronic kidney diseased patient order compare parameter healthy subjects analytical type crosssectional study carried Physiology department Mymensingh Medical College Mymensingh Bangladesh July 2018 June 2019 total number 200 subjects age range 3070 year included study Among 200 subjects 100 healthy taken control group Group I 100 chronic kidney diseased patient taken study group Group II Control group Group I subdivided male healthy subject Group IA female healthy subject Group IB Also study group Group II subdivided male chronic kidney diseased patient Group IIA female chronic kidney diseased patient Group IIB result calculated analyzed using SPSS version21 Expression data mean±SE statistical significance difference among group calculated unpaired students t test study found mean±SE serum calcium Group IA Group IIA 960±009mgdl  804±003mgdl respectively mean±SE serum calcium Group IB Group IIB 938±0096mgdl  819±005mgdl respectively Serum calcium significantly decreased study group comparison control group p0001 study therefore recommended routine estimation parameter important prevention complication related chronic kidney disease leading healthy life",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Bangladesh",
            "Calcium",
            "Chronic Disease",
            "Cross-Sectional Studies",
            "Female",
            "Glomerulonephritis",
            "Humans",
            "Kidney",
            "Male",
            "Middle Aged",
            "Renal Insufficiency, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36189533/"
    },
    {
        "pmid": "36143293",
        "title": "Nomogram-Based Chronic Kidney Disease Prediction Model for Type 1 Diabetes Mellitus Patients Using Routine Pathological Data.",
        "abstract": "Type 1 diabetes mellitus T1DM patient significant threat chronic kidney disease CKD development life However always high chance delay CKD detection CKD asymptomatic T1DM patient bypass traditional CKD test routine checkups study aim develop validate prediction model nomogram CKD T1DM patient using readily available routine checkup data early CKD detection research utilized 1375 T1DM patients sixteen year longitudinal data multicenter Epidemiology Diabetes Interventions Complications EDIC clinical trial conducted 28 site USA Canada considered 17 routinely available features Three feature ranking algorithms extreme gradient boosting XGB random forest RF extremely randomized tree classifier ERT applied create three feature ranking lists logistic regression analysis performed develop CKD prediction model using ranked feature list identify best performing topranked feature combination Finally significant feature selected develop multivariate logistic regressionbased CKD prediction model T1DM patients model evaluated using sensitivity specificity accuracy precision F1 score train test data nomogram final model generated easy application clinical practices Hypertension duration diabetes drinking habit triglycerides ACE inhibitors lowdensity lipoprotein LDL cholesterol age smoking habit top8 feature ranked XGB model identified important feature predicting CKD T1DM patients eight feature selected develop final prediction model using multivariate logistic regression showed 9004 8859 accuracy internal test data validation proposed model showed excellent performance used CKD identification T1DM patient routine checkups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36143293/"
    },
    {
        "pmid": "35987656",
        "title": "Disease-specific distress healthcare financing and catastrophic out-of-pocket expenditure for hospitalization in Bangladesh.",
        "abstract": "Financial risk protection equity two fundamental component global commitment achieve Universal Health Coverage UHC mandate health system reform based population needs disease incidence economic burden ensure everyone access health service without financial hardship estimated diseasespecific incidence catastrophic outofpocket health expenditure distress financing investigate progress toward UHC financial risk indicator investigated inequality financial risk protection indicator wealth quintiles addition explored determinant financial hardship indicator result hospitalization costs order conduct research data extracted latest Bangladesh Household Income Expenditure Survey HIES conducted Bangladesh Bureau Statistics 20162017 Financial hardship indicator UHC measured catastrophic health expenditure distress financing salemortgage borrowing family support Concentration curve CC index CI estimated measure pattern severity inequality across socioeconomic classes Binary logistic regression model used assess determinant catastrophic health expenditure distress financing found 26 household incurred catastrophic health expenditure CHE 58 faced distress financing hospitalization Bangladesh highest incidence CHE cancer 50 followed liver disease 492 paralysis 436 financial hardship indicator term CHE CI  0109 distress financing CI  0087 concentrated among lowincome households Hospital admission private health facilities noncommunicable diseases presence chronic patient household significantly increase likelihood higher UHC financial hardship indicators study finding strongly suggest need nationallevel social health security scheme particular focus lowincome households since identified greater inequality low highincome household UHC financial hardship indicators Regulating private sector implementing subsidized healthcare programme disease high treatment costs cancer heart disease liver disease kidney disease also expected effective protect household financial hardship Finally order reduce reliance OOPE government consider increasing allocation health sector",
        "mesh_terms": [
            "Bangladesh",
            "Catastrophic Illness",
            "Family Characteristics",
            "Financing, Personal",
            "Health Expenditures",
            "Healthcare Financing",
            "Hospitalization",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35987656/"
    },
    {
        "pmid": "35969429",
        "title": "Chronic Kidney Disease Awareness Campaign and Mobile Health Education to Improve Knowledge, Quality of Life, and Motivation for a Healthy Lifestyle Among Patients With Chronic Kidney Disease in Bangladesh: Randomized Controlled Trial.",
        "abstract": "Chronic kidney disease CKD linked major health consequence poor quality life Despite fact CKD becoming prevalent public knowledge disease remains low study aimed evaluate outcome health education intervention designed enhance knowledge healthrelated quality life QOL motivation healthy lifestyle among adult CKD study parallelgroup 11 randomized controlled trial Mirzapur subdistrict Bangladesh compared 2 group patient CKD Adults CKD stages 13 enrolled November 2020 randomly assigned intervention control group intervention group received health education CKD awareness campaign mobile health technology observed 6 months whereas control group received standard treatment primary outcome evaluation improved score CKD knowledge questionnaire secondary outcome improved QOL change level blood pressure BP BMI serum creatinine fasting blood sugar FBS hemoglobin cholesterol highdensity lipoprotein cholesterol triglyceride serum uric acid blood urea nitrogen BUN albumintocreatinine ratio study enrolled 126 patient control n63 intervention n63 performed intentiontotreat analysis analysis included repeated measure ANOVA result observed significantly different within group P001 group P001 interaction group × time factor P001 knowledge score Diastolic BP BMI showed significant difference arising within group P001 P01 respectively interaction group × time factor P001 P02 respectively food salinity hip circumference showed significant difference arising within group P001 P03 respectively group P001 P02 respectively Moreover systolic BP waist circumference showed significant difference within group P001 P003 respectively However significant difference found arising within groups groups interaction group × time QOL urine salinity midupper arm circumference Regarding laboratory findings baseline 6 months mean SD FBS decreased 051 377 mmolL intervention group 010 144 mmolL control group P03 however blood urea nitrogen increased 364 717 mgdL intervention group 168 1010 mgdL control group P01 health education strategy included campaign mobile health showed promise enhancing CKD knowledge among patient CKD strategy may also aid patient CKD controlling FBS BP combined health education initiative give evidence scaling Bangladesh possibly low middleincome countries particularly rural periurban settings ClinicalTrialsgov NCT04094831 httpsclinicaltrialsgovct2showNCT04094831 RR210219630191",
        "mesh_terms": [
            "Adult",
            "Bangladesh",
            "Health Education",
            "Healthy Lifestyle",
            "Humans",
            "Motivation",
            "Quality of Life",
            "Renal Insufficiency, Chronic",
            "Telemedicine",
            "Uric Acid"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35969429/"
    },
    {
        "pmid": "35966126",
        "title": "Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney disease.",
        "abstract": "SARSCoV2 virus cause Coronavirus disease infectious disease majority people infected virus mild moderate respiratory symptoms Multiple study proved substantial pathophysiological link COVID19 disease patient comorbidities cystic fibrosis chronic kidney disease study attempted identify differentially expressed gene well gene intersected among order comprehend compatibility Gene expression profiling indicated 849 gene mutually exclusive functional analysis done within context gene ontology key pathway involvement Three gene PRPF31 FOXN2 RIOK3 commonly upregulated analysed datasets three disease categories gene could potential biomarkers patient COVID19 cystic fibrosis COVID19 chronic kidney disease extensive analysis performed describe gene regulated various transcription factor microRNAs Then analysis revealed six hub gene PRPF31 FOXN2 RIOK3 UBC HNF4A ELAVL involved interaction COVID19 patient CF CKD could help researcher identify potential therapeutic molecules drug predicted based upregulated genes may significant impact reducing burden disease future",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35966126/"
    },
    {
        "pmid": "35949693",
        "title": "Association of comorbidities with the COVID-19 severity and hospitalization: A study among the recovered individuals in Bangladesh.",
        "abstract": "aimed identification association comorbidities COVID19 severity hospitalization retrospective crosssectional study investigate variation age sex dwelling comorbidities medication COVID19 severity hospitalization enrolling 1025 recovered individual comparing time recovery without comorbidities COVID19 patient mostly suffered fever predominant underlying medical condition hypertension HTN followed diabetes mellitus DM Patients cardiovascular disease CVD 543 hepatic disorder HD 436 experienced higher severity risk symptomatic case higher aged odds ratio  104 95 CI  102106 comorbid OR  187 95 CI  134260 patients Ttest confirmed difference comorbid noncomorbid patients recovery duration presence multiple comorbidities increased time recovery 1527 days hospitalization 2040 Increased symptomatic case found patient DMHTN whereas CVDAsthma patient found higher percentage severity Besides DMCKD chronic kidney disease associated higher hospitalization rate Higher odds severity found DMCVD OR  442 95 CI  1811078 patients Hospitalization risk also increased OR  514 95 CI  2021307 Moreover HTN along DMCVD found even higher odds OR  682 95 CI  2371958 hospitalization study indicates people aged females living urban area comorbid condition higher risk developing COVID19 severity Clinicians health management authority prioritize highrisk group reduce mortality attributed disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35949693/"
    },
    {
        "pmid": "35919197",
        "title": "Experiences of performing ABO-incompatible kidney transplantation in Bangladesh.",
        "abstract": "number endstage renal disease ESRD patient increasing Bangladesh Currently living kidney donation viable option transplantation Bangladesh restricted ABO compatibility issues performed ABOincompatible kidney transplantation ABOi KTs Bangladesh since 2018 study examines experience seven case ABOi KT desensitization protocol included lowdose rituximab 100 mgbody followed plasma exchange PEX followed 5g dose intravenous immunoglobulin Immunosuppression undertaken using tacrolimus 01 mgkgday mycophenolate mofetil 1500 mgday prednisolone 05 mgkgday patient received basiliximab induction therapy median baseline antiABO antibody titer 164 range 1321128 Transplantation performed titer ≤18 patient attended three five PEX session transplantation Graft survival 100 seven case mean period 22 months mean creatinine level 2046±474 µmolL Two patient suspected developed acute rejection received intravenous methylprednisolone resulting improved kidney function One patient required posttransplant hemodialysis due delayed graft function subsequently improved Infection common complication experienced ABOi KT patients Two patient developed severe cytomegalovirus pneumonia died functioning grafts ABOi KT Bangladesh substantially expand living kidney donor pool bring hope large number ESRD patient without ABOcompatible donors However high cost risk acute rejection infection remain major concerns",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35919197/"
    },
    {
        "pmid": "35910356",
        "title": "Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction.",
        "abstract": "Kidney diseases including acute kidney injury AKI chronic kidney disease CKD become critical clinical socioeconomic public health concern worldwide kidney requires lot energy mitochondrion act central organelle proper functioning kidney Mitochondrial dysfunction associated pathogenesis AKI CKD Natural product structural analog sought alternative therapeutic strategy despite challenge drug discovery Many study shown smallmolecule natural product improve renal function ameliorate kidney disease progression review summarizes nephroprotective effect smallmolecule natural products berberine betulinic acid celastrol curcumin salidroside polydatin resveratrol Treatment smallmolecule natural product shown attenuate renal oxidative stress mitochondrial DNA mtDNA damage restore mitochondrial biogenesis dynamic kidney various injury stimuli Therefore smallmolecule natural product recognized multitarget therapeutic promising drug prevent kidney diseases particularly mitochondrial dysfunction",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35910356/"
    },
    {
        "pmid": "40821777",
        "title": "Composition of peripheral blood immune cell compartment in stage 5 chronic kidney disease is affected by smoking and other risk factors associated with systemic inflammatory response.",
        "abstract": "Stage 5 chronic kidney disease CKD5 linked complex yet fully understood disturbance immune system study aimed investigate disturbance exploring detailed composition peripheral blood immune cell compartment CKD5 patient provide integrative multivariable dissection common inflammatory risk factor shape immune landscape crosssectional study included 107 patient chronic kidney disease stage 5 CKD5 29 healthy blood donor controls Peripheral blood B cells cells dendritic cell measured using standardized validated flow cytometry panel impact selected clinical factor immune cell composition initially evaluated using robust multivariate method PERMANOVA Variables significantly affected immune cell composition included subsequent series Poisson regression models assessing predictor influence count individual immune cell subpopulations Compared healthy controls CKD5 patient presented B cell lymphopenia across measured subset except plasmablasts cell lymphopenia immunosenescent phenotype predominantly CD4supsup compartment significantly higher count LINHLADRsupsup antigenpresenting cells mainly due increase myeloid dendritic cell subpopulations PERMANOVA identified smoking CMV seropositivity age dialysis treatment atherosclerotic cardiovascular disease factor significantly influencing peripheral blood immune composition Subsequent Poisson regression model revealed smoking associated mainly increase switched memory B cells CMV seropositivity increase CD4supsup CD8supsup TEMRA cells age decrease naive CD8supsup cells dialysis treatment increase marginalzone B cells Patients CKD5 exhibit distinct composition peripheral blood immune cells modified factor associated systemic inflammatory response factor considered immunomonitoring protocol may enhance prediction clinical outcome vaccine responses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821777/"
    },
    {
        "pmid": "40821332",
        "title": "Chronic Kidney Disease as a Predictor of Mortality in Hospitalized Inflammatory Bowel Disease Patients With Clostridioides difficile Infection.",
        "abstract": "Introduction Clostridioides difficile infection CDI lead significant morbidity mortality hospitalized patients aim investigate whether chronic kidney disease CKD endstage renal disease ESRD predictor mortality admitted patient CDI whether presence inflammatory bowel disease IBD impact mortality rate Methods data 133099 hospitalized patient CDI analyzed National Inpatient Sample NIS database 2016 2018 Baseline risk factor identified using ICD10 codes Propensity score matching used match CKDESRD patient patient without kidney disease based age gender IBD status Crohns disease ulcerative colitis multivariable logistic regression model used establish relationship variable adjusted underlying risk factors primary endpoint allcause mortality among hospitalized patient CDI particularly IBD Results cohort included 133099 hospitalized patient CDI among 20700 156 CKD 12178 91 ESRD 6104 46 IBD mean age 74 63 63 year p0001 patient CKD ESRD without kidney disease respectively CDI patient ESRD higher proportion male 6095 503 compared CKD without kidney disease 9494 459 40876 408 respectively p0001 Propensity score matching performed patient matched age resulting 11 exact match 32878 patients Logistic regression analysis showed CDI patient IBD CKD associated statistically insignificant trend towards higher allcause mortality rate compared CDI patient without IBD odds ratio 1682 v odds ratio 1229 p005 However ESRD patient significantly higher allcause mortality rate Odds ratio 3738 95 CI 21756425 among hospitalized CDI patient IBD compared without IBD odds ratio 1612 95 CI 14861749 p005 Conclusion Kidney disease particularly ESRD associated significant increase mortality CDI patient IBD compared without IBD finding highlight importance aggressive CDI management patient IBD ESRD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821332/"
    },
    {
        "pmid": "40821166",
        "title": "In-Hospital Outcomes of Acute Myocarditis in Adults With Systemic Inflammatory Disease: A Perspective on the Nationally Representative Sample Within the United States.",
        "abstract": "Background Systemic inflammatory disease SID associated adverse cardiovascular CV event due derangement innate immunity Understanding association acute myocarditis AMC crucial preemptive management strategy improving patient outcomes Methods identified compared adult 18 years SID versus nonSID hospitalized AMC using large nationally representative inpatient database 2016 2021 standardized diagnostic codes Six SIDs selected based distribution human leukocyte antigen HLA risk allcause mortality major adverse cardiac cerebrovascular event ischemic stroke cardiac arrest acute heart failure AHF ventricular arrhythmia VA complete atrioventricular block acute myocardial infarction AMI use circulatory support assessed adult AMC admission without SID adjusting confounders SID divided six cohorts systemic lupus erythematosus SLE rheumatoid arthritis RA psoriasis PS inflammatory bowel disease IBD Hashimotos thyroiditis multiple sclerosis MS subgroups Results Overall 34540 adult admission AMC Prevalence AMC nonSID 96 3454035865 mean age nonSID similar across four cohorts relatively older RA MS 608 595 years respectively cohort also higher proportion female PS IBD cohorts Hypertension peripheral vascular disease smoking frequently seen SIDAMC cohort time obesity regularly seen RA MS diabetes mellitus DM commonly seen SLE MS hyperlipidemia frequent SLE RA PS MS RAAMC cohort significantly higher adjusted odds using mechanical circulatory support adjusted odds ratio aOR 28 CI 122655 p  0015 adjusting sex dyslipidemia DM chronic kidney disease CKD However odds outcome acute VA mortality major adverse cardiovascular event statistically significant Conclusions RAAMC cohort 280 likely require mechanical circulatory support hospitalization AMC suggesting worse AHF cardiogenic shock outcomes Prospective study would necessary examine cardiovascular outcome cohort",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821166/"
    },
    {
        "pmid": "40821045",
        "title": "Treatment of chronic active EBV infection in children and management of post-transplant complications: a case report.",
        "abstract": "Chronic active EpsteinBarr virus CAEBV infection rare fatal disease caused persistent EBV infection progressive phase CAEBV child highly susceptible lifethreatening complication hemophagocytic syndrome multiple organ failure particularly liver kidney failure coagulation disorders hemangiomas resulting high mortality rate Traditional treatment immunotherapy chemotherapy limited effectiveness child may succumb disease within years Currently allogeneic therapy hematopoietic stem cell transplantation HSCT curative measure disease However procedure may lead series complication threaten life transplanted children Therefore mastering correct management approach exploring new preventive therapeutic measure crucial paper report case child CAEBV developed complication allogeneic HSCT comprehensive use immunomodulators personalized treatment strategies patients condition improved significantly",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821045/"
    },
    {
        "pmid": "40821029",
        "title": "Anesthetic management of diabetic foot amputation in a patient with renal failure and maintenance hemodialysis: case report and short communication.",
        "abstract": "Chronic kidney disease CKD progress advanced stage eventually developing endstage renal disease ESRD Currently effective treatment ESRD renal replacement therapy maintenance hemodialysis MHD widely used modality accounting approximately 90 dialysis patients However perioperative risk surgery anesthesia patient remains extremely high Therefore careful selection surgical timing appropriate anesthetic agents suitable anesthetic technique crucial report describes anesthetic management 62yearold female patient hospitalized orthopedic ward nine month due left toe necrosis secondary diabetic foot setting CKD requiring MHD later admitted Xingtai Central Hospital progressive necrosis involving left second third toe extending dorsum plantar aspect foot patient diagnosed leftsided diabetic foot necrosis stage 5 CKD type 2 diabetes mellitus multiple complications grade 3 hypertension high risk chronic hepatitis B infection elective transtibial belowknee amputation left lower limb planned Anesthesia provided using color Doppler ultrasoundguided left iliac fascia block left lateral femoral cutaneous nerve block left sciatic nerve block Intravenous isoproterenol infusion dexmedetomidine dizocine injection administered intraoperative sedation analgesia patients intraoperative vital sign remained stable Postoperatively patient awake good general condition transferred ward regular monitoring",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821029/"
    },
    {
        "pmid": "40819682",
        "title": "Clinical characteristics, complications and outcomes of critically ill patients with Dengue in Brazil, 2012-2024: a nationwide, multicentre cohort study.",
        "abstract": "Dengue outbreak major public health issue Brazil reporting 71 global case 2024 study aim describe profile severe dengue patient admitted Brazilian Intensive Care unit ICUs 20122024 assess trend time describe new onset complication ICU determine risk factor admission develop complication ICU stay performed prospective study dengue patient 253 ICUs across 56 hospitals used descriptive statistic describe dengue ICU population logistic regression identify risk factor complication ICU stay machine learning framework predict risk evolving complications Visualisations generated using ISARIC VERTEX 11047 admissions 1117 admission 101 evolved complications including noninvasive 437 admissions invasive ventilation 166 vasopressor 364 blood transfusion 353 renal replacement therapy 103 Age ≥80 OR 310 95 CI 202492 chronic kidney disease OR 294 222389 liver cirrhosis OR 365 182704 low platelet 50000 cellsmm³ OR OR 225 189268 high leukocyte 7000 cellsmm³ OR 247 202303 significant risk factor complications machine learning tool predicting complication proposed showing accurate discrimination calibration described large cohort dengue patient admitted ICUs identified key risk factor severe dengue complications advanced age presence comorbidities higher level leukocyte lower level platelets proposed prediction tool used early identification targeted intervention improve outcome dengueendemic regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819682/"
    },
    {
        "pmid": "40818237",
        "title": "Risk communication during treatment decision-making conversations with older people with advanced kidney disease.",
        "abstract": "older people advanced kidney disease medically ineligible transplant hence treatment available dialysis conservative kidney management CKM Previous research indicates information patient receive clinicians dialysis often prioritised CKM However evidence older people health issues dialysis always beneficial aim investigate whether risk benefit discussed relation option consultations convey CKM valid option Outpatient consultation recorded across four UK renal unit purposively selected variability CKM rate amongst patient age 65 Chronic Kidney Disease data British English total 30 conversation identified concerned decision dialysis CKM 22 led doctor 8 led nurses included 20 conversation option listed undecided patients eight prior decision revisited two recommendation made dialysis Conversations analysed using conversation analysis found CKM treated valid option patient risks burden limited benefit dialysis framed significant term quality andor length life found following aspect clinician communication enabled patient respond way treated CKM valid treatment option 1 talking impact dialysis persons quality life 2 conveying uncertainty regarding potential benefit dialysis length life 3 conveying risk personally relevant patients circumstances Findings demonstrate clinician convey information patient risk dialysis advanced kidney disease enable patient recognise consider CKM valid option",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818237/"
    },
    {
        "pmid": "40817567",
        "title": "The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference.",
        "abstract": "Laboratory investigation important clinical management study chronic kidney diseasemineral bone disorder CKDMBD including CKDassociated osteoporosis Parathyroid hormone PTH major hormone regulation bone calcium balance significantly affected advanced CKD Knowledge PTH concentration important assessment osteoporosis including CKDassociated osteoporosis however measurement PTH laboratory bedevilled interference intermethod difference compounded lack standardisation commonly used immunoassays Vitamin important bone health deficiency contributes development osteoporosis Vitamin metabolism impaired advanced CKD augmenting effect deficiency bone health Lack consensus optimal serum 25hydroxyvitamin 25OHD concentration bone health including various CKD stages compounded lack analytical specificity immunoassays Liquid chromatography tandem mass spectrometry LCMSMS assay would help overcome issues Ionised calcium measurement recommended assessment serum calcium especially CKD Fibroblast growth factor 23 FGF23 important homeostasis phosphate accumulates CKD though marker yet utilized clinical context Calculated maximal tubular reabsorption phosphate normalized glomerular filtration rate TmPGFR may help assessment phosphate homeostasis Bone specific alkaline phosphatase BALP tartrateresistant acid phosphatase isoform 5b TRACP5b reference marker bone formation resorption CKDassociated osteoporosis shown reflect bone turnover histomorphometry patient advanced CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817567/"
    },
    {
        "pmid": "40815832",
        "title": "Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective Study.",
        "abstract": "Psoriasis chronic inflammatory disease associated multiple comorbidities including metabolic syndrome cardiovascular disease Although specific dietary interventions intermittent fasting caloric restriction shown ameliorate inflammation promote weight loss effect intervention independent weight loss remains unclear Timerestricted eating TRE type intermittent fasting limit daily eating window fixed number hours Recent study suggest TRE may improve immune function individual metabolic syndrome cardiovascular risk factors crucial advantage TRE investigated dietary restriction strategy reported high adherence rate making feasible intervention longterm use Therefore exploring effect TRE metabolic immunological parameter psoriasis warranted study designed evaluate effect shortterm isocaloric TRE independent weight loss immune cell function serum metabolite profile volunteer mildtomoderate psoriasis compared healthy individuals casecontrol prospective study performed 10 healthy male participant 10 age BMI sexmatched individual mildtomoderate psoriasis individual psoriasis stable disease treated topical therapy without exposure immunomodulatory biologics study conducted National Institutes Health Clinical Center Immune profiles glucose handling energy expenditure participants weight assessed baseline 3 day TRE following daily 6hour eating window 18hour fast trial commenced June 2021 completed February 2023 total 20 participant enrolled10 mildtomoderate psoriasis 10 age BMI sexmatched healthy individuals time manuscript submission data processing ongoing Multiomic datasets including gene expression surface intracellular protein levels metabolite profiles generated peripheral blood mononuclear cells CD4supsupenriched Tcells serum samples integrated bioinformatics analysis reported data analysis completed clinical protocol designed characterize effect short term 3day TRE psoriasis independent weight loss comparing immune cell regulatory response healthy individual psoriasis specifically aim map molecular pathway activated TRE assess affect immune cell composition activation metabolism Additionally component metabolic response isocaloric TRE explored Insights dietary intervention impact metabolism immune system enhance understanding pathogenesis psoriasis may reveal new therapeutic avenue managing inflammatory condition ClinicalTrialsgov NCT04728165 httpsclinicaltrialsgovstudyNCT04728165",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815832/"
    },
    {
        "pmid": "40814749",
        "title": "Microfluidic Chip with Integrated Whole Blood Separation for Simultaneous Accurate Quantification of Multiple Chronic Kidney Disease Markers and Long-Term Monitoring.",
        "abstract": "Chronic kidney disease CKD become public health burden high mortality rate trend toward youthfulness imperative develop home monitoring system early diagnosis longterm monitoring CKD serum biomarkers However due limitation conventional centrifugation preprocessing whole blood samples realtime detection platform cannot fully meet requirement obtaining quantitative result directly whole blood Herein novel smartphoneassisted microfluidic chip integration whole blood separation pointofcare testing POCT system proposed achieve accurate quantification CKD biomarkers uric acid UA creatinine CR albumin Alb based 30 μL whole blood fingertip blood whole blood separation module allows rapid separation plasma whole blood sample vertical flow smartphone App automated image recognition processing developed applied athome routine healthcare detection limit UA CR Alb 01127 mmolL 02978 μmolL 07696 mgmL respectively meeting clinical requirements Additionally quantitative performance 83 clinical whole blood sample showed high consistency clinical analyzer Beckman AU 5400 automatic biochemical analyzer system simple operate userfriendly providing accurate rapid costeffective reliable detection method early screening realtime monitoring CKD hold significant potential enhancing home selfmanagement CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814749/"
    },
    {
        "pmid": "40814743",
        "title": "Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years.",
        "abstract": "dual burden diabetes kidney disease pose growing public health challenge aging populations yet longitudinal trend modifiable determinant China remain understudied study aim track trend prevalence comorbidity diabetes kidney disease Chinese middleaged older adult 10year period 20112020 identify social determinant lifestyle factor associated comorbidity study utilized data five wave China Health Retirement Longitudinal Study CHARLS Temporal trend geographical distribution comorbidity diabetes kidney disease analyzed across survey years disaggregated sex residence geographical region Cox proportional hazard regression model employed explore association SDOH burden lifestyle factors risk comorbidity prevalence diabetes kidney disease comorbidity exhibited clear upward trend among Chinese adult aged ≥ 45 years increasing 060 2011 310 2020 Geographical analysis revealed significant regional disparities Northeast China highest prevalence throughout decade 476 2020 High SDOH burden associated increased risk comorbidity HR  124 95 CI  101152 Conversely maintaining good HR  038 95 CI  027054 moderate HR  074 95 CI  059091 lifestyle associated reduced risk rising prevalence significant regional disparity diabetes kidney disease comorbidity underscore urgent need targeted public health intervention China",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814743/"
    },
    {
        "pmid": "40814623",
        "title": "Economic Evaluation of System-Wide Implementation of Kidney Supportive Care.",
        "abstract": "evaluation explored economic value kidney supportive care KSC patient endstage kidney disease ESKD receiving dialysis conservative management ESKD public health system New South Wales Australia Deidentified patientlevel data extracted linked dataset admitted nonadmitted patient data emergency department episodes death registrations Data 1 July 2015 30 June 2019 compared usual treatment prior statewide KSC implementation 20152016 financial years costbenefit analysis model estimated current economic value KSC 1 July 2015 30 June 2019 projected value 30 June 2030 different scenarios proportion patient ESKD receiving KSC increased 5 2015 2016 ini  443 16 2018 2019 period KSC estimated increase survival 3 21 weeks depending patient characteristics Projections showed continued delivery KSC ESKD treatment modality pattern cost remaining stable would deliver net economic benefit A 109 million avoided cost care return investment ROI 212 adjusted include survival improvement attributable KSC net economic benefit increased A 275 million ROI 535 Economic evaluation statewide KSC service showed survival benefit net economic benefit 4 year implementation Net economic value 10 year estimated A 275 million would increase greater participation patient ESKD suitable KSC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814623/"
    },
    {
        "pmid": "40814615",
        "title": "Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.",
        "abstract": "Type 2 diabetes chronic kidney disease CKD preventable treatable silent progressive clinical course call structured assessment timely feedback patient care provider activating decisionmaking Apart CKD patient diabetes complication affecting multiple organs notably cardiovascular system eyes feet International practice guideline recommend annual assessment eyes feet blood urine detect silent complication measure cardiovascularkidneymetabolic CKM risk factor ensure early intervention including treatment multiple target use organprotective drugs report highlight barrier gap implementation practice guideline managing diabetes CKD proposed solution overcome barriers improving practice environment workflow nurse trained perform protocolguided evaluation medical supervision systematic data collection enables physician make timely decisions including drug prescription referral specialist promote collaborative care whereas nurse use personalized data empower patient selfmanagement improve health literacy ongoing data collection form register align payers providers patient delivering datadriven valuebased care creation realworld evidence verify treatment effectiveness identify care gap providing onthejob training accompanied biobank ongoing collection analysis multidimensional data refine diagnosis classification prognosis treatment pursuit precision medicine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814615/"
    },
    {
        "pmid": "40814014",
        "title": "Chronic and reactivated dengue infection in an immunocompromised host: insights from a case report.",
        "abstract": "Dengue viral infection transmitted mosquitoes growing global health concern particularly spread put half worlds population risk dengue usually resolve primary infection persistent chronic case occur immunocompromised individuals case study report 43yearold woman lupus nephritis endstage kidney disease experienced symptomatic dengue reactivation nearly three year initial infection Despite low viral loads dengue RNA detectable blood multiple time 32 34 month initial detection Genomic analysis confirmed DENV1 strain persisted suggesting chronic infection rather reinfection patients immunosuppressive treatments including rituximab likely impaired immune response initial infection contributing viral persistence Additionally profound immunosuppressive state time reactivation potentially exacerbated coinfections may triggered virus reemerge case highlight rare clinically relevant possibility chronic dengue infection immunocompromised patients confirmed persistence viral strain nearly three year challenge conventional view dengue strictly acute infection raise concern potential reintroduction reemergence previously circulating strains well detrimental tissue consequence chronic infection virus finding important implication clinical management diagnostic strategies public health surveillance underscore need research better understand mechanism dengue chronicityparticularly involving viral immune evasion host immune dysfunction",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814014/"
    },
    {
        "pmid": "40813151",
        "title": "Kidney failure risk equation (KFRE), A risk-based triage for nephrology referrals: A mixed-methods study at pre-implementation phase among healthcare providers.",
        "abstract": "Chronic kidney disease CKD pose significant health challenge globally limited understanding challenge opportunity enhance CKD management perspective healthcare provider HCPs involved direct care patient CKD integrate riskbased triage nephrology referrals namely kidney failure risk equation KFRE explored HCPs perspective facilitator barrier CKD management implementation KFRE used mixed method approach explore HCPs perspective 1 facilitator barrier CKD management 2 perceived benefit challenge implementing KFRE riskbased triage guide nephrology referral Universiti Malaya Medical Centre UMMC Kuala Lumpur Malaysia Interviews audio recorded transcribed verbatim thematically analyzed Quantitatively provider job satisfaction survey performed Overall 111 HCPs completed surveys majority mostly satisfied physical surroundings coworkers supervision received Mixed response expressed amount work equipment provided Interviews conducted among 27 HCPs three main CKD care provider group primary care medicine nephrology endocrinology facilitators barriers theme identified top three barrier CKD management suboptimal patients insights gap practice confidences shortfall healthcare system contrast good interdisciplinary network accessibility specialist resource key facilitators underscored importance human resource empowerment continuous patient education structured interdisciplinary collaboration HCPs perceived riskbased triage using KFRE potentially useful targeted care identified several modifiable barrier facilitator warranting attention improve health outcome people CKD riskbased triage approach using KFRE appears promising facilitating targeted nephrology referral better care resource allocations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813151/"
    },
    {
        "pmid": "40812774",
        "title": "Renal Involvement in Chronic Graft-Versus-Host Disease.",
        "abstract": "Graft versus host disease GvHD common complication allogeneic hematopoietic stem cell transplantation HSCT skin eyes mouth liver commonly affected organ chronic GvHD increasing recognition less typical site involvement Emerging evidence suggests kidney may also affected however current data remain limited largely derived small retrospective study case series examined cohort 1441 patient transplanted identified 12 patient 08 presenting nephrotic syndrome renal biopsy consistent membranous nephropathy MN None patient preexisting renal disease patient nephrotic range proteinuria median 66 g24 h range 41178 presentation median time diagnosis glomerular disease 18 year range 0643 years HSCT median time diagnosis nephrotic syndrome 407 day range 951415 days initial diagnosis chronic GvHD Three patient feature renal vein thrombosis presentation patient showed typical pathologic feature MN additional mild microangiopathic feature ultrastructural examination nine tested PLA2R negative patient received immunosuppressive therapy Seven complete response treatment four achieved partial response one respond Herein describe clinical characteristics disease course clinical outcomes None patient developed irreversible renal impairment outlining importance rapid intervention appropriate immunosuppression absence effective biomarkers management suspected renal GvHD presenting proteinuria include renal biopsy identify appropriately classify lesion",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812774/"
    },
    {
        "pmid": "40812709",
        "title": "Ozone serve as mediator and effect modifier in the temperature-eGFR association: A longitudinal study on health examination cohort.",
        "abstract": "precise role ozone Osub3sub modulating temperatures impact kidney function remains unclear study systematically investigates Osub3subs modification mediation effect association temperature glomerular filtration rate eGFR collected 26244 individual First Affiliated Hospital Jinan University Generalized Linear Mixed Model used analyze mediation interaction effect Osub3sub temperatureeGFR association QuantileBased gComputation model estimated joint effect found eGFR decreased 029 mLmin173 msup2sup 95  CI 032 026 per 1 °C increase temperature 036 mLmin173 msup2sup 95  CI 039 032 per 10 μgmsup3sup Osub3sub increase IQR increase temperature Osub3sub led 325 mLmin173 msup2sup eGFR decline 95  CI 327 323 temperature Osub3sub contributing 6753  3247  respectively significant synergistic effect Osub3sub temperature observed high temperaturehigh Osub3sub HTHO event associated greatest relative risk RR  271 95  CI 236313 low eGFR compared low temperaturelow Osub3sub LTLO events Approximately 2056  total effect partly explained Osub3sub Individuals rapid renal function decline vulnerable temperature Osub3sub associated reduced renal function Osub3sub acting mediator modifier",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812709/"
    },
    {
        "pmid": "40812666",
        "title": "Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors - a cross-site multi-cycle audit.",
        "abstract": "Sodiumglucose transport2 inhibitor commonly prescribed management type 2 diabetes mellitus chronic kidney disease heart failure However continuation perioperative setting people diabetes precipitate euglycaemic diabetic ketoacidosis eDKA potentially lifethreatening complication multicycle audit evaluated adherence perioperative guideline regarding preoperative cessation postoperative reinitiation SGLT2 inhibitors Electronic health record consecutive surgical patient type 2 diabetes reviewed sixmonth period Two case eDKA identified Targeted interventionsincluding staff education dissemination guidancewere implemented followed reaudit fourmonth period Documentation perioperative SGLT2 inhibitor cessation improved significantly postintervention however postoperative ketone monitoring remained suboptimal one case eDKA identified Since then capillary blood ketone monitoring introduced clinical areas finding add body evidence perioperative use SGLT2 inhibitors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812666/"
    },
    {
        "pmid": "40811628",
        "title": "Chronic kidney disease among HIV-positive Zambian adults with tenofovir-associated nephrotoxicity at University Teaching Hospital (UTH) in Lusaka.",
        "abstract": "Tenofovir disoproxil fumarate TDF nucleotide reverse transcriptase inhibitor NRTI widely used firstline antiretroviral therapy ART Despite efficacy TDF associated nephrotoxicity particularly patient renal impairment background country including Zambia replacing TDFbased regimen Tenofovir Alafenamide TAF study aimed determine association TDFinduced nephrotoxicity three month chronic kidney disease CKD within five year among people living HIV PLWH Zambia retrospective cohort study 182 PLWH conducted Adult Center Infectious Disease Research AIDC Lusaka Zambia incidence CKD factor associated development PLWH initiated TDF evaluated Kidney function trend monitored five years Statistical analysis including MixedEffect model Cox Proportional Hazards Regression model conducted assess relationship early nephrotoxicity longterm CKD total 63 3462 182 file showed patient developed CKD contributing total persontime 910 personyears incidence rate CKD 692 case per 1000 personyears finding indicated significant association TDFassociated nephrotoxicity development CKD within five years mixedeffects model accounted populationlevel trend individual variability ensuring robust results Findings showed removing outlier made model representative significant decline kidney function time Cox regression model identified male sex baseline creatinine substantial risk factor CKD good model fit discriminatory power Given findings recommended regular monitoring early intervention strategy reinforced patients Furthermore continuous evaluation kidney function time crucial effectively manage mitigate risk associated CKD PLWH",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811628/"
    },
    {
        "pmid": "40811028",
        "title": "Association of Volume Status Assessed by Bioimpedance with Blood Pressure in CKD.",
        "abstract": "Hypertension common among patient CKD risk factor cardiovascular event mortality Though hypervolemia contributor hypertension association blood pressure biomarkers volume among patient CKD unclear Using data 5384 patient Chronic Renal Insufficiency Cohort CRIC fit linear regression model examine association vector length bioimpedance proxy volume systolic diastolic blood pressure BP employed categorical analysis given evidence nonlinear associations also assessed whether change vector length two year baseline associated change BP mean age 59 ±11 years 44 female 43 Black mean systolic BP eGFR 129 ±21 mmHg 48 ±16 mLmin173m2 respectively association vector length systolic BP nonlinear lowest quartile vector length a proxy hypervolemia associated 32 mmHg 95CI 11 53 higher systolic BP compared third quartile Compared third quartile two years lowest quartile change vector length a proxy volume expansion associated increase systolic BP 30 mmHg 95CI 10 51 Diastolic BP associated vector length Shorter shortening vector length independently associated higher increasing systolic BP respectively Whether bioimpedanceguided optimization volume status could improve BP management among patient CKD requires investigation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811028/"
    },
    {
        "pmid": "40810375",
        "title": "Safety of Hemorrhoid Procedures in Patients who are Immunocompromised: The Mayo Clinic Experience.",
        "abstract": "Hemorrhoidal disease immunosuppression prevalent Management hemorrhoidal disease patient population challenging society recommend conservative management due presumed risk morbid complications including sepsis impaired healing Data risk officebased operative procedure immunocompromised patient scant evaluate postoperative outcome officebased procedure operative intervention hemorrhoidal disease immunocompromised patients Retrospective chart review Singlecenter tertiary referral center Adult patient hemorrhoidal disease primarily medicationinduced immunosuppression undergoing officebased procedure operative intervention hemorrhoidal disease immunosuppression Mayo Clinic Rochester 2010 2023 primary outcome development infectious complication wound complications Fiftyfive immunocompromised patients median age 60 underwent total 68 hemorrhoidal procedure study time frame patient immunosuppression induced medication except one patient bone marrow failure syndrome common reason immunosuppression rheumatoid arthritis followed prior kidney transplant common medication chronic corticosteroid methotrexate third patient each 68 total interventions hemorrhoidectomy 32 excision thrombosed hemorrhoid 26 two common operation performed Sixteen adverse event reported 14 25 patients Three case postoperative cellulitis documented thrombosed external hemorrhoid excision hemorrhoidopexy Whitehead hemorrhoidectomy postoperative intravenous antibiotic administered case pelvic sepsis documented retrospective nature study heterogeneity study population data suggest officebased surgical procedure safe feasible patient immunosuppression See Video Abstract",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810375/"
    },
    {
        "pmid": "40810067",
        "title": "Predictive value of ferritin heavy chains in the development of coronary artery calcification in patients on maintenance hemodialysis: a prospective cohort study.",
        "abstract": "Vascular calcification VC wellestablished risk factor cardiovascular disease CVD mortality patient maintenance hemodialysis MHD patient frequently present hyperphosphatemia well disorder iron metabolism study aim explore role ferritin heavy chain FTH development progression coronary artery calcification CAC patient MHD assess predictive value Using bioinformatics approach analyzed datasets related VC prospective study evaluated Coronary Artery Calcification Score CACS alongside clinical markers including serum FTH serum ferritin transferrin saturation TSAT patient MHD baseline 1year followup Fth1 identified differentially expressed gene significantly upregulated aorta ApoEsupsup mouse atherosclerotic calcification model chronic kidney disease CKD mouse medial calcification model Among patient MHD 8571 exhibited CAC 4909 showing progression Patients CAC tended older higher body mass index BMI Notably serum FTH phosphorus P level significantly elevated progressive CAC Elevated serum FTH high serum P independent risk factor CAC progression showed predictive value Elevated serum FTH high serum phosphorus clinically significant predictor VC progression patient MHD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810067/"
    },
    {
        "pmid": "40809416",
        "title": "Advancements in the non-invasive diagnosis of renal fibrosis.",
        "abstract": "Renal fibrosis central pathological pathway various primary secondary kidney disease progress endstage renal disease characterized excessive extracellular matrix deposition destruction native renal parenchyma ultimately leading irreversible loss nephrons Currently percutaneous renal biopsy histopathological evaluation remains diagnostic gold standard renal fibrosis allowing semiquantitative scoring renal interstitial fibrosis glomerulosclerosis eg Banff grading However invasive procedure carry risk bleeding limited sampling error interobserver variability making impractical dynamic disease monitoring recent years significant advance made noninvasive diagnostic techniques include 1 blood urine biomarkers marker ECM metabolism inflammatory factors tubular injury markers extracellular vesicles 2 imaging modality including novel ultrasound techniques shear wave elastography functional magnetic resonance imaging MRI method diffusionweighted imaging blood oxygen leveldependent MRI magnetic resonance elastography positron emission tomographycomputed tomography using radiotracers targeting fibrosisassociated molecule sup68supGaFAPI review systematically summarizes latest evidence biomarkers advanced imaging modalities emphasis diagnostic performance sensitivityspecificity utility dynamic monitoring bottleneck clinical translation aim develop multimodal noninvasive assessment system enable earlier fibrosis detection stratified disease management precise intervention targeting fibrogenic pathways ultimately improving renal disease outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809416/"
    },
    {
        "pmid": "40809316",
        "title": "The anti-aging potential of antihypertensive peptides of <i>Pariset</i>, a dataset of algal peptides.",
        "abstract": "Cellular senescence drive aging disease promoting inflammation tissue dysfunction kidneys highly susceptible aging worsen hypertension increasing chronic disease risk Managing blood pressure angiotensinconverting enzyme ACE inhibitor natural bioactive peptide help maintain kidney health study explores kidneyassociated aging network algal peptide renoprotective antiaging effects Senescenceassociated gene Human Ageing Genomic Resources HAGR used construct analyze proteinprotein interaction PPI network refining kidneyrelated subset ACE angiotensin II Receptor Type 1 AGTR1 angiotensin II Receptor Type 2 AGTR2 Algal antihypertensive peptide filtered laboratory dataset algal peptides iPariseti assessed allergenicity antigenicity toxicity antiaging potential via sequence similarity searches Selected peptide prepared molecular docking tested kidneyaging targets visualized senescenceassociated PPI network revealed key agingrelated proteinsIL1R CD4 FN1 STAT3 CD45 APOE CD44 ITGAM CD8A CD68 CDH1 ACE AGTR1 AGTR2linked inflammation immunity fibrosis Screening identified 54 antihypertensive peptides among seven predicted nonallergenic nonantigenic peptides six exhibited antiaging properties KTFPY others exhibited strong binding ACE kidneyaging proteins suggesting therapeutic benefits senescenceassociated PPI network reveals potentially important agingrelated protein affecting kidney health Algal peptides particularly KTFPY VYRT PGDTY PVAFN MTFF exhibit strong ACE binding suggesting potential antihypertensive antiaging benefits CD68 expressed reliable binding affinity smallmolecule ACE inhibitors indicated repurposing potential drug agingassociated conditions computational result highlight potential peptidebased therapy addressing agerelated kidney dysfunction warrant experimental investigations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809316/"
    },
    {
        "pmid": "40808960",
        "title": "Risk factor analysis and outcomes of heart transplant recipients infected by COVID-19.",
        "abstract": "study aim evaluate prevalence clinical characteristics severity mortality outcome COVID19 infection heart transplant recipients focusing risk factor severe disease retrospective observational study conducted adult heart transplant patient HTxs Fuwai Hospital December 1 2022 February 28 2023 followup May 30 2024 Clinical data collected via telephone survey medical records Logistic regression analysis conducted explore risk factor severe disease total 728 916 HTxs infected COVID19 7948 vaccination rate 2795 infected cases 5618 mild 1882 moderate 1926 severe 577 critical Severe disease occurred 2500 mortality rate 454 Logistic regression analysis revealed age OR 1048 95 CI 10311066 P0001 history diabetes OR 1829 95 CI 12212740 P0005 Chronic kidney disease stage≥3 OR 2557 95 CI 16503963 P0001 immunosuppressive regimen including sirolimus OR 1639 95 CI 11452348 P0007 independent risk factor severe infection age OR 1102 95 CI 10531154 P0001 Chronic kidney disease stage≥3 OR 6342 95 CI 298013499 P0001 independent risk factor postinfection mortality COVID19 vaccination OR 0169 95 CI 00390733 P0018 found protective factor postinfection mortality COVID19 vaccination recommended HTxs reduce severe outcome mortality Sirolimus use independently associated severe infection highlighting need careful management immunosuppression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808960/"
    },
    {
        "pmid": "40808229",
        "title": "Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease.",
        "abstract": "Cardiovascular disease CVD chronic kidney disease CKD major global health concerns CKD significantly amplifying cardiovascular mortality Statins widely used manage hyperlipidemia recognized lipidlowering property additional benefits including antiinflammatory antioxidant plaquestabilizing effects review explores multifaceted role statin cardiovascular renal protection particularly among CKD patients narrative review synthesizes evidence clinical study assessing cardiovascular renal outcome statin use patient CKD examines effect statin across various clinical scenarios demographics comorbidities focus impact cardiovascular events renal function Statins significantly reduce allcause mortality major adverse cardiovascular event patient mild moderate CKD evidence supporting efficacy across diverse populations Trials JUPITER Heart Protection Study highlight cardiovascular benefit potential stabilize kidney function surgical settings statin show promise mitigating acute kidney injury inflammatory pathway modulation However impact renal outcomes proteinuria albuminuria glomerular filtration rate inconsistent Highdose statins especially advanced CKD may carry risk including hematuria rhabdomyolysis particularly improper dosing drug interactions Safety depends statin type dose renal function Additionally statin reduce risk contrastinduced nephropathy slow CKD progression select populations though variability study design limit generalizability Statins provide substantial cardiovascular benefit CKD patients renal effect remain uncertain Future research aim optimize treatment strategies including personalized regimens balance cardiovascular protection renal safety effectively",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808229/"
    },
    {
        "pmid": "40807073",
        "title": "Incidence and Predictive Factors of Acute Kidney Injury After Major Hepatectomy: Implications for Patient Management in Era of Enhanced Recovery After Surgery (ERAS) Protocols.",
        "abstract": "bBackgroundb Acute kidney injury AKI frequently occurs following major liver resection adversely affecting short longterm outcomes study aimed determine incidence AKI posthepatectomy identify relevant pre intraoperative risk factors secondary objective develop predictive score postoperative AKI assess association AKI chronic kidney disease CKD 1year mortality bMethodsb retrospective study cancer referral center Marseille France 2018 2022 bResultsb Among 169 patients 55 325 experienced AKI Multivariate analysis revealed several independent risk factor postoperative AKI including age body mass index use angiotensinconverting enzyme inhibitorsangiotensin receptor blockers time liver resection intraoperative shock bile duct reconstruction Neoadjuvant chemotherapy protective AKIMEBO score developed threshold ≥156 demonstrating sensitivity 895 specificity 764 positive predictive value 618 negative predictive value 944 AKI associated increased postoperative morbidity oneyear mortality following major hepatectomy bConclusionb AKI common complication posthepatectomy Factors time liver resection intraoperative shock management present potential clinical intervention points AKIMEBO score provide valuable tool postoperative risk stratification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807073/"
    },
    {
        "pmid": "40806393",
        "title": "Assessment of Eotaxin Concentration in Children with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD progressive condition still lead significant morbidity mortality among patient ages proper management focused slowing disease sequelae well establishing early diagnosis treatment complications Eotaxin potent selective eosinophil chemoattractant reported impact various kidney diseases Nevertheless data regarding potential correlation eotaxin CKD pediatric population still scarce study aim assess concentration eotaxin child CKD evaluate potential correlation selected biochemical marker disease occurrence serum urine eotaxin concentration markedly higher child CKD compared healthy controls Moreover Receiver Operating Characteristic ROC curve shown serum eotaxin urine eotaxin level demonstrated high sensitivity high specificity allocation patient study control groups author advanced thesis eotaxin might serve marker CKD occurrence pediatric population research design innovative since analyzed literature yet However study required",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806393/"
    },
    {
        "pmid": "40804428",
        "title": "Patient characteristics and adverse effects of allogeneic blood transfusion following lower extremity joint replacement in rheumatoid arthritis: a nationwide inpatient sample database study.",
        "abstract": "Allogeneic blood transfusion common therapeutic intervention patient rheumatoid arthritis RA undergoing lower extremity joint replacement LEJR Despite potential adverse outcome associated blood transfusion risk related procedure RA patient remain underexplored particularly within framework largescale national dataset study analyzed data National Inpatient Sample NIS database 2010 2019 identifying 66674 patient diagnosed RA underwent LEJR case subsequently divided two group based whether received blood transfusion Univariate multivariate logistic regression analysis conducted patient demographics prevalence comorbidities hospitallevel characteristics total financial charges insurance coverage inhospital mortality rates cumulative blood transfusion rate among RA patient undergoing LEJR 109 showing declining trend study period from 2379 2010 367 2019 Several factor associated increased likelihood receiving blood transfusion including advanced age ≥ 65 years female sex deficiency anemia chronic blood loss anemia weight loss coagulopathy fluid electrolyte imbalances neurological disorders pulmonary circulatory disturbances congestive heart failure chronic kidney disease uncomplicated diabetes Moreover patient received blood transfusion demonstrated higher risk specific complications including wound infection acute myocardial infarction pneumonia acute kidney injury urinary tract infection postoperative delirium deep vein thrombosis lower limb nerve injury sepsis respiratory failure Thorough preoperative assessment essential identifying RA patient likely receive blood transfusion subjected adverse outcomes Proactive intervention perioperative period coupled implementation comprehensive blood management strategy optimize blood transfusion RA patient LEJR",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804428/"
    },
    {
        "pmid": "40804029",
        "title": "Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study.",
        "abstract": "Appropriate interpretation kidney function essential clinical therapeutic management heart failure HF evaluated prognostic accuracy 6 glomerular filtration rate estimation eGFR formula HF patient reduced ejection fraction HFrEF impact Metabolic Exercise test data combined Cardiac Kidney Indexes MECKI score prognostic accuracy retrospectively analyzed 6933 patient enrolled MECKI score database GFR estimated using Modification Diet Renal Disease MDRD MRDR modified MDRDm CockcroftGault CG CG modified CGm Chronic Kidney Disease Epidemiology Collaboration CKDEPI European Kidney Function Consortium EKFC Survival assessed composite cardiovascular death left ventricular assist device implantation urgent heart transplantation 2 years GFR estimation demonstrated similar moderate prognostic capacity area curve AUC predicting survival ranging 06271 EKFC 0635 MDRD cardiovascular death AUC value ranged 0668 0677 prevalence severe CKD defined eGFR 30 mlmin173 m² ranged 32 MDRD 45 EKFC included MECKI score 6 formula showed MECKI AUC prognosis ranging 07841 07883 EKFC CKDEPI showing best performance GFR estimation play role HFrEF prognosis without difference among 6 frequently used formulas Furthermore using eGFR calculated 6 different formula MECKI score significantly alter strong prognostic power highlighting MECKI reliability risk stratification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804029/"
    },
    {
        "pmid": "40803979",
        "title": "Impact of medication therapy management on medication adherence and health-related quality of life among non-dialysis chronic kidney disease patients.",
        "abstract": "Chronic kidney disease CKD progressive disease often associated poor medication adherence reduced health related quality life HRQoL Medication therapy management MTM range service provided patient shown enhance medication adherence HRQoL yet impact nondialysis CKD patient remains underexplored So study aimed see impact MTM medication adherence HRQoL among nondialysis CKD patients prospective openlabelled randomizationcontrolled study conducted among CKD nondialysis patients HRQoL assessed using KDQoL36 questionnaire Medication adherence assessed using medication adherence scale assessed baseline 6supthsup 12supthsup month follow up MTM group received clinical pharmacists MTM service along usual care UC UC group received hospital teams general care Doctors Nurses health care professionals total 220 CKD patient enrolled group 11 ratio baseline patient medium adherence MTM 82 7454 UC 77 70 groups followed low adherence p value 0131 6supthsup 12supthsup month followup Medication adherence increased MTM group compared UC group p value 0001 baseline HRQoL score found domain symptoms problem list MTM 704 UC group 715 p value 005 HRQoL score 5 domain significantly increased 6th month 12th month MTM group compared UC group p value 005 Study concluded MTM service increased medication adherence HRQoL CKD non dialysis patient MTM group compared UC group future MTM service implemented healthcare settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803979/"
    },
    {
        "pmid": "40803826",
        "title": "Rest, shade, hydration and hygiene for the prevention of kidney injuries and inflammation in a Nicaraguan sugarcane worker cohort.",
        "abstract": "study effect progressively enhanced restshadehydrationhygiene RSHH intervention kidney injury inflammation biomarkers rate clinical acute kidney injury AKI Nicaraguan sugarcane worker high rate chronic kidney disease nontraditional origin CKDnt analysed serum creatinine Creactive protein CRP leukocyturia sample obtained end four harvest season H14 increase creatinine≥030 mgdL harvest considered incident kidney injury IKI Rates clinically diagnosed AKI obtained medical records season RSHH intervention included progressively longer frequent rest period improved access shade hydration implementation monitoring qualitative interview health outcome assessments 1044 worker followed 1938 personharvests Among burned cane cutters job group highest workload worst outcome initially decreasing rate IKI 21 H1 1 H4 p001 AKI 201000 workermonths 81000 workermonths p001 endharvest leukocyturia 26 1 p001 less rise crossharvest CRP median 175fold increase H1 100 H4 p001 Kidney outcome among outdoor heatstressed worker high risk CKDnt improved structured RSHH intervention implemented committed workplace management finding support causal relationship occupational heat stress kidney injury CKDnt point possibility prevention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803826/"
    },
    {
        "pmid": "40803598",
        "title": "The Association of Repair Timing on Outcomes following Thoracic Endovascular Aortic Repair for Intramural Hematoma.",
        "abstract": "Intramural hematoma IMH carry significant risk morbidity mortality although thoracic endovascular aortic repair TEVAR increasingly utilized treatment optimal timing intervention remains uncertain study aim compare outcome patient undergoing urgent TEVAR within 24 hour admission receiving elective TEVAR beyond 24 hour admission Patients underwent TEVAR aortic zone 2 5 IMH 2013 2023 included excluding rupture Propensity score generated using covariates age sex race obesity anemia transfer status hypertension diabetes prior myocardial infarction congestive heart failure smoking history chronic obstructive pulmonary disease cerebrovascular disease dialysis status medication use previous aortic surgery adjust assignment urgentemergent elective TEVAR Perioperative outcome assessed using inverse probabilityweighted logistic regression Association urgent elective TEVAR 5year mortality assessed using Cox regression stratified IMH symptom status Among 345 patients 165 48 underwent elective repair urgent group higher rate transfer outside institution 64 vs 43 p001 less likely use betablockers presentation 69 vs 84 p0003 frequently symptomatic presentation 98 vs 72 p0001 significant difference IMH disease extent graft landing zone groups Perioperative mortality 63 vs 06 adjusted aOR 19 95 CI 301764 p002 reintervention index admission 83 vs 24 aOR 492 95 CI 167195 p001 significantly greater urgent group Fiveyear survival lower urgent group statistically significant symptomatic patients urgent cohort significantly higher perioperative mortality 73 vs 08 aOR 10 95 CI 211152 p002 acute kidney injury 90 vs 25 aOR 328 95 CI 112121 p004 reintervention 85 vs 25 aOR 526 95 CI 161256 p001 Conversely elective group longer total length stay 32 vs 21 aOR 048 95 CI 028082 p001 Fiveyear survival symptomatic cohort lower urgent group statistically significant Patients undergoing urgent TEVAR IMH experience worse perioperative outcome compared undergoing elective repairs despite comparable baseline risk profiles emergent repair may necessary certain cases data advocate patient management strategy prioritizes stabilization intervention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803598/"
    },
    {
        "pmid": "40802676",
        "title": "Renal Denervation: A New Era in the Management of Resistant Hypertension.",
        "abstract": "Hypertension one leading cause mortality related cardiovascular disease Since advent modern medicine multitude effort made achieve better blood pressure control However despite wide range monitoring protocol medication therapies 23 patient hypertension achieve blood pressure control1 Renal Denervation RDN emerged adjunctive therapy medication lifestyle modification blood pressure control Two method RDN approved US Department Food Drug Administration 2023 Radiofrequency Ablation RFA ultrasoundbased method RFA employ heatgenerating electrode placed renal artery via catheter delivers heat alternating current2 Ultrasoundbased technique us ultrasonic heating create ring ablative energy interrupt renal nerve signaling last two decades wellconducted randomized sham control trial registry analysis proven RDN effective safe treatment option resistant hypertension promising results RDN also becomes appealing chronic kidney disease CKD patient underlying sympathetic overactivity3 article aim provide comprehensive review RDN including current evidence implication routine clinician practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802676/"
    },
    {
        "pmid": "40802441",
        "title": "Chronic kidney disease patient safety in hemodialysis: evidence of scale validity and reliability.",
        "abstract": "analyze evidence validity reliability Chronic Kidney Disease Patient Safety Assessment Scale Hemodialysis Sessions EASPRCH methodological study analysis validity evidence content construct reliability temporal stability internal consistency parameterization total 11 judge 240 patient three hemodialysis clinic participated EASPRCH consists 15 item distributed across three domains 1 Strategic Procedures Error Prevention 6 items 2 Organizational Processes Health Management 5 items 3 Care Practices Infection Control 4 items scoring available domain overall scale maximum score 45 point cutoff point adequateinadequate 34 achieved Cronbachs alpha 078 explained 7241 total variance scale provides evidence weakness strength related specific indicators may may impact patient safety hemodialysis care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802441/"
    },
    {
        "pmid": "40802428",
        "title": "Knowledge and practices of conservative treatment of chronic kidney disease in the perception of elderly women.",
        "abstract": "understand knowledge practice conservative treatment chronic kidney disease perspective elderly women descriptive qualitative study carried Nephrology outpatient clinic public referral hospital city Recife PE Brazil 21 elderly women Data collection took place January July 2023 semistructured interview composed two guiding questions What understand chronic kidney disease What care take treatment interview recorded analyzed help Iramuteq® software Manifest Content Analysis used analyze data presented Descending Hierarchical Classification Similarity Analysis five thematic category identified difficulty understanding communicating health condition superficial knowledge insecurity severity kidney disease eating practice dietary restrictions selfcare practice health management monitoring laboratory tests study identified elderly woman limited knowledge conservative treatment chronic kidney disease influenced social economic educational barriers need accessible public policy educational strategy support care highlighted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802428/"
    },
    {
        "pmid": "40801823",
        "title": "The Synergistic Treatment of Heart and Kidney Disease.",
        "abstract": "incidence prevalence cardiac renal disease Germany steadily rising Heart disease common cause death especially among people chronic kidney disease Impaired kidney function increase risk cardiovascular events vice versa narrative review based pertinent publication retrieved literature search year 2025 particular attention guideline Association Scientific Medical Societies Germany Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften AWMF European Society Cardiology ESC Supplementary search conducted individual aspect epidemiology diagnosis treatment heart kidney disease heart kidney closely pathophysiologically linked damaged shared vascular risk factors including diabetes mellitus arterial hypertension chronic inflammation shared mechanism give rise continuum diseases Multiple RCTs shown recent year morbidity mortality patient heart kidney disease significantly lowered treatment ACE inhibitors also sodiumglucose cotransporter 2 SGLT2 inhibitors glucagonlike peptide 1 receptor agonist GLP1RA nonsteroidal mineralocorticoid receptor antagonist nsMRA Absolute risk reduction range 18 67 found achievable combined endpoint studied depending particular active substance used Heart kidney disease often arise together treated new pharmacotherapeutic strategies Open question remain concerning potential synergistic effect drug mentioned above suitable management polypharmacy enabling costeffective care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801823/"
    },
    {
        "pmid": "40800124",
        "title": "The prognostic implications of comorbidities in septic arthritis.",
        "abstract": "Septic arthritis SA orthopedic emergency characterized joint inflammation secondary infectious etiologies commonly iStaphylococcus aureusi prompt recognition SA crucial due significant morbidity mortality Fever along swollen painful joint limited range motion typical manifestations however presentation vary incidence SA adult population rising accompanied unfavorable mortality rates trend exacerbated comorbid condition substantially influence outcomes Among literature diabetes mellitus DM rheumatoid arthritis RA chronic kidney disease CKD emerged key prognostic factor SA DM exacerbates severity SA impairment polymorphonuclear function ultimately leading increased susceptibility infection higher risk acquiring infection atypical pathogens CKD cause uremiainduced immune dysfunction leading immunocompromised state well repeated vascular access increasing infection susceptibility leading increased mortality Patients RA harbor elevated risk SA attributed immune dysregulation immunosuppressive therapy diagnostic challenges Additionally comorbidities complicate surgical management SA increase likelihood treatment failure Therefore given rising burden comorbid condition worldwide impact SA prognosis healthcare professional remain vigilant managing factors holistic multidisciplinary approach management vital ensure SA patient certain comorbid condition experience fewer complication improved survival minireview aim highlight key comorbid condition impact prognosis SA patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40800124/"
    },
    {
        "pmid": "40799827",
        "title": "Factors that influence the Na/K-ATPase signaling and function.",
        "abstract": "transmembrane NaKATPase located plasma membrane mammalian cells utilizes energy ATP hydrolysis execute pumping function interacts protein andor kinase molecule execute signaling function Digoxin one earliest identified cardiotonic steroid CTS specifically bind NaKATPase widely prescribed manage patient cardiovascular disease CVD heart failure HF 200 years Elevated plasma level CTS observed patient hypertension chronic kidney disease CKD CVD congestive HF extensive research effort spanning decades remain unresolved disagreement regarding various mechanism underlying NaKATPase signaling functions article examines known controversial mechanism initiate NaKATPase signaling function related regulatory mechanisms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799827/"
    },
    {
        "pmid": "40799824",
        "title": "The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3-4: A randomized controlled trial.",
        "abstract": "Chronic kidney disease CKD patient high prevalence mortality rates however current treatment option remain limited Shenkang suppository SKS traditional Chinese medicine used clinical management CKD Increasing evidence suggests close relationship gut microbiome CKD aimed investigate impact SKS kidney function gut microbiota CKD stage 34 patients singlecenter randomized controlled trial n  80 CKD stage 34 patient randomly assigned 11 ratio either control group n  40 SKS group n  40 followed 8 weeks Baseline data clinical indicators kidney markers stool sample obtained participant treatment bacterial DNA isolated fecal sample analyzed via highthroughput 16S rRNA sequencing total 34 patient SKS group 36 control group completed study Kidney function control group significantly worsened 8 week iP  005i whereas SKS positive effect slowing progression kidney function decline 8 week SKS intervention beneficial bacteria Coriobacteriaceae RuminococcaceaeiRuminococcusi proliferated dramatically whereas abundance harmful bacteria Veillonellaceae decreased Linear discriminant analysis LDA revealed SKS treatment increased proportion iStreptococcusi decreased proportion Planctomycetes Spirochaetes Rhodocyclales Actinomycetaceae Veillonellaceae Dechloromonas change observed control group Correlation analysis revealed negative association iBifidobacteriumi iBlautiai EnterococcaceaeiEnterococcusi clinical kidney function indicators whereas iParabacteroidesi iAcinetobacteri iSutterellai iOscillospirai iAlistipesi positively correlated kidney function SKS could delay progression kidney function CKD stage 34 patients possibly modulating dysbiosis gut microbiota close association certain gut microbiota clinical kidney function indicator suggest gut microbiota could serve new therapeutic target CKD httpswwwchictrorgcn Chinese Clinical Trial Registry Identifier ChiCTR2200058493",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799824/"
    },
    {
        "pmid": "40799007",
        "title": "Association between consumption of different food groups and risk of chronic kidney disease: A dose-response meta-analysis of prospective cohort studies.",
        "abstract": "light varying outcome prior research concerning relationship different food group risk chronic kidney disease CKD study conducted examine relationship consumption various food group CKD risk via dosedependent metaanalysis prospective cohort studies Searches conducted Web Science PubMed Google Scholar database January 2025 6460 publications twentyone study selected final analysis result revealed red meat consumption associated increased risk CKD RR 139 95 CI 113 171 Conversely consumption fish RR 088 95 CI 080 097 grain RR 087 95 CI 077 099 legume RR 083 95 CI 072 092 showed protective effect CKD linear doseresponse analysis indicated every 100 gday increment red meat total meat consumption risk CKD escalated 34 2 respectively Furthermore increase 15 gday dietary fish 28 gday nuts 50 gday legume associated 6 21 13 decreased risk CKD respectively Overall higher red meat intake correlate heightened CKD risk whereas consumption fish grains legume associated lowered risk longitudinal cohort study extended followup recommended validate findingsThis trial registered PROSPERO CRD42023465532",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799007/"
    },
    {
        "pmid": "40797423",
        "title": "Neutrophil-to-albumin ratio for predicting mortality in chronic kidney diseases: A cohort study on all-cause and cardiovascular mortality from NHANES 1999 to 2018.",
        "abstract": "Chronic kidney disease CKD significantly impact quality life survival patient globally neutrophiltoalbumin ratio NAR scoring system reflects inflammation nutritional mortality risk chronic diseases study aim evaluate role NAR predicting CKD mortality Data NHANES 1999 2018 analyzed participant grouped NAR quartiles COX regression KaplanMeier curve used examine CKD mortality Piecewise restricted cubic spline analysis COX regression assessed nonlinear relationship NAR mortality alongside piecewise subgroup analyses total 6042 participant included Q4 exhibited significantly higher allcause mortality 2469 v 3392 P  001 cardiovascular disease CVD mortality 1109 v 1495 P  028 compared Q1 KaplanMeier curve showed Q4 lowest survival rate Logrank P  001 final adjusted model Model 2 Q4 significantly higher allcause HR  153 95 CI  135174 P  001 CVD mortality HR  154 95 CI  124192 P  003 nonlinear relationship found NAR allcause P  001 P nonlinear  005 CVD mortality P  001 P nonlinear  038 higher risk NAR ≥ 19 study identified complex nonlinear relationship NAR CKD mortality NAR level negatively correlating survival probability particularly higher range specific highrisk populations finding support use NAR tool assessing CKD mortality risk providing insight early prevention prognosis assessment management CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797423/"
    },
    {
        "pmid": "40797230",
        "title": "Pregnancy-associated acute kidney injury as an important driver of chronic kidney disease in females in developing countries: A systematic review.",
        "abstract": "Pregnancyrelated AKI PRAKI profound maternal fetal implications including high mortality longterm risk development chronic kidney disease CKD systematic review aim evaluate burden CKD owing PRAKI case followup developing countries particularly India systematic search PubMed Embase Cochrane database performed Indian study published 2000 June 2024 included crosssectional retrospective prospective cohort study reported incidence PRAKI subsequent CKD dialysis dependency Indian cohort followup Details etiology PRAKI adverse fetal maternal outcome also recorded study provided followup kidney outcome considered total 25 study comprising 2306 participant included analysis incidence PRAKI ranged 1 12 across different studies Sepsis common cause PRAKI accounting 78 cases followed hypertensive disorders obstetric haemorrhage tropical etiologies Hemodialysis required 2085 patients CKD development followup observed 12835 cases 30 remaining dialysisdependent Maternal mortality ranged 25 34 perinatal mortality reached high 673 Preterm delivery rate varied 139 58 onethird PRAKI patient may develop CKD remain dialysisdependent followup PRAKI significantly impact maternal fetal morbidity mortality Early prevention prompt management healthcare professional critical improving outcome PRAKI Pregnancyrelated acute kidney injury PRAKI significantly affect maternal fetal health leading high mortality longterm complication chronic kidney disease CKD systematic review focusing developing country like India evaluated burden CKD due PRAKI patients review analyzed Indian study published 2000 June 2024 including 25 study 2306 participants PRAKI incidence ranged 1 12 sepsis leading cause 78 cases followed hypertensive disorders obstetric hemorrhage tropical fevers RRT needed 2085 patients 12835 developed CKD followup 30 remaining dialysisdependent Maternal mortality varied 25 34 perinatal mortality reached 673 study emphasizes critical need early prevention timely intervention need longterm followup reduce high morbidity mortality rate associated PRAKI",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797230/"
    },
    {
        "pmid": "40796290",
        "title": "What do clinical trials teach us about the pathophysiology of human IgA nephropathy?",
        "abstract": "Immunoglobulin nephropathy IgAN primary glomerulonephritis characterized IgAdominant codominant mesangial immune deposit seen routine immunofluorescence staining kidney biopsy tissue Approximately 40 patient develop kidney failure within ten year diagnosis IgAN variable clinical presentation ranging characteristic synpharyngitic macroscopic hematuria persistent microscopic hematuria without proteinuria often accompanied reduced kidney function disease recognition delayed Recent data UK National Registry Rare Kidney Diseases underscore need early diagnosis prompt management stringent proteinuria reduction avoid kidney failure throughout affected patients lifetime recently paucity disease specific treatment options However elucidation IgAN pathophysiology data genome wide association study Kidney Health Initiative that identified change proteinuria acceptable surrogate endpoint clinical trials revolutionized IgAN therapeutic landscape Beyond systemic steroids targeted release formulation budesonide thought act primarily gutassociated lymphoid tissue reduce production pathogenic galactosedeficient IgA1 first United States Food Drug Administration approved IgAN treatment B cell plasma cell play central role production galactosedeficient IgA1 autoantibody targeted using Bcell Activating Factor ProliferationInducing Ligand cytokine inhibitor well CD38  plasma cell depleting drugs Recognizing role alternative complement cascade IgAN mediated glomerular injury inflammation identified new potential therapeutic target ultimately led approval complement Factor B inhibitor iptacopan nonimmunosuppressive treatment also available investigated aim reducing proteinuria slowing chronic kidney disease progression including endothelin receptor antagonists paper review current clinical trial IgAN critically examine teach u IgAN pathogenesis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796290/"
    },
    {
        "pmid": "40796264",
        "title": "Type 2 diabetes in South Asians.",
        "abstract": "Type 2 diabetes pose substantial public health challenge South Asia marked distinctive feature pathogenesis phenotype management review explores characteristic type 2 diabetes South Asians tend develop condition younger average age lower body mass index white populations Prevalence high varies across region recent increase youth onset type 2 diabetes Environmental influence driving greater sedentary behavior dietary shift towards processed food leading higher body weights concerning South Asians show greater abdominal obesity ectopic fat accumulation particularly hepatic fat lower skeletal muscle mass white people similar age body mass index features coupled rapid β cell dysfunction contribute earlier onset accelerated glycemia progression greater aggregated hyperglycemia white people contributing retinopathy cardiovascular disease chronic kidney disease Management type 2 diabetes region hindered delayed diagnosis inadequate healthcare access economic barrier limiting sustainable glucose lipid blood pressure management Evidence support lifestyle dietary weight loss viable approach prevention diabetes remission respectively though sustained remission untested Recently introduced drug sodiumglucose cotransporter 2 inhibitor newer glucagonlike peptide 1 receptor agonists offer promise weight management cardiovascular kidney protection often inaccessible owing cost constraints Future effort prioritize affordable innovative solutions strengthen healthcare systems implement population wide preventive measure account regions socioeconomic complexities practical contextual research",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796264/"
    },
    {
        "pmid": "40795933",
        "title": "MRI-Based Stratification and Surgical Management of Hydrocolpos in Children and Adolescents.",
        "abstract": "report present new anatomical stratification vaginal obstruction hydrocolpos based MRI finding referring level obstruction fixed bony landmark the pubic symphysis new approach overcome limitation current classifications prone approximation error measurement fail account variation body mass across different age groups Data case diagnosed vaginal obstruction retrospectively analysed Cases cloaca vaginal obstruction excluded MRI confirmed diagnosis enabled classification level vaginal obstruction relative pubic symphysis midsagittal plane low intermediate highopposite lower mid upper end pubic symphysis respectively Thirteen girl presented vaginal obstruction period 2010 2024 age ranged 1 month 14 year mean 54 months median 18 months Three case presented neonatal period antenatal diagnosis hydrocolpos six case referred later infancychildhood centers Another group adolescent girl 4 cases presented clinical picture cryptomenorrhea cause vaginal obstruction imperforate hymen one vaginal atresia six persistent urogenital sinus five cases one case obstructed hemivagina series six case 46 feature related genetic syndrome Bardet Biedl McKusickKaufman spectrum Chronic parenchymatous renal disease present 3 case among syndromic feature Bardet Biedl syndrome addition another case Obstructed left hemivagina absent left kidney HerlynWernerWunderlich syndrome Surgical technique included simple excision distal obstructing membrane 4 cases abdominal assisted vaginoplasty 2 cases vaginal pullthrough 4 cases simple introitoplasty 1 case urogenital sinus mobilization 1 case division longitudinal vaginal septum case obstructed hemivagina Vaginal stenosis retraction occurred three case intermediate highlevel obstructiontwo following abdominalassisted vaginoplasty one vaginal pullthrough MRIbased stratification vaginal obstruction using pubic symphysis reference provides practical reproducible approach surgical planning",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795933/"
    },
    {
        "pmid": "40795345",
        "title": "Occupational Risk Factors for Kidney Disease: A Comprehensive Review.",
        "abstract": "Chronic kidney disease CKD major global health concern traditional risk factor diabetes hypertension well established However emerging evidence suggests occupational exposure could play significant role CKD development review comprehensively summarizes current evidence concerning occupational risk factor contributing kidney disease including exposure heavy metal lead cadmium mercury chromium organic solvent trichloroethylene methanol ethylene glycol heat stress jobrelated stress factor occupational stress long working hours shift work Epidemiological study indicate nephrotoxic agent contribute renal dysfunction oxidative stress mitochondrial damage impaired ion transport Industries manufacturing agriculture mining pose particularly high risk due hazardous exposures strong evidence link nephrotoxic metal solvent early renal dysfunction longterm effect chronic lowdose exposure remain unclear Additionally heat stressrelated CKD particularly MesoAmerican nephropathy highlight growing concern climaterelated occupational risks Jobrelated stress factors including long working hour shift work may accelerate CKD progression stressinduced hypertension metabolic disturbances Given substantial public health implications preventive strategy focus reducing workplace exposures implementing heat stress management programs addressing impact jobrelated stress factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795345/"
    },
    {
        "pmid": "40795063",
        "title": "Enhancing end-stage renal disease outcome prediction: a multisourced data-driven approach.",
        "abstract": "improve prediction chronic kidney disease CKD progression endstage renal disease ESRD using machine learning ML deep learning DL model applied integrated clinical claim data varying observation windows supported explainable artificial intelligence AI enhance interpretability reduce bias utilized data 10 326 CKD patients combining clinical claim information 2009 2018 preprocessing cohort identification feature engineering evaluated multiple statistical ML DL model using 5 distinct observation windows Feature importance SHapley Additive exPlanations SHAP analysis employed understand key predictors Models tested robustness clinical relevance misclassification patterns bias Integrated data model outperformed single data source models long shortterm memory achieving highest area receiver operating characteristic curve AUROC 093 F1 score 065 24month observation window optimally balanced early detection prediction accuracy 2021 estimated glomerular filtration rate eGFR equation improved prediction accuracy reduced racial bias particularly African American patients Improved prediction accuracy interpretability bias mitigation strategy potential enhance CKD management support targeted interventions reduce healthcare disparities study present robust framework predicting ESRD outcomes improving clinical decisionmaking integrated multisourced data advanced analytics Future research expand data integration extend framework chronic diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795063/"
    },
    {
        "pmid": "40795012",
        "title": "Impact of Twice-weekly Scheduled Dialysis Through the Emergency Department for Patients with End-stage Renal Disease.",
        "abstract": "Patients endstage renal disease ESRD access standard dialysis often rely emergencyonly dialysis EOD emergency department ED Compared standard dialysis EOD lead higher hospitalization rates hospital days higher mortality objective study examine hospitalization rate total hospital day transitioning patient ESRD ED EOD scheduled ED dialysis subsequently standard outpatient dialysis performed retrospective study single academic teaching hospital course 10 year 20142023 Patients 18 year age received dialysis primarily ED one year included study studied two cohorts Cohort 1 consisted patient ESRD transitioned ED EOD twiceweekly ED dialysis Cohort 2 composed patient transitioned twiceweekly ED dialysis standard outpatient dialysis performed paired patient analysis using Wilcoxon signedrank test Primary outcome included hospitalization per month total hospital days Overall seven patient cohort 1 mean age 39 years 86 female 20 patient cohort 2 mean age 44 50 female Patients transitioned twiceweekly ED dialysis ED EOD lower hospitalization per month 144 v 026 P 05 fewer total hospital day per month 218 v 120 P  05 Patients transitioned twiceweekly scheduled ED dialysis standard outpatient dialysis even lower hospitalization per month 010 v 002 P  01 total hospital day 031 v 008 P  01 Introducing scheduled twiceweekly ED dialysis session unfunded patient endstage renal disease associated lower overall hospitalization rate hospital day emergencyonly dialysis measure decreased transitioning patient ED scheduled dialysis standard dialysis",
        "mesh_terms": [
            "Humans",
            "Kidney Failure, Chronic",
            "Emergency Service, Hospital",
            "Female",
            "Male",
            "Retrospective Studies",
            "Renal Dialysis",
            "Adult",
            "Hospitalization",
            "Middle Aged",
            "Length of Stay",
            "Appointments and Schedules"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795012/"
    },
    {
        "pmid": "40794410",
        "title": "Work Impairment and Financial Outcomes Among Adults With vs Without Long COVID.",
        "abstract": "much focus long COVID LC defined developing new persistent symptom lasting 3 month longer SARSCoV2 infection health status quality life impact individual work productivity financial distress less well established assess difference work financial outcome among individual current resolved LC 3 year initial infection prospective multisite longitudinal cohort study enrolled adult participant age ≥18 years least 1 reported SARSCoV2 infection December 7 2020 August 29 2022 Followup electronic survey collected April 2 2024 Data analyzed January 20 February 4 2025 Selfreported resolved current LC vaccination status Financial toxicity measured using Comprehensive Score Financial ToxicityFunctional Assessment Chronic Illness Therapy FACITCOST work impact measured using Work Productivity  Activity Impairment questionnaire version 20 3663 participant mean SD age 402 142 years 2429 663 female 994 271 reported current LC 2604 711 never LC 65 18 resolved LC Participants current LC reported overall work impairment due health mean SD 177 253 total hour worked per week compared never LC mean SD 32 118 total hours resolved LC mean SD 56 122 total hours significantly increased odds work impairment compared never LC adjusted odds ratio aOR 724 95 CI 568921 current LC group increased odds missing work due health aOR 262 95 CI 193357 experiencing work impairment aOR 1182 95 CI 8901570 compared group never LC Individuals current LC increased odds moderate high FACITCOST score compared never LC aOR 520 95 CI 392689 compared resolved LC aOR 316 95 CI 119841 Participants vaccinated lower overall work impairment aOR 071 95 CI 055092 impairment working aOR 066 95 CI 050087 impairment nonwork activity aOR 074 95 CI 057096 financial toxicity leastsquares mean difference 107 95 CI 019195 compared vaccinated prospective cohort study adult SARSCoV2 infection participant current selfreported LC reported worse work impairment missed work financial distress compared never LC vaccination associated improved work outcome less financial distress even among individual LC data underscore need postpandemic assistance programs well vaccination decrease societal harms",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "COVID-19",
            "Adult",
            "Middle Aged",
            "Prospective Studies",
            "Longitudinal Studies",
            "SARS-CoV-2",
            "Quality of Life",
            "Efficiency",
            "Surveys and Questionnaires",
            "Financial Stress"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794410/"
    },
    {
        "pmid": "40794339",
        "title": "Optimizing Care for Cardiovascular-Kidney-Metabolic Syndrome: Leveraging Implementation Science in the Path Toward Pharmacoequity.",
        "abstract": "Overview current landscape pharmacoequity cardiovascularkidneymetabolic CKM syndrome CKM syndrome key driver significant morbidity mortality associated cardiovascular disease pose significant threat public health Despite growing armamentarium evidencebased therapy prevention management CKM syndrome access treatment remains unequal instance gender race ethnicitybased disparity noted use firstline guidelinedirected diseasemodifying drugs Barriers pharmacoequity CKM including multimorbiditypolypharmacy low awareness clinical inertia cost pharmacy inaccessibility unequal sociocontextual factors fragmented care require urgent attention including equitypromoting policy​​ Individual systemlevel barrier pharmacoequity CKM syndrome impede optimal CKM management particularly among minoritized populations describe multifaceted multilevel approach CKM equity including interdisciplinary care clinical decision support tool designed implementation science lens may help combat inequities",
        "mesh_terms": [
            "Humans",
            "Metabolic Syndrome",
            "Cardiovascular Diseases",
            "Implementation Science",
            "Cardio-Renal Syndrome",
            "Healthcare Disparities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794339/"
    },
    {
        "pmid": "40793887",
        "title": "[Economic impact of diabetes and its main complications in Argentina].",
        "abstract": "Cardiovascular disease leading cause mortality patient type 2 diabetes mellitus T2DM weighted prevalence argentine patient 415The aim study estimate direct medical cost associated treatment followup T2DM addition main chronic complications Microcosting analysis calculate estimate frequency resource use determine overall cost Argentine peso ARS August 2022 T2DM related complication described Argentinean population CAPTURE study estimated annual direct cost followup treatment T2DM per patient ARS 252 89945 United States dollar USD 177448 social security subsector ARS 257 79910 USD 180886 private subsector Stroke expensive diabetesrelated complication complexity care increased relative decrease medication cost concomitant increase cost interventions considering cost treatment uncomplicated T2DM baseline parameter cardiovascular renal cerebrovascular event multiplied value 99 84 478 times respectively significant economic burden T2DM complication Argentine healthcare system social security private sectors highlight importance understanding cost make effective strategic decision regarding disease management population health policy planning",
        "mesh_terms": [
            "Humans",
            "Argentina",
            "Diabetes Mellitus, Type 2",
            "Female",
            "Cardiovascular Diseases",
            "Male",
            "Middle Aged",
            "Health Care Costs",
            "Diabetes Complications",
            "Cost of Illness",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793887/"
    },
    {
        "pmid": "40792246",
        "title": "Enhancing the use of sodium-glucose cotransporter-2 inhibitors in type-2 diabetic patients with chronic kidney disease, through a key performance indicator program.",
        "abstract": "Despite substantial clinical evidence recommendation international society supporting use sodiumglucose cotransporter2 inhibitor SGLT2i managing patient type2 diabetes T2D chronic kidney disease CKD adoption remained limited address this nephrology quality improvement QI team Hamad Medical Corporation HMC Qatar implemented key performance indicator KPI program March 2022 aiming ensure least 80 eligible T2DCKD patient HMC receiving SGLT2i December 31 2023 use SGLT2i angiotensinconverting enzyme inhibitor ACEi angiotensin II receptor blocker ARB T2DCKD patient attending nephrology clinic HMC hospital assessed retrospective survey using clusterbased sampling approach Nephrology physician updated result retrospective survey well evidence SGLT2i trial guidelines aims objectives target KPI program clearly defined Three additional survey conducted 6month intervals multifaceted QI intervention approachcombining audit feedback leadership engagement peer consultationwas implemented drive improvement Retrospective survey conducted November 2021 February 2022 revealed 38 44 eligible T2DCKD patient receiving SGLT2i therapy compared 98 99 ACEiARB Four month implementing KPI program July 2022 survey revealed change SGLT2i use 41 ACEiARB prescription rate remained near 100 Following QI intervention November 2022 February 2023 survey revealed significant increase SGLT2i use rising 88 SGLT2i initiation naive patient increasing 34 61 final survey conducted August 2023 showed 84 patient receiving SGLT2i therapy KPI program boosted SGLT2i prescription rate eligible T2DCKD patient nephrology clinics resulting 47 rise 41 88 overcame prescription inertia accelerated guideline adoption combining realtime feedback leadership engagement peer discussions sharp rise new prescription following November 2022 feedback underscore direct influence behavior modification rather broader trend",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792246/"
    },
    {
        "pmid": "40791237",
        "title": "Differential effects of plant protein ratio on renal function and mortality across CKD stages.",
        "abstract": "plant protein suggested offer renoprotective benefits optimal proportion dietary plant protein relationship outcome across different stage chronic kidney disease CKD remains unclear Using data National Health Nutrition Examination Survey NHANES examined association plant protein ratio estimated glomerular filtration rate eGFR across CKD stages Plant protein ratio categorized low  33 medium 3366 high ≥ 66 Multiple imputation performed missing data Weighted linear regression model used analyze plant protein ratioeGFR associations Cox proportional hazard model assessed mortality risk Doseresponse relationship evaluated using restricted cubic splines Among 16163 participants distinct pattern emerged across CKD stages NonCKD high plant protein ratio associated significantly higher eGFR compared low plant protein ratio β  0790 iPi  0039 CKD G4 medium plant protein ratio showed significantly higher eGFR β  1791 iPi  0025 compared low plant protein ratio mortality risk CKD G3 patient medium plant protein ratio demonstrated significantly lower risk HR  067 95 CI 044100 iPi  0047 compared low plant protein ratio Doseresponse analysis revealed stagespecific patterns Ushaped relationship early CKD transitioning inverted Ushaped Jshaped pattern advanced stages association plant protein ratio outcome varies across CKD stages suggesting need stagespecific dietary recommendations moderate plant protein intake might beneficial early CKD finding advanced stage largely nonsignificant require confirmation larger study clinical recommendation made finding support nuanced approach dietary protein source management CKD though prospective study needed confirm associations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791237/"
    },
    {
        "pmid": "40790782",
        "title": "Optimizing care for chronic kidney disease: Considerations from A to Z.",
        "abstract": "Chronic kidney disease CKD management requires comprehensive multidisciplinary approach optimize clinical outcomes review systematically outline essential component CKD care Z offering evidencebased guidance enhance patient management Anemia treatment emphasizes iron supplementation erythropoiesisstimulating agents novel hypoxiainducible factor prolyl hydroxylase inhibitors Achieving optimal blood pressure control reninangiotensin system inhibitor calcium channel blocker reduces cardiovascular risk delay CKD progression Cardiovascular risk management includes statin combined ezetimibe proprotein convertase subtilisinkexin type 9 inhibitors along appropriate anticoagulation therapy atrial fibrillation Individualized glycemic control strategy prioritize sodiumglucose cotransporter2 inhibitor glucagonlike peptide1 receptor agonist cardiovascular renal protective effects Vigilance avoiding nephrotoxic agents nonsteroidal antiinflammatory drugs proton pump inhibitors aminoglycosides contrast media essential preventing renal injury Rigorous management electrolyte acidbase disturbances involving dietary sodium potassium restrictions phosphate binders bicarbonate supplementation reduces CKD progression related complications Appropriate fluid management dietary sodium water restriction individualized diuretic therapy prevents volume overload associated cardiovascular complications Nutritional interventions particularly lowprotein diet supplemented ketoanalogues amino acids effectively delay CKD progression control metabolic disturbances Therapies addressing CKDrelated mineral bone disorders including phosphate binders vitamin analogues calcimimetics reduce risk vascular calcification addition lipidlowering therapies anticoagulation therapy optimal vascular access management dialysis early detection arrhythmia thrombotic microangiopathy significantly enhance patient outcomes Attention qualityoflife issues alleviating xerosis symptoms promoting optimal body mass index weight management strategies providing psychosocial support enhances patientcentered care comprehensive review highlight crucial importance multidisciplinary approach CKD management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790782/"
    },
    {
        "pmid": "40790474",
        "title": "From acute kidney injury to chronic kidney disease in children: maladaptive repair and the need for long-term surveillance - a literature review.",
        "abstract": "Pediatric Acute Kidney Injury AKI increasingly prevalent global health concern extends far beyond transient clinical event posing significant risk longterm kidney dysfunction review consolidates current knowledge pathophysiological transition pediatric AKI Chronic Kidney Disease CKD critically evaluating mechanism maladaptive repair utility biomarkers state longterm surveillance strategies progression CKD driven maladaptive repair process kidneys healing mechanism become dysregulated following severe prolonged insult pathological cascade involves persistent inflammation endothelial dysfunction tubular epithelial cell cycle arrest activation myofibroblasts culminating irreversible interstitial fibrosis nephron loss kidney preterm infant neonate particularly vulnerable preterm infant may incomplete nephrogenesis leading reduced nephron endowment neonate exhibit functional immaturity AKI critical early period disproportionately large impact amplifying lifetime risk hypertension accelerated CKD Evidence confirms pediatric AKI survivor face substantially increased risk incident CKD hypertension proteinuria even serum creatinine level return baseline Current diagnostic tools reliant creatinine insensitive lag behind actual injury hindering timely intervention novel biomarkers show promise early AKI detection ability predict transition CKD remains area active investigation Major conclusion review highlight pediatric AKI must reframed sentinel event necessitates longterm approach kidney health However care often fragmented challenge compounded lack pediatricspecific evidencebased followup guidelines Future progress depends dedicated research unique aspect maladaptive repair developing kidneys validation predictive biomarkers development targeted ageappropriate therapies",
        "mesh_terms": [
            "Humans",
            "Acute Kidney Injury",
            "Renal Insufficiency, Chronic",
            "Child",
            "Disease Progression",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790474/"
    },
    {
        "pmid": "40790363",
        "title": "Kidney stone disease: risk factors, pathophysiology and management.",
        "abstract": "Nephrolithiasis common health condition affecting kidney urinary tract constitutes major global healthcare problem prevalence nephrolithiasis increased substantially past five decades irrespective age sex ethnicity Kidney stone cause substantial morbidity reduced quality life enormous healthcare expenditure largely due frequent recurrence Furthermore nephrolithiasis recognized systemic condition associated increased risk chronic kidney disease cardiovascular disease metabolic syndrome low bone mass Nephrolithiasis exhibit marked pathophysiological heterogeneity Dietary environmental exposure interact genetic predisposition shape individual disease risk Calcium oxalate stone prevalent commonly driven hypercalciuria hyperoxaluria hypocitraturia low urine volume whereas formation uric acid calcium phosphate stone commonly linked urinary pH comprehensive clinical evaluation uncover underlying metabolic abnormalities distinguish idiopathic secondary Mendelian form nephrolithiasis identify systemic disease association guide therapy Recurrence prevention requires individualized strategy combine dietary pharmacological interventions established stones surgical management effective ureteroscopy percutaneous nephrolithotomy achieving high stonefree rates Despite considerable clinical societal burden nephrolithiasis remains underrecognized underserved underresearched Greater awareness investment research innovation education urgently needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790363/"
    },
    {
        "pmid": "40789986",
        "title": "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.",
        "abstract": "Gout inflammatory arthritis caused monosodium urate crystal deposition joints clinical presentation varies age onset study compared clinical feature treatment pattern olderonset gout commonageofonset gout analyzed data Urate Lowering TheRApy Gout registry Eligible participant aged ≥ 18 year met 2015 American College RheumatologyEuropean League Rheumatism classification criterion gout Olderonset gout defined gout diagnosed age 65 years commonageofonset gout gout diagnosed age 65 years Demographics clinical features treatment patterns quality life laboratory finding collected baseline 6 months Among 477 patients 105 220 olderonset gout 372 780 commonageofonset gout olderonset group included woman 257 versus 24 P  0001 showed higher frequency radiographic goutrelated joint damage erosion 305 versus 196 P  0018 comorbidities eg hypertension cardiovascular disease chronic kidney disease malignancy glucocorticoid use flare prophylaxis contrast commonageofonset group higher body mass index BMI frequent flares unhealthier lifestyle habit eg smoking alcohol higher rate nonsteroidal antiinflammatory drug NSAID benzbromarone use Febuxostat frequently prescribed olderonset group 714 versus 589 P  0019 benzbromarone use common commonageofonset group 73 versus 0 P  0004 febuxostat dose lower olderonset group 6 months group showed similar followup adherence flare frequency healthcare utilization Olderonset gout commonageofonset gout distinct clinical characteristics particularly comorbidities lifestyle factors treatment patterns Gout management tailored basis age onset",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789986/"
    },
    {
        "pmid": "40788686",
        "title": "Lupus Nephritis: Unmet Needs and Evolving Solutions.",
        "abstract": "Lupus nephritis LN seeing enriching immunotherapies important unmet need remain discus focus histological sign immunological activity triggering immunotherapy versus sign irreversible kidney injury requiring care chronic kidney disease Also correct interpretation residual proteinuria requires dissecting immunological activity glomerular hyperfiltration eg repeat biopsy Despite modern triple immunotherapy perprotocol biopsy still document irreversible injury occur first year Immediate inhibition complement system may address unmet need may even help ultimately replace early glucocoorticoid therapy advocate concept clonedirected therapy sufficiently suppress autoreactive clone memory B cell inside lymphoid tissue well longlived plasma cell bone marrow maintain activity systemic lupus erythematosus SLE drive disease flares Numerous B cell plasma celltargeting therapy gradually becoming available parenteral route application may also avoid oral drug nonadherence Replacing oral toxic medication steroids mycophenolate calcineurin inhibitor goal next decade Obtaining orphan disease designation LN would accelerate progress supported latest data LN prevalence conceptual management improvements LN complex frequently fatal may become easytomanage autoimmune diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788686/"
    },
    {
        "pmid": "40788620",
        "title": "Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry.",
        "abstract": "Patients heart failure HF high risk hyperkalaemia underrepresented prospective HF registries CAREHK HF registry sought characterize prospectively clinical profile management outcome patient HF high risk hyperkalaemia CAREHK HF multinational prospective registry outpatient HF regardless left ventricular ejection fraction LVEF treated angiotensinconverting enzyme inhibitorangiotensin II receptor blockerangiotensin receptorneprilysin inhibitor ACEIARBARNI either receiving potential candidate mineralocorticoid receptor antagonist MRA patient increased risk hyperkalaemia defined hyperkalaemia baseline prior hyperkalaemia estimated glomerular filtration rate eGFR 45 mlmin173 msup2sup Outcomes included frequency hyperkalaemic event defined clinician report associated potassium value achievement reninangiotensin system inhibitor RASi optimization defined ≥50 target dos ACEIARBARNI MRA medication change following hyperkalaemic episodes clinical events Overall 2558 patient 111 site across nine country included Median 25th75th age 73 6580 years 32 women 61 LVEF ≤40 40 prior laboratory evidence hyperkalaemia Median baseline eGFR serum potassium 44 3360 mlmin173 msup2sup 50 4453 mEqL respectively median followup 123 94181 months 29 patient hyperkalaemic event 7 multiple events characterizing treatment prescribed followup 29 patient received optimal RASiMRA therapy 69 received suboptimal RASiMRA therapy 3 received RASiMRA 30 day following first hyperkalaemic event RASiMRA downtitrated discontinued 36 cases Potassium binder use low patiromer 91 sodium zirconium cyclosilicate 59 Compared patient without hyperkalaemic event patient experiencing hyperkalaemic event similar risk allcause mortality hazard ratio HR 122 95 confidence interval CI 092162 p  016 higher risk subsequent hospitalization HR 159 95 CI 135186 p  0001 contemporary multinational prospective registry patient HF high risk hyperkalaemia hyperkalaemic event common infrequently associated RASiMRA modification potassium binder use Fewer one three patient received optimal RASiMRA therapy majority followup hyperkalaemic event associated higher risk adverse clinical outcomes ClinicalTrialsgov NCT04864795",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788620/"
    },
    {
        "pmid": "40788539",
        "title": "Chronic comorbidities and risk of 30-day mortality in hip fracture patients- a Danish National patient registry study.",
        "abstract": "Hip fracture major health issue among elderly population associated increased mortality Chronic comorbidities may cause increased mortality risk among patients study examined impact chronic comorbidities 30day mortality among Danish hip fracture patient along risk factor sex fracture type study used data Danish National Patient Registry included patient aged ≥ 70 year sustained hip fracture January 1 1999 December 31 2012 Chronic comorbidities dementia heart failure chronic obstructive pulmonary disease asthma ischemic heart disease diabetes mellitus complications chronic kidney disease cancer well fracture type identified using ICD10 codes total 98850 hip fracture patient included 115 died within 30 days Male patient significantly higher 30day mortality rate 177 female patient 92 Patients multiple chronic comorbidities increased mortality risk patient ≥ 5 chronic comorbidities exhibiting 30day mortality rate 283 compared 78 patient without chronic comorbidities Regarding fracture types patient subtrochanteric fracture mortality risk 132 compared patient femoral headneck fracture mortality risk 108 adjusted analysis chronic kidney disease male sex highest association increased 30day mortality risk study show significant impact chronic comorbidities well sex fracture type 30day mortality hip fracture patients Patients multiple chronic comorbidities highest risk increased 30day mortality finding underline importance intervention orthogeriatric care lower 30day mortality risk patients",
        "mesh_terms": [
            "Humans",
            "Male",
            "Denmark",
            "Female",
            "Hip Fractures",
            "Aged",
            "Registries",
            "Comorbidity",
            "Aged, 80 and over",
            "Risk Factors",
            "Chronic Disease",
            "Sex Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788539/"
    },
    {
        "pmid": "40788064",
        "title": "Personalized Medication for Chronic Diseases Using Multimodal Data-Driven Chain-of-Decisions.",
        "abstract": "precise matching medication regimen individual patients known personalized medication critical effective management chronic diseases Traditional machine learningbased model personalized medication regimen typically rely solely either clinical macrophenotypes molecularlevel drug characteristics remains challenging capture patientmedication relationship comprehensive perspective integrates individual patient characteristic macro microlevel property medication Determining patientmedication relationship constitutes threestage sequential decision process clinical decisionmaking perspective Therefore inspired ChainofThought prompting simulates decisionmaking process human experts Multimodal DataDriven ChainofDecisions MDDCoD framework proposed threestage deep learning task sequentially organized reflect upstreamdownstream logical dependencies thereby forming coherent clinical decisionmaking process model incorporates multimodal clinical phenotype data multiattribute medication data insight clinical experts Performance evaluation model involved comprehensive experiment utilizing five datasets covering four chronic disease sourced three hospitals dataset comprises information chronic kidney disease CKD membranous nephropathy MN rheumatoid arthritis RA colorectal cancer CRC knee osteoarthritis KOA totaling 3173 unimodal 502 multimodal 2187 medication record 3675 patients Experimental result demonstrate framework achieves enhanced predictive performance personalized medication decisionmaking based individual patient disease characteristics surpassing strongest baseline across tasks framework serf foundational model clinical mixed data improved generalization interpretability crossdisease personalized decisionmaking tasks offer scalable solution implementation personalized medication regimen chronic diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788064/"
    },
    {
        "pmid": "40786778",
        "title": "Bilateral Total Hip Arthroplasties Secondary to Renal Osteodystrophy in a Patient with a Rare Cromer Antibody: A Case Report.",
        "abstract": "Bilateral displaced femoral neck fracture uncommon adult without significant trauma especially absence highenergy impact case highlight importance considering underlying metabolic disorder endstage renal disease ESRD significant contributing factors one reported case demonstrating interplay ESRD renal osteodystrophy anemia chronic disease presence rare Cromer blood group antibodies adding unique dimension orthopedic hematological literature present case 50yearold African American female history ESRD dialysis presented bilateral hip pain minor fall Imaging revealed bilateral displaced femoral neck fractures Laboratory workup showed hemoglobin level 74 gdL microcytic anemia Due chronic kidney disease diagnosed renal osteodystrophy contributing bone fragility rare Cromer blood group antibody also detected complicating transfusion planning underwent surgical repair hips postoperative management involved coordinated multidisciplinary care addressing orthopedic hematologic nephrologic concerns case underscore need clinician consider renal osteodystrophy patient ESRD potential cause spontaneous lowimpact fractures addition highlight transfusion challenge posed rare blood group antibody like Cromer system case demonstrates value early recognition prompt surgical intervention interprofessional collaboration managing complex comorbid conditions contributes broader clinical understanding linking metabolic bone disease chronic anemia immunohematologic complication fracture management research personalized treatment protocol rare blood antigen matching could enhance outcome medically complex patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786778/"
    },
    {
        "pmid": "40786540",
        "title": "Rethinking Glycemic Thresholds: Diabetic Kidney Disease in the Absence of Overt Diabetes.",
        "abstract": "Diabetic kidney disease traditionally regarded complication chronic hyperglycaemia associated diabetes However relationship glycaemic threshold development diabetic kidney disease increasingly questioned present case 69yearold woman progressive renal dysfunction biopsy finding suggestive diabetic kidney disease despite repeatedly normal glycosylated haemoglobin haemoglobin A1c without clinical diagnosis diabetes prediabetes case highlight limitation current haemoglobin A1c threshold raise question whether diabetic kidney disease truly develop absence diabetes Stricter glycaemic criterion may help identify atrisk patient earlier prevent renal complications Diabetic kidney disease occur without overt diabetes prediabetes challenging current diagnostic methodsReliance haemoglobin A1c alone may miss atrisk individuals stricter glycaemic threshold may warrantedThe diagnosis diabetic kidney disease normoglycemic patient challenge disease definition pathogenesis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786540/"
    },
    {
        "pmid": "40786396",
        "title": "Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Frequently Overlooked and Underdiagnosed Condition.",
        "abstract": "Bradycardia renal failure atrioventricular nodal blockade shock hyperkalemia BRASH syndrome defined simultaneous presence five hallmark features Despite potentially severe clinical implications frequently underdiagnosed due symptom overlap conditions Increased awareness understanding syndrome essential prompt diagnosis effective management key preventing serious morbidity 65yearold male medical history cirrhosis portal hypertension heart failure reduced ejection fraction chronic kidney disease ventricular bigeminy presented dizziness low blood pressure started six seven day prior initial examination found bradycardic heart rate 30s laboratory finding revealed hyperkalemia 66 mEqL acute kidney injury creatinine 29 mgdL patient stable dose metoprolol AV nodal blocking agent recently reduced clinic due worsening renal function BRASH syndrome suspected ED prompting initiation treatment epinephrine drip insulin address hyperkalemia Upon admission ICU cardiac catheterization revealed nonobstructive coronary artery disease patients condition improved five days normalization potassium levels restoration normal sinus rhythm resolution kidney injury ultimately leading recovery discharge metoprolol discontinued close cardiology followup arranged Recognizing BRASH syndrome multifaceted clinical entity critical Early identification comprehensive approach managing interdependent component  bradycardia renal failure hyperkalemia  essential halt syndromes progression improve patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786396/"
    },
    {
        "pmid": "40785929",
        "title": "Prospective evaluation of arterial spin labeling and diffusion tensor imaging-magnetic resonance imaging for the non-invasive assessment of renal allograft dysfunction.",
        "abstract": "optimal management strategy endstage renal disease renal transplantation graft function must monitored regularly postoperatively crosssectional study aimed explore value combining functional magnetic resonance imaging MRI parameter laboratory parameter assessing chronic allograft dysfunction CAD compare whether combined approach superior singleparameter indicators total 86 subject enrolled study whom 20 stable renal function 66 biopsyconfirmed CAD Imaging performed 15T MRI system using T2weighted imaging arterial spin labeling ASL diffusion tensor imaging DTI serum creatinine estimated glomerular filtration rate eGFR 24hour urinary protein 24hUP renal blood flow RBF fractional anisotropy FA value subject measured Correlation analysis applied assess MRI parameters association eGFR receiver operating characteristic ROC curve used evaluate diagnostic efficacy fMRI parameter clinical parameter CAD subject categorized CAD group based eGFR levels control group higher renal RBF 27769±6717 ivsi 13860 995419351 FA value cortex 016 014016 ivsi 013 011016 medulla 032±006 ivsi 024 020029 CAD group P001 Cortical RBF decreased progressively across CAD subgroup group 1 mild 21333±6707  group 2 moderate 15114±5321  group 3 severe 9289±3562 P005 Similarly gradual decrease medullary FA across CAD subgroup group 1 029±004 group 2 024 019029 group 3 020±006 However statistically significant difference found medullary FA group 2 3 P0102 correlation analysis showed cortical RBF medullary FA positively correlated eGFR CAD group r0604 P0001 r0574 P0001 combined RBF medullary FA 24hUP eGFR model RBFFA24hUPeGFR area curve AUC 095 95 confidence interval CI 091100 significantly better AUCs single indicator 24hUP medullary FA AUC 078 95 CI 068088 AUC 079 95 CI 069089 P005 Further combined RBF medullary FA and 24hUP model RBFFA24hUP significantly superior single 24hUP differentiating among subgroup all P005 CAD subgroups performance RBF close RBFFA24hUP model AUC combined model showed increasing trend compared RBF Notably RBFFA24hUP model AUC 086 95 CI 076097 P0001 also surpassed medullary FA alone AUC 069 95 CI 054085 P0023 distinguishing subject group 2 group 3 P005 study two multiparametric MRI model RBFFA24hUPeGFR RBFFA24hUP developed shown superior noninvasive CAD assessment tools model outperformed conventional singleparameter method diagnosis moderatetosevere subgroup stratification certain extent model could prevent unnecessary puncture biopsies reduce occurrence complication bleeding infection RBF particular FA showed utility noninvasive biomarkers CAD risk stratification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785929/"
    },
    {
        "pmid": "40785747",
        "title": "Safe and effective antireflux surgery in lung transplant recipients: preliminary results.",
        "abstract": "Obliterative bronchiolitis clinical manifestation bronchiolitis obliterans syndrome BOS major complication lung transplantation one primary cause chronic lung allograft dysfunction leading poor survival outcomes aim study evaluate safety outcome antireflux surgery lung transplant recipient LTRs BOS associated gastroesophageal reflux disease GERD singlecenter study included 8 consecutive patient median interquartile range IQR age 29 2546 year underwent bilateral lung transplantation subsequent antireflux surgery due BOS decision proceed laparoscopic surgery based diagnosis GERD associated decline pulmonary function confirmed bronchoscopy indicative BOS Followup lasted 12 months Median IQR time since transplantation 27 15555 months Significant improvement spirometric parameter observed 3 12 month postoperatively compared baseline including forced expiratory volume 1 second FEVsub1sub iPi  002 FEVsub1sub predicted iPi  002 forced vital capacity FVC iPi  0003 FVC predicted iPi  002 difference spirometric parameter 3 12 month postoperatively surgical complication observed within 30 day surgery followup Two patient developed pulmonary complications 1 patient history kidney transplantation experienced renal complications postoperative deaths Median IQR hospital stay 12 329 days study suggests antireflux surgery LTRs safe effective approach GERD management improving lung function minimal adverse effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785747/"
    },
    {
        "pmid": "40784581",
        "title": "EVOLUTION OF VESICOURETERAL REFLUX IN PATIENTS WITH MYELOMENINGOCELE IN A PROACTIVE FOLLOW-UP PROTOCOL.",
        "abstract": "first six month life patient myelomeningocele MMC incidence vesicoureteral reflux VUR 17 263 proactive treatment approach associated VUR resolution rate 30 50 within 23 years aim assess incidence VUR pediatric patient MMC identify variable involved occurrence analyzed evolution VUR chronic kidney disease CKD using proactive approach compared outcome MMC patient without VUR retrospective observational study included newborn MMC managed proactively 2015 2020 institution Patients grouped based presence absence VUR first videourodynamic study VUDS Demographic characteristic nephronurological variable compared first last year followup 68 patient analyzed 14 VUR first VUDS mean age 6 month R 215 Lowgrade VUR observed 11 786 highgrade VUR three patients resolution rate VUR 643 within 22 month R 749 Surgical closure defect beyond first 24 hour life associated VUR p  0001 57 developed CKD incidence VUR pediatric patient MMC 16 proactive protocol implemented resolution rate VUR 65 within 2 years patient progress CKD Observational cohort study LEVEL EVIDENCE III",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784581/"
    },
    {
        "pmid": "40783939",
        "title": "Uncovering the mechanistic basis of <i>Rheum palmatum</i> L. (rhubarb) in the treatment of chronic kidney disease: an integrative approach using network pharmacology, molecular docking, and experimental validation.",
        "abstract": "iRheum palmatumi L Rhubarb shown potential managing Chronic Kidney Disease CKD protective mechanism remain unclear study investigates rhubarbs therapeutic effect underlying mechanism CKD Highperformance liquid chromatography HPLC established rhubarb fingerprint ensure quality control Network pharmacology Mendelian randomization identified primary CKD therapeutic targets Inflammation oxidative stress renal performance assessed ELISAs biochemical tests Renal structure fibrosis examined using hematoxylineosin Masson staining Protein expression related fibrosis apoptosis NFκB pathway activity measured iviai Western blotting Discovery Studio 2019 DS 2019 used molecular docking HPLC fingerprinting confirmed high batchtobatch consistency rhubarb identifying five key anthraquinones aloeemodin rhein emodin chrysophanol physcion similarity index 091 Network pharmacology identified 19 active compound targeting 2597 CKDrelated proteins 47 overlapping target including IL6 TNF TP53 CASP3 IL1B core nodes MR analysis demonstrated statistically significant causal association TNF CKD OR  102 ipi  005 positive trend IL6 CASP3 CKD rat models rhubarb significantly improved renal function reducing blood urea nitrogen BUN serum creatinine SCr uric acid UA level ipi  005 Histopathology showed reduced glomerulosclerosis tubular atrophy interstitial fibrosis inflammatory infiltration treatment Rhubarb markedly decreased renal fibrosis marker including collagen I collagen III αSMA TGFβ ipi  001 Proinflammatory cytokine IL6 IL1β TNFα level significantly suppressed ipi  0001 Antioxidant enzyme activity superoxide dismutase SOD glutathione peroxidase GSHPx restored lipid peroxidation LPO reduced ipi  005 Rhubarb inhibited NFκB pathway activation lowering phosphorylated NFκB IκBα increasing total IκBα expression ipi  001 Apoptosisrelated protein showed upregulated Bcl2 downregulated Bax cleaved caspase3 expression ipi  005 Molecular docking confirmed strong binding affinity rhubarbs core compound key target TNF IL6 supporting therapeutic roles Rhubarb significantly reduces renal impairment fibrosis inflammation apoptosis NFκB pathway supporting traditional use potential adjunct therapy CKD",
        "mesh_terms": [
            "Rheum",
            "Animals",
            "Molecular Docking Simulation",
            "Network Pharmacology",
            "Renal Insufficiency, Chronic",
            "Male",
            "Rats",
            "Rats, Sprague-Dawley",
            "Plant Extracts",
            "Chromatography, High Pressure Liquid",
            "Oxidative Stress",
            "Anthraquinones",
            "Kidney",
            "Apoptosis",
            "Disease Models, Animal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783939/"
    },
    {
        "pmid": "40783902",
        "title": "Recurrent pathological fractures in chronic kidney disease revealing overlapping neglected primary hyperparathyroidism and GDF5-associated skeletal dysplasia.",
        "abstract": "Primary hyperparathyroidism PHPT common endocrine disorder characterized excessive secretion parathyroid hormone PTH resulting significant hypercalcemia skeletal complications context chronic kidney disease CKD neglected PHPT progress biochemical profile resembling tertiary hyperparathyroidism THPT complicating diagnosis especially concomitant genetic skeletal disorder GSD exist present rare complex case 63yearold woman stage 3 CKD presented recurrent pathological fractures severe hypercalcemia extensive osteolytic bone lesion femurs patients clinical picture complicated notable skeletal anomalies including short stature brachydactyly hypoplastic metatarsals Elevated serum calcium markedly increased PTH levels hypercalciuria hyperphosphaturia parathyroid imaging confirmed previously untreated PHPT resulting THPTlike biochemical profile setting CKD patient ultimately underwent surgical fixation bilateral lower limb fractures followed simple parathyroidectomy achieving symptomatic relief metabolic stabilization genetic investigation prompted distinctive skeletal features uncovered frameshift mutation growth differentiation factor 5 GDF5 gene indicative brachydactyly type C rare form GSD case highlight complexity differentiating PHPT cause hyperparathyroidism setting CKD particularly concurrent skeletal dysplasia present thorough clinical biochemical imaging genetic assessment pivotal reaching accurate diagnosis guiding appropriate surgical management",
        "mesh_terms": [
            "Humans",
            "Female",
            "Middle Aged",
            "Hyperparathyroidism, Primary",
            "Renal Insufficiency, Chronic",
            "Fractures, Spontaneous",
            "Brachydactyly",
            "Frameshift Mutation",
            "Parathyroidectomy",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783902/"
    },
    {
        "pmid": "40783836",
        "title": "[Application of animal drugs in uro-andrological diseases under the guidance of diversified theories of traditional Chinese medicine].",
        "abstract": "Animal drug used treatment uroandrological disease since ancient times present clinical use animal drug mostly based experience doctors perspective diversified theory traditional Chinese medicine TCM paper summarizes experience predecessor use animal drugs belief guidance TCM theories application animal drug treatment uroandrological disease achieved multidimensional diversified development treatment chronic prostatitis based theory heat poison stasis poison aromatherapy orifice management ED perspective kidney deficiency qiblood disharmony collateral disease accord mainstream thought current scholar differentiation treatment uroandrological diseases time pointed problem attended clinical use animal drugs aiming provide reference idea clinical treatment uroandrological disease animal drugs",
        "mesh_terms": [
            "Medicine, Chinese Traditional",
            "Humans",
            "Animals",
            "Urologic Diseases",
            "Drugs, Chinese Herbal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783836/"
    },
    {
        "pmid": "40783717",
        "title": "Gender-based distribution of depression and anxiety following acute coronary syndrome in the Turkish population: are women at higher risk?",
        "abstract": "Depression anxiety common psychological disorder following acute coronary syndrome ACS potentially affecting patient outcomes Sexbased disparity prevalence disorder may significantly impact recovery rehabilitation postACS evaluate genderbased difference depression anxiety prevalence among Turkish patient following ACS identify sociodemographic clinical factor associated psychological distress crosssectional observational study 604 patient 144 woman 460 men diagnosed ACS enrolled initial outpatient followup 48 week postdischarge Data collection included demographic clinical survey along Hospital Anxiety Depression Scale HADS Depression anxiety significantly prevalent woman men 611 vs 374 depression p  0001 306 vs 200 anxiety p  0008 Moderatetosevere symptom also common among woman condition p  0001 Lower education level income expense associated higher anxiety depression score p  0025 Among women married individual reported higher anxiety widoweddivorced woman p  0001 Hypertension significantly increased distress particularly men p  0001 chronic kidney disease stronger impact among woman p  0018 marked gender disparity depression anxiety prevalence postACS woman significantly affected Socioeconomic disadvantage comorbid condition contribute psychological distress Routine psychological screening sexsensitive interventions especially vulnerable groups crucial improving outcome ACS Significant gender disparity exist postACS depression anxiety woman disproportionately affected Socioeconomic disadvantage comorbidities compound psychological distress Integrating routine mental health screening sexsensitive intervention postACS care essential particularly highrisk populations improve longterm outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Turkey",
            "Acute Coronary Syndrome",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Depression",
            "Prevalence",
            "Anxiety",
            "Risk Factors",
            "Sex Factors",
            "Aged",
            "Health Status Disparities",
            "Risk Assessment",
            "Sex Distribution",
            "Adult",
            "Psychological Distress",
            "Socioeconomic Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783717/"
    },
    {
        "pmid": "40783307",
        "title": "Clinical Frailty Scale and Charlson Comorbidity Index as predictors of hospitalization and mortality risk after kidney transplant failure.",
        "abstract": "Kidney transplant KT recipient experience graft failure return dialysis face higher risk adverse outcomes study aimed identify risk factor hospitalization mortality two year postgraft failure conducted retrospective cohort study endstage kidney disease patient initiated hemodialysis following graft failure January 2019 December 2020 Clinical Frailty Scale CFS Charlson Comorbidity Index CCI assessed patient time graft loss primary outcome hospitalization allcause mortality twoyear followup period total 107 patient included mean age 559 year mean graft survival 134 months twoyear hospitalization rate 374 lower residual diuresis higher CFS identified independent risk factors twoyear mortality rate 168 multivariate regression model explaining 82 variance confirmed higher CCI higher CFS lower residual diuresis significantly increased mortality risk CCI cutoff ≥8 AUC 095 stratified patient elevated mortality risk Immunological transplantrelated variable influence mortality hospitalization risk cohort frailty defined CFS associated hospitalization mortality comorbidity burden evaluated CCI strongly related mortality tool may help personalize care patient failing graft",
        "mesh_terms": [
            "Humans",
            "Kidney Transplantation",
            "Male",
            "Female",
            "Middle Aged",
            "Retrospective Studies",
            "Hospitalization",
            "Frailty",
            "Kidney Failure, Chronic",
            "Risk Factors",
            "Aged",
            "Adult",
            "Postoperative Complications",
            "Renal Dialysis",
            "Treatment Failure",
            "Comorbidity",
            "Risk Assessment"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783307/"
    },
    {
        "pmid": "40783306",
        "title": "Particularities of peritoneal dialysis in diabetic patients.",
        "abstract": "Diabetes major cause chronic kidney disease worldwide Managing CKD diabetic patient complex due accumulation comorbid condition hypertension cerebrovascular peripheral artery disease well increased risk infection malnutrition Reaching endstage kidney disease many diabetic patient choose peritoneal dialysis review explores epidemiology outcomes specific management challenge diabetic patient undergoing peritoneal dialysis Literature PubMed MEDLINE 2000 2023 methodically reviewed patient population increased cardiovascular risk unique metabolic challenges need individualized treatment strategy order improve clinical outcome underscored",
        "mesh_terms": [
            "Humans",
            "Peritoneal Dialysis",
            "Diabetic Nephropathies",
            "Kidney Failure, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783306/"
    },
    {
        "pmid": "40782275",
        "title": "Renal Function in Patients after Metabolic and Bariatric Surgery.",
        "abstract": "Obesity risk factor chronic kidney disease CKD also accelerates progression Metabolic bariatric surgery shown improve course CKD significantly study aim explore impact metabolic bariatric surgery renal function various angles including pre postoperative comparisons difference surgical techniques subgroup analysis based kidney function analyzed outcome patient underwent RouxenY gastric bypass RYGB laparoscopic Sleeve Gastrectomy LSG January 2020 May 2023 prospectively managed database hospital Patients grouped based baseline glomerular filtration rate GFR hyperfiltration GFR  125 mLmin normal GFR 12590 mLmin CKD stage 2 GFR 8960 mLmin CKD stage 3 GFR 5930 mLmin Pre postoperative outcome compared subgroup analysis conducted total 278 patient included study 741 undergoing LSG cohort 597 female average BMI 383 ± 847 kgmsup2sup mean age 329 ± 954 years Postoperative GFR slightly increased 115 ± 148 mLmin presurgery 118 ± 154 mLmin postsurgery Significant improvement weight blood glucose lipid levels blood pressure also observed RYGB LSG group showed significant improvement renal function postoperatively GFR decreasing 115 ± 188 mLmin 112 ± 166 mLmin RYGB group 119 ± 139 mLmin 115 ± 188 mLmin LSG group However significant difference two group renal function improvement P  005 subgroup analyses hyperfiltration present 291 patient CKD 5 hyperfiltration group GFR decreased 134 ± 549 mLmin 127 ± 846 mLmin 407 patient returning normal GFR levels However 87 patient normal group developed hyperfiltration 49 showed sign renal impairment Among patient CKD stage 2 3 renal function improved 50 cases Linear regression analysis showed age hypertension status serum urea level significantly associated postoperative GFR level P  05 Metabolic bariatric surgery positively impact renal function one year postoperatively Preoperative attention age hypertension status serum urea level may positively influence patient outcomes addition potential postoperative renal insufficiency considered regular followup assessment essential Early identification treatment abnormality crucial optimizing outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782275/"
    },
    {
        "pmid": "40781195",
        "title": "Femoral artery calcification predicts hip fracture in maintenance hemodialysis patients.",
        "abstract": "Femoral artery calcification FAC significant predictor hip fracture hemodialysis patients higher FAC score associated increased fracture risk poor survival outcomes Identifying FAC radiographic assessment may improve fracture risk stratification clinical management highrisk population Patients endstage renal disease ESRD hemodialysis HD increased risk vascular calcification VC bone fractures previous study linked aortic calcification hip fractures relationship mediumcaliber arteryfemoral artery calcification FAC fallrelated hip fracture HD patient remains unclear retrospectively analyzed 170 HD patient experienced fall sought treatment emergency department ED 2007 2014 FAC score representing severity femoral artery calcification calculated ratio total length calcification plaque length femoral vessel visible plain radiograph hip femur logistic regression model assessed association FAC score hip fracture risk receiver operating characteristic curve analysis evaluated predictive power Among 130 patient meeting inclusion criteria 55 fallrelated hip fractures incidence rate hip fracture among dialysis patient 618 case per 1000 personyears dividing total number hip fracture event cumulative dialysis duration in years enrolled patients Fracture patient older lower serum creatinine sodium albumin level higher aspartate aminotransferase levels fracture group also higher FAC score 047 IQR 028  076 vs 000 IQR 000  040 p  0001 Multivariable analysis identified old age heart failure reduced ejection fraction EF higher FAC score independent risk factor hip fractures Survival curve showed increased mortality among patient higher FAC score hip fracture p  001 High FAC score associated increased risk hip fracture HD patients independent traditional risk factors linked poor survival outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Renal Dialysis",
            "Hip Fractures",
            "Retrospective Studies",
            "Aged",
            "Vascular Calcification",
            "Kidney Failure, Chronic",
            "Middle Aged",
            "Femoral Artery",
            "Accidental Falls",
            "Risk Factors",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781195/"
    },
    {
        "pmid": "40779654",
        "title": "Active Surveillance of Biopsy-Confirmed Oncocytic Renal Tumors: Growth Dynamics and Impact on Renal Function.",
        "abstract": "Oncocytic neoplasm account 15 small renal masses Active surveillance AS increasingly adopted lesions however knowledge gap remain regarding growth kinetics concordance renal tumor biopsy impact renal function study review factor largest cohort biopsyconfirmed oncocytic neoplasm managed AS singlecenter retrospective study included patient biopsyconfirmed oncocytoma chromophobe renal cell carcinoma chRCC 20032021 Tumor growth rate change renal function eGFR analyzed using linear mixed models development chronic kidney disease assessed using Cox proportional hazard model Biopsytosurgical pathology concordance trigger intervention examined Among 229 patient 245 lesions 222 oncocytomas 23 chRCC median time first last imaging 47 25 years respectively Predicted growth rate 021 cmyear oncocytoma 031 cmyear chRCC Larger baseline tumor size correlated faster growth p004 age inversely correlated growth rate p001 Intervention common chRCC cohort 35 vs 13 Biopsytosurgical pathology concordance rate 80 oncocytoma 86 chRCC significant association found tumor size renal function decline p03 level p06 event metastasis kidney cancerrelated death median followup 57 year IQR 30 87 Oncocytic lesion demonstrate slow growth low intervention rate preservation renal function excellent diseasespecific survival biopsy limitation exist histologyguided provides effective management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779654/"
    },
    {
        "pmid": "40779332",
        "title": "A Qualitative Study to Investigate the Nutrition Perspectives and Experiences of Veterans with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD affect susceptible population higher rate general public Dietary adherence quality behavior play crucial role CKD chronic disease management However individual CKD including Veterans missiondriven occupation cultures face unique challenge navigating dietary recommendation kidneyhealth promoting diets Understanding factor military occupational experiences comorbidities dietary barriers may lead developing effective patientcentered dietary interventions conducted qualitative descriptive study semistructured interview 32 Veterans CKD stages 3b5 including dialysis mean age 71 years 54 WhiteCaucasian 16 women receiving care Veterans Affairs VA Eastern Colorado Health Care System June 2023 July 2024 Interview construct included healthy eating CKD management food preference decision making conducted thematic analysis using inductive approach understand participants perspective experiences Three overarching domain emerged 1 Moments Matter shaping dietary behavior theme health crises diagnoses perceived mortal consequence food choices 2 Chronic Disease Perceptions Management Adaptation capturing burden rigid dietary restrictions conflicting recommendations dichotomy strict rule versus flexible healthy diet principles 3 Contextual Factors Influence Health Nutrition Adaptation highlighting impact social support military culture environmental influence food behaviors Veterans experience CKD nutrition management shaped pivotal health events rigid dietary frameworks militaryinfluenced eating habits socialemotional contextual factors Nutrition healthcare approach focus personalized flexible approach leveraging existing VAbased principle emphasize patientcentered care experience include supporting individual acknowledging urgency dietary decisionmaking capitalizing key moment intervention increasing awareness nutritions role health without reinforcing restrictive unsustainable dietary patterns",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779332/"
    },
    {
        "pmid": "40778913",
        "title": "[Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry].",
        "abstract": "Cardiovascular disease CVD chronic obstructive pulmonary disease COPD two leading cause death world Studies show close mutually aggravating relationship arterial hypertension AH COPD Antihypertensive therapy patient AH COPD number features aiming reduce risk developing cardiovascular complication mortality CVD without worsening lung function analyze data patient AH COPD included national registry determine burden CVD risk factors concomitant cardiovascular cerebrovascular disease chronic kidney disease obesity diabetes mellitus gout characteristic antihypertensive therapy comparative analysis patient hypertension registry conducted outpatient clinics performed depending presence ini3323 absence ini54073 chronic obstructive pulmonary disease Statistical analysis obtained data performed using R 433 statistical computing environment R Foundation Statistical Computing Vienna Austria prevalence COPD patient hypertension 58 3323 cases presence COPD patient hypertension regardless gender age statistically significantly associated higher odds coronary artery disease odds ratio OR 221 95 confidence interval CI 206238 ipi0001 history myocardial infarction OR 173 95 CI 159187 ipi0001 chronic heart failure OR 195 95 CI 18221 ipi0001 history acute cerebrovascular accident OR 125 95 CI 107146 ipi0004 transient ischemic attack OR 29 95 CI 231359 ipi0001 atrial fibrillation OR 168 95 CI 145193 ipi0001 Patients hypertension COPD often received drug group angiotensinII receptor antagonist patient hypertension without COPD 227 v 177 prescription drug group betablockers patient hypertension COPD lower 4 Cardiovascular risk factors comorbidities diabetes mellitus gout obstructive sleep apnea patient hypertension COPD common Patients COPD hypertension higher incidence risk factors CVD comorbid pathologies require closer attention examination selection antihypertensive therapy patient hypertension COPD angiotensinconvertingenzyme inhibitor betablockers prescribed less frequently patient hypertension without COPD due possible side effect contraindications",
        "mesh_terms": [
            "Humans",
            "Pulmonary Disease, Chronic Obstructive",
            "Male",
            "Female",
            "Registries",
            "Antihypertensive Agents",
            "Hypertension",
            "Middle Aged",
            "Comorbidity",
            "Aged",
            "Russia",
            "Prevalence",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778913/"
    },
    {
        "pmid": "40777989",
        "title": "Renal aging and its consequences: navigating the challenges of an aging population.",
        "abstract": "aggravation population aging kidney aging impact health widely concerned Renal aging involves structural functional change also significantly linked occurrence progression kidney diseases Mechanisms renal aging include oxidative stress reduced Klotho levels cellular senescence chronic inflammation change lead sustained reduction renal filtration reabsorption secretion well endocrine function turn affect overall health Renal structural change mainly include glomerulosclerosis tubular degeneration interstitial fibrosis structural change closely related decline kidney function may lead occurrence chronic kidney disease CKD addition elderly individual experience higher rate acute kidney injury AKI face poorer prospect recovery prevalence agerelated kidney disease especially diabetic nephropathy DN increase age Endstage renal disease ESRD refers advanced stage CKD kidney patient show sign premature aging compared healthy people Measures prevent delay renal aging daily life including healthy lifestyle proper diet adequate exercise also discussed manuscript",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777989/"
    },
    {
        "pmid": "40777564",
        "title": "A rare dermatological manifestation of follicular spicules in a patient with multiple myeloma and end-stage renal disease on hemodialysis: A case report.",
        "abstract": "Multiple myeloma MM hematological malignancy characterized clonal expansion malignant plasma cell within bone marrow leading diverse systemic complications cutaneous manifestation MM uncommon follicular spicule represent highly specific rare dermatological finding associated MM present study present case 59yearold man MM exhibited follicular acanthosis hyperkeratosis cutaneous indicator malignancy patient history stage 5 chronic kidney disease undergoing maintenance hemodialysis diagnosed follicular spicule MM FSMM clinical evaluation laboratory investigations present case highlight clinical importance recognizing rare cutaneous manifestation MM serve critical diagnostic clues Improved awareness FSMM may facilitate timely diagnosis optimize patient management ultimately contributing improved clinical outcome challenging population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777564/"
    },
    {
        "pmid": "40776944",
        "title": "Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists.",
        "abstract": "Cardiovascular CVkidneymetabolic CKM syndrome complex disorder characterized cooccurrence CV risk factors including chronic kidney disease CKD hypertension metabolic dysfunction creates vicious cycle one factor negatively impact others ultimately leading poor overall CV kidney outcomes Overactivation mineralocorticoid receptor binding aldosterone ligandindependent mechanisms implicated pathogenesis CKM mineralocorticoid receptor antagonist MRAs block interaction Steroidal MRAs currently recommended people heart failure HF reduced ejection fraction hypertension however role nonsteroidal MRAs CKM evolving Indeed steroidal MRAs demonstrated efficacy composite CVrelated mortality hospitalization elevated systolic blood pressure hospitalization worsening HF clinical trial individual HF CKD treatmentresistant hypertension Moreover nonsteroidal MRA finerenone demonstrated risk reduction composite CVrelated outcome CKD progression patient HF mildly reduced preserved ejection fraction people CKD associated type 2 diabetes Ongoing phase 3 trial evaluating efficacy safety nonsteroidal MRAs individual HF reduced ejection fraction well mildly reduced preserved ejection fraction potentially expanding role managing CKM conditions review examines current clinical evidence use MRAs people CKM syndrome",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776944/"
    },
    {
        "pmid": "40776292",
        "title": "A Personalized Chatbot to Support Kidney Disease Patients in Saudi Arabia: A Preliminary Study.",
        "abstract": "Chronic kidney disease CKD significant health issue worldwide study investigates potential personalized chatbots support kidney disease patient caregiver Saudi Arabia Using crosssectional design data collected via online questionnaire get insight patient preference willingness use chatbots kidney disease care Findings revealed high acceptance chatbot technology 955 participant willing engage virtual assistant Key feature identified include dietary guidance educational content psychological support study highlight chatbots potential address significant challenge limited knowledge high treatment costs dietary management insight provide foundation developing prototype chatbot tailored need kidney disease patient Saudi Arabia potential enhance healthcare accessibility patient quality life",
        "mesh_terms": [
            "Humans",
            "Saudi Arabia",
            "Cross-Sectional Studies",
            "Female",
            "Male",
            "Middle Aged",
            "Adult",
            "Renal Insufficiency, Chronic",
            "Surveys and Questionnaires",
            "Patient Education as Topic",
            "Patient Preference",
            "Aged",
            "Generative Artificial Intelligence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776292/"
    },
    {
        "pmid": "40776040",
        "title": "Personalized Prediction of Chronic Kidney Disease Progression in Patients with Chronic Kidney Disease Stages 3-5: A Multicenter Study Using the Machine Learning Approach.",
        "abstract": "Chronic Kidney Disease CKD prevalent progressive condition lead endstage renal disease ESRD left unmanaged Accurate prediction CKD progression particularly patient CKD stage 35 essential early intervention personalized treatment study utilized machine learning ML model predict decline estimated glomerular filtration rate eGFR one year models including LGBM Random Forest trained large cohort CKD patient Taipei Medical University Clinical Research Database TMUCRD LightGBM emerged topperforming model AUC value 076 082 predicting 5 25 decline eGFR respectively SHAP Shapley Additive Explanations analysis identified baseline eGFR eGFR slope BUN key predictive features result demonstrate utility ML CKD management highlight importance personalized prediction model improving patient outcomes",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "Disease Progression",
            "Renal Insufficiency, Chronic",
            "Glomerular Filtration Rate",
            "Female",
            "Male",
            "Precision Medicine",
            "Taiwan",
            "Middle Aged",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776040/"
    },
    {
        "pmid": "40775604",
        "title": "Identification of novel pathogenic mutations in <i>ATP6V0A4</i> associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease.",
        "abstract": "Distal renal tubular acidosis dRTA rare renal disorder caused genetic mutation secondary factors untreated result significant electrolyte imbalance progressive chronic kidney disease CKD study investigated key gene involved renal tubular acidbase regulation iSLC4A1i iATP6V1B1i iATP6V0A4i whole exome sequencing WES clinical cohort Notably patient iATP6V0A4i mutation diagnosed younger age mean 05 years exhibited severe renal impairment including reduced estimated glomerular filtration rate eGFR indicating heightened susceptibility kidney damage identified novel iATP6V0A4i mutation c2219C  T c1971G  C c2293c2296del AGCG confirmed pathogenicity using bioinformatics iin vitroi experiments demonstrated c1971G  C mutation disrupted mRNA splicing causing exon 5 skipping introducing premature termination codon c2293c2296del AGCG introduced premature termination codon c2219C  impaired protein expression intracellular pH regulation ATPase activity Additionally ATP6V0A4 expression decrease diabetes progression contributing tubular dysfunction development diabetic kidney disease DKD finding underscore crucial role ATP6V0A4 maintaining renal acidbase balance influence CKD progression importance genetic analysis early diagnosis personalized management dRTA",
        "mesh_terms": [
            "Humans",
            "Acidosis, Renal Tubular",
            "Vacuolar Proton-Translocating ATPases",
            "Male",
            "Female",
            "Exome Sequencing",
            "Mutation",
            "Glomerular Filtration Rate",
            "Infant",
            "Child, Preschool",
            "Child",
            "Anion Exchange Protein 1, Erythrocyte",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775604/"
    },
    {
        "pmid": "40775330",
        "title": "Prevalence and determinants of thirst distress amongst patients on maintenance haemodialysis.",
        "abstract": "Thirst xerostomia main cause poor adherence fluid restriction excessive intake fluid patient chronic haemodialysis Thirst distress defined degree person bothered thirst hence cause high interdialytic weight gain consequence cardiovascular death deterioration quality life hospitalbased crosssectional study carried 18th Dec 2023 11th April 2024 4 governmentfunded haemodialysis centre three randomly selected region Cameroon Patients received twiceweekly dialysis Three hundred patient maintenance haemodialysis 3 month evaluated thirst distress using thirst distress scale characteristics using structured questionnaire dialysis sessions 184 6133 patient thirst distress 123 577 patient Always thirsty 90 patient never consulted thirst distress Two hundred twelve 706 patient felt thirst well managed 194 647 patient felt thirst negative impact comfortable life were Strategies used patient avoid thirst included staying hot sun 256 853 drinking cold iced water 222 739 taking medication meal fluid 222 739 limiting salt food 192 642 xerostomia severity score significantly associated thirst distress p  0001  193 every patient perceived thirst adequately managed significant 389fold decrease TDS score p  0001  3896 Thirst distress negatively impacted quality life patient OR 076 p  0021 61 patient maintenance haemodialysis thirst distress patient never consulted thirst distress determinant thirst distress included xerostomia thirsty frequently well thirst patient felt negative impact comfortable life were applicable",
        "mesh_terms": [
            "Humans",
            "Thirst",
            "Male",
            "Renal Dialysis",
            "Female",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Prevalence",
            "Aged",
            "Xerostomia",
            "Adult",
            "Cameroon",
            "Kidney Failure, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775330/"
    },
    {
        "pmid": "40774919",
        "title": "Complexities in Variant Analysis, Classification, and Interpretation in Kidney Disease-Related Genes.",
        "abstract": "Advancements chronic kidney disease CKD genetic research nextgeneration sequencing improved CKD diagnosis personalized treatment Broad gene panel testing whole exomegenome sequencing greatly improved understanding genetic etiology kidney disease also increased complexity interpretation Standardized variant classification guideline help challenge remain due subjective evidence limited functional phenotypic data Careful consideration genetic clinical evidence along collaboration clinicians genetics experts laboratories essential accurate interpretation patient care article examines nephrology genetic testing focusing complexity variant analysis classification interpretation Variant classification monogenic kidney disease crucial accurate diagnosis patient management outline classification method highlighting several variant example using ACMGAMP framework quantitative approach pathogenicity assessment highlight challenge integrating genetic finding nephrology emphasize clinical impact accurate genetic diagnosis precision medicine CKD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774919/"
    },
    {
        "pmid": "40773437",
        "title": "Interventions to improve cognitive performance in chronic kidney disease: A scoping review.",
        "abstract": "Cognitive impairment commonly associated chronic kidney disease CKD number intervention approach potential improve cognitive performance CKD objective characterize intervention studied improve cognitive performance adult CKD across category severity including kidney failure Scoping review following JBI methodology Adults ≥18 years CKD kidney failure searched 5 electronic database study published April 5 2024 Eligible source primary research study investigated intervention targeting cognition adult ≥18 years CKD kidney failure Fulltext article screening performed duplicate Characteristics interventions population studied outcome investigated Descriptive statistic narrative syntheses Seventyone study included half n  37 52 conducted within past five years study n  47 66 targeted people maintenance hemodialysis therapy onethird study investigated pharmacological interventions much pharmacological medical research focusing anemia management dialysis adequacy Although recent research expanded focus many purported mechanism cognitive dysfunction CKD remain understudied interventional research Exercise training n  14 common nonpharmacological approach studied study explored promising nonpharmacological approach cognitive rehabilitation interventions Abstract screening performed duplicate nonEnglish study excluded Research cognitive intervention people kidney disease primarily focused hemodialysis population investigated erythropoietin stimulating agents frequent prolonged dialysis exercise although recent growth research activity interventions Future research aim address broader range purported pathophysiological mechanism cognitive impairment CKD investigate intervention predialysis peritoneal dialysis patients explore impact established cognitive rehabilitation approaches",
        "mesh_terms": [
            "Humans",
            "Renal Insufficiency, Chronic",
            "Cognition",
            "Cognitive Dysfunction",
            "Renal Dialysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773437/"
    },
    {
        "pmid": "40773030",
        "title": "Subaortic membrane in adult patients: retrospective study of clinical characteristics, outcomes, and echocardiographic associations and review of literature.",
        "abstract": "study aim describe clinical characteristics outcomes echocardiographic association subaortic membrane adult patients providing insight multifactorial etiology implication management retrospective study involved identifying patient underwent Transthoracic Echocardiography TTE past 10 year June 2013 June 2023 due clinical suspicion subaortic membrane received confirmed diagnosis subaortic membrane either TTE alone subsequent Transesophageal Echocardiogram TEE demographic patients including age diagnosis sex medical comorbidities aortic mitral valve disease hypertension history arrhythmias coronary artery disease heart failure diabetes mellitus chronic kidney disease included Features TTE documented subsequent surgical intervention recorded specifically subaortic membrane resection valve repair total 22 case studied mean age cohort 581 ± 106 years Common comorbidities included hypertension 636 obesity 454 heart failure 318 Quantitatively left ventricular LV ejection fraction varied normal 59764 moderately decreased 438 mean ejection fraction 659 ± 80 Diastolic dysfunction present various grades Six patient one ICU hospitalization 273 one patient one ICU hospitalization 45 subaortic membrane 909 visualized TTE Two patient possible finding suggestive subaortic membrane confirmed TEE 222 91 patient relatively benign course three patient 136 undergone surgical interventions majority patient survived 1722 773 Subaortic membrane rare condition limited incidence prevalence management data largescale study necessary investigate compile data establish guideline treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773030/"
    },
    {
        "pmid": "40771954",
        "title": "Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.",
        "abstract": "10yearold neutered male Ragdoll cat presented symptom anorexia nausea vomiting lethargy progressive weight loss Laboratory parameter clinical sign led diagnosis International Renal Interest Society IRIS Chronic Kidney Disease CKD Stage III Following basic supportive therapy clinical symptom subsided patient discharged home management Three month later cats condition worsened upon reassessment met diagnostic criterion IRIS CKD Stage IV 4 month guidelinedirected supportive care in accordance IRIS recommendations significant change clinical symptom laboratory markers cat continued exhibit cachectic condition Subsequently allogeneic adiposederived mesenchymal stem cell ADMSCs therapy 2 × 10sup6sup cellskg initiated via intravenous IV infusion administered weekly three consecutive weeks adverse events fever vomiting observed therapy Prior ADMSCs therapy cats serum creatinine SCr blood urea nitrogen BUN phosphorus P level normal reference ranges Three week final three ADMSC treatments SCr level returned reference range CKD Stage II BUN P level showed improving trend cats mental status appetite also improved Reevaluation according IRIS CKD staging criterion confirmed functional enhancement Stage IV Stage II subsequent followup period cats physical condition improved shown increase body weight improved Body Condition Score BCS normalization mucous membrane color Concurrently laboratory result revealed decrease key renal biomarkers SCr BUN P amelioration nonregenerative anemia case report suggests allogeneic ADMSCs potential therapeutic efficacy feline endstage CKD offering new possibility treatment terminal chronic kidney disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771954/"
    },
    {
        "pmid": "40771508",
        "title": "Nutrition Users' Guides: an introduction to structured guides to evaluate the nutrition literature.",
        "abstract": "Despite evidence nutrition play substantial role curbing burden chronic disease finding reported nutrition literature plagued debate uncertainty including question confidence place evidence observational studies validity dietary intake data applicability randomised trial realworld patient member public Structured nutrition users guide NUGs evaluate common research study design ie randomised trials cohort studies systematic review clinical practice guidelines addressing nutrition question help clinician patients well health service worker policymakers use evidence make informed decision disease management prevention addition NUGs provide comprehensive teaching material nutrition trainee appraise interpret apply research evidence hereby introduce series structured NUGs literature nutrients food dietary pattern programmes article address three key component assessing different study design used assess nutrition intervention exposures including 1 assessing methodological quality study 2 interpreting study result magnitude precision treatment exposure effect outcome benefit harm 3 applying result unique patient population scenario based healthrelated value preference related potential benefits harms convenience cost intervention series article serve empower clinicians health service worker health policymakers better understand validity interpretability applicability nutrition literature also helping practitioner client make evidencebased valuesensitive preferencesensitive nutrition decisions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771508/"
    },
    {
        "pmid": "40771113",
        "title": "From Metabolic Syndrome to Cardiovascular-Kidney-Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction.",
        "abstract": "landscape metabolic health evolved dramatically recent years viewed collection distinct conditions disorder like obesity type 2 diabetes cardiovascular disease chronic kidney disease fatty liver disease understood share common pathophysiological roots review explores transition traditional concept metabolic syndrome toward comprehensive clinically relevant frameworks namely cardiovascularkidneymetabolic CKM syndrome proposed American Heart Association systemic metabolic disorder SMD framework introduced European Atherosclerosis Society model recognize progressive multisystemic nature metabolic dysfunction highlight need stagebased risk stratification emphasize early intervention author discus central role dysfunctional adiposity ectopic fat driving organspecific damage examine growing body evidence supporting use novel therapy sodiumglucose cotransporter 2 SGLT2 inhibitors glucagonlike peptide1 receptor agonist GLP1RA gastric inhibitory polypeptide GIPGLP1RA delivering multiorgan protection comparing CKM SMD models author highlight complementary nature shared call shift clinical thinking away isolated management toward integrated multidisciplinary care burden metabolic dysfunction continues rise need recognize obesity chronic disease develop practical collaborative strategy across cardiology nephrology endocrinology hepatology becomes even urgent rise cardiometabolic medicine offer timely necessary response growing challenge creating opportunity better prevention earlier detection improved outcome patients",
        "mesh_terms": [
            "Humans",
            "Metabolic Syndrome",
            "Cardiovascular Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771113/"
    },
    {
        "pmid": "40770794",
        "title": "Prognostic value of left atrioventricular coupling index assessed by 3D echocardiography in patients with chronic kidney disease and heart failure with preserved ejection fraction.",
        "abstract": "evaluate prognostic value threedimensional echocardiographyderived left atrioventricular coupling index LACI patient chronic kidney disease CKD concomitant heart failure preserved ejection fraction HFpEF analysis 108 patient CKD combined HFpEF conducted Participants categorized three group based LACI difference clinical echocardiographic characteristic group assessed Independent association LACI clinical outcome assessed using Cox proportional hazard regression modeling addition analysis performed determine predictive performance LACI adverse cardiovascular event calculating area curve AUC optimal threshold median LACI study 025 stratified tertiles patient high LACI group  033 significantly older advanced CKD stages severe left ventricular diastolic dysfunction LVDD all P  005 increasing LACI levels proportion grade 1 LVDD progressively decreased grade 3 LVDD increased 7 21 58 P  0001 LACI ≥ 0235 demonstrated discriminative capability moderatetosevere LVDD AUC  0739 P  0001 Multivariable Cox proportional hazard regression confirmed LACI independent predictor major clinical outcome HR  132 95 CI 07920894 P  0001 optimal cutoff value 026 AUC  0843 P  0001 effectively stratified highrisk patient logrank P  0001 Net reclassification improvement NRI analysis demonstrated incorporating LACI significantly enhanced incremental predictive value traditional clinical models LACI quantified threedimensional echocardiography 3DE correlate severity LVDD LACI independent predictor adverse clinical outcome patient CKD combined HFpEF providing objective quantitative metric guide therapeutic decisionmaking highrisk population",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Heart Failure",
            "Renal Insufficiency, Chronic",
            "Aged",
            "Predictive Value of Tests",
            "Stroke Volume",
            "Echocardiography, Three-Dimensional",
            "Middle Aged",
            "Prognosis",
            "Ventricular Function, Left",
            "Risk Factors",
            "Atrial Function, Left",
            "Retrospective Studies",
            "Ventricular Dysfunction, Left",
            "Risk Assessment",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770794/"
    },
    {
        "pmid": "40770708",
        "title": "Whole exome sequencing and polygenic risk assessment for kidney functions and clinical management in both hospital-based cohort and population-based Asian cohorts.",
        "abstract": "Taiwan highest prevalence chronic kidney disease CKD endstage kidney disease ESKD globally making major public health concern significant morbidity mortality healthcare burden genetic risk factor kidney disease identified previous studies contribution rare genetic variant remains unclear study utilized wholeexome sequencing WES investigate role missense rare variant CKD ESKD susceptibility Genomic data 500 Taiwanese individual Taipei Medical University Hospital included based strict clinical diagnostic criteria comprising 200 CKD cases 200 ESKD cases 100 healthy controls Independent validation performed using ESKD Asian cohort Us Research Program AoU N  222 Tohoku Medical Megabank Organization ToMMo N  140 identified rare pathogenic variant known monogenic kidney disease genes including PKD1 COL4A4 confirming role disease susceptibility replicated GWASreported gene SPI1 RIN3 FTO SIPA1L3 EEF1E1 highlighting contribution common rare variants Beyond previously reported genes identified novel rare pathogenic variant PEX1 GANAB DYNC2H1 PROKR2 Pathway enrichment analysis suggested ciliopathies inflammation metabolic dysfunction may contribute kidney disease progression Furthermore polygenic score PGS ESKD demonstrated strong predictive utility kidney function high genetic risk greater influence comorbidities diabetes overweight prediction power ESKD PGS confirmed AoU Asian population study provides novel insight genetic architecture CKD ESKD Taiwanese population utilizing hospitalbased cohort strict clinical diagnostic criterion ensure precise phenotype classification propose individual high genetic risk may benefit earlier interventions lower PGS may better managed lifestyle modification targeting comorbidities finding highlight importance preventive strategy precision medicine kidney disease management",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Exome Sequencing",
            "Middle Aged",
            "Renal Insufficiency, Chronic",
            "Taiwan",
            "Cohort Studies",
            "Multifactorial Inheritance",
            "Kidney Failure, Chronic",
            "Adult",
            "Genetic Predisposition to Disease",
            "Risk Assessment",
            "Asian People",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770708/"
    },
    {
        "pmid": "40770657",
        "title": "Glycemic index of some protein-free food products for individuals with non-dialysis-dependent chronic kidney disease.",
        "abstract": "Chronic kidney disease CKD major public health issue third leading cause death globally conservative phase CKD lowprotein diet recommended slow disease progression proteinfree product commonly used clinical nutrition CKD Since diabetes highly prevalent population crucial food also low glycemic index GI support glycemic control reduce associated complications study aimed assess GI selected commercial proteinfree products Twelve healthy volunteer six males six females mean age 207 ± 08 years BMI 226 ± 36 kgm² consumed four commonly available proteinfree foods sliced white bread pasta crackers cooky filled vanilla cream with sweeteners GI product calculated according ISO 2010 standards using glucose reference test meal provided 50 g available carbohydrates GI value ranged 48 cooky filled vanilla cream 69 crackers Sliced white bread GI 494 cooky GI 478 classified lowGI foods pasta GI 682 cracker GI 692 fell within mediumGI range Several commercially available proteinfree product exhibit low moderate GI values supporting use dietary management patient nondialysisdependent CKD risk diabetes However given growing market products studiesincluding patient CKDare needed expand current evidence base",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770657/"
    },
    {
        "pmid": "40769320",
        "title": "UV Spectrophotometric analysis of phosphate content in plant-based milk alternatives in relation to Advanced Chronic Kidney Disease.",
        "abstract": "Managing dietary phosphorus critical advanced chronic kidney disease CKD excess intake lead complication hyperphosphataemia Plantbased milk alternative PBMAs increasingly consumed yet phosphorus content particularly relation phosphate additives remains poorly defined UK study aimed quantify compare total phosphorus content phosphorustoprotein ratio PPR range commercially available UK PBMAs without phosphate additives using UV spectrophotometric analysis Fourteen PBMAs from seven plant sources analysed using molybdenum blue method Samples categorised based presence absence phosphate additives Phosphorus content mg100g PPR mgg protein calculated compared previously documented data cows milk PBMAs phosphate additive contained significantly higher phosphorus level mean 5847 mg100g without mean 738 mg100g p  001 Similarly PPR substantially higher additivecontaining PBMAs mean 19776 mgg versus additivefree option mean 1625 mgg p  001 PBMAs additive phosphorus content PPR value exceeding cows milk raising concern phosphate management CKD Phosphate additive significantly increase phosphorus load PPR PBMAs may readily apparent consumer clinician due insufficient labelling patient advanced CKD selecting additivefree PBMAs may support better phosphorus control dietary management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769320/"
    },
    {
        "pmid": "40769236",
        "title": "Metabolic syndrome, ischemic heart disease, and heart failure: insights from the Colombian Heart Failure Registry (RECOLFACA).",
        "abstract": "Ischemic heart disease IHD still leading cause morbidity mortality worldwide major implication healthcare systems especially low middleincome countries Effective metabolic control risk factor management including evidencebased pharmacological therapy statins ACE inhibitor ACEIs angiotensin receptorneprilysin inhibitor ARNIs essential reducing adverse outcomes However gap persist implementation therapies particularly resourcelimited regions evaluate metabolic control use evidencebased therapy patient IHD enrolled Colombian Heart Failure Registry RECOLFACA identify barrier optimal treatment implementation crosssectional study analyzed demographic clinical biochemical data well medication usage patient confirmed IHD Descriptive inferential statistical analysis performed identify treatment pattern associated factors Among 2528 patient heart failure HF 1123 IHD Statins prescribed 736 827 antiplatelets 663 745 ARNIs 101 114 despite guideline recommendations Statin use notably low among patient chronic kidney disease CKD 181 diabetes mellitus type 2 158 condition combined 32 Despite robust evidence supporting efficacy use statins ACEIs ARNIs remains suboptimal Colombia Addressing barrier access adherence healthcare delivery crucial improve outcome align clinical practice international standards finding highlight need targeted intervention future study evaluate strategy enhance access adherence guidelinedirected therapies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769236/"
    },
    {
        "pmid": "40768492",
        "title": "Limited predictive value of traditional comorbidities for readmission in acute decompensated heart failure.",
        "abstract": "Common comorbidities heart failure HF including chronic kidney disease CKD diabetes mellitus DM ischemic heart disease IHD atrial fibrillation frequently presumed predict hospital readmission However recent study challenged predictive strength raising question clinical utility risk stratification conducted retrospective cohort study 7652 patient admitted acute decompensated heart failure ADHF tertiary center 2007 2017 Associations comorbidities readmission 30 100 day assessed using FineGray competing risk models death competing event Subdistribution hazard ratio sHRs reported Model performance evaluated using receiver operating characteristic ROC analysis area curve AUC values assessing individual comorbidities incremental combinations comorbidities included irrespective univariable significance based clinical relevance Several comorbidities significantly associated readmission including CKD sHR 116123 DM sHR 118127 IHD sHR 110115 anemia sHR 111 However predictive power poor 30day readmission AUC value ranged 0516 COPD 0529 CKD maximal AUC 0555 combining four strongest predictors 100day readmission AUC value ranged 0528 DM 0545 CKD maximal combined AUC 0593 Despite consistent statistical associations common comorbidities perform poorly predictive tool identifying individual patient risk HF readmission finding highlight need robust risk model integrating dynamic clinical laboratory patientcentered factors",
        "mesh_terms": [
            "Humans",
            "Heart Failure",
            "Patient Readmission",
            "Male",
            "Female",
            "Aged",
            "Comorbidity",
            "Retrospective Studies",
            "Middle Aged",
            "Aged, 80 and over",
            "Renal Insufficiency, Chronic",
            "Risk Factors",
            "ROC Curve",
            "Diabetes Mellitus",
            "Risk Assessment",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768492/"
    },
    {
        "pmid": "40768478",
        "title": "Mediating effects of mental and physical health on the association between chronic disease conditions and colorectal cancer screening utilization among breast cancer survivors.",
        "abstract": "Breast cancer survivor increased risk colorectal cancer CRC chronic disease likely experience poor mental physical health study examined mediating effect mental physical health association chronic disease condition guidelineconcordant colorectal cancer CRC screening among breast cancer survivors included 1885 breast cancer survivor aged 4575 year eligible CRC screening 2016 2018 2020 Behavioral Risk Factor Surveillance System exposure chronic disease defined prevalent diabetes coronary heart diseasemyocardial infarction stroke chronic obstructive pulmonary disease emphysemachronic bronchitis arthritis depressive disorders kidney diseases outcome receipt guidelineconcordant CRC screening Mediators defined selfreported frequent poor mentalphysical health past 30 day 1430 vs 013 days Multivariable logistic regression model adjusted sociodemographic cancerrelated factors used method proposed Valeri  VanderWeele mediation analyses Breast cancer survivor chronic disease 17fold likely CRC screening compared without chronic disease OR 168 95 CI 127221 mediation analysis found frequent poor mental health mediated association chronic disease condition CRC screening utilization 44 mediated pvalue  0035 also observed reduction frequent poor physical health 105 pvalue  0008 Frequent poor mental physical health negatively mediated association presence chronic disease CRC screening utilization higher estimate poor physical health Effective implementation integrated followup care needed among breast cancer survivor address chronic disease management prioritize mental physical health patient receive guideline concordant CRC screening recommendations",
        "mesh_terms": [
            "Humans",
            "Female",
            "Breast Neoplasms",
            "Colorectal Neoplasms",
            "Middle Aged",
            "Cancer Survivors",
            "Aged",
            "Early Detection of Cancer",
            "Chronic Disease",
            "Mental Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768478/"
    }
]